{"idx": 0, "sentence": "BRCA0 is secreted and exhibits properties of a granin .", "entities": []}
{"idx": 1, "sentence": "Germline mutations in BRCA0 are responsible for most cases of inherited breast and ovarian cancer .", "entities": [{"start": 10, "end": 15, "span": "inherited breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 2, "sentence": "However , the function of the BRCA0 protein has remained elusive .", "entities": []}
{"idx": 3, "sentence": "We now show that BRCA0 encodes a 0 - kD protein with sequence homology and biochemical analogy to the granin protein family .", "entities": []}
{"idx": 4, "sentence": "Interestingly , BRCA0 also includes a motif similar to the granin consensus at the C terminus of the protein .", "entities": []}
{"idx": 5, "sentence": "Both BRCA0 and the granins localize to secretory vesicles , are secreted by a regulated pathway , are post - translationally glycosylated and are responsive to hormones .", "entities": []}
{"idx": 6, "sentence": "As a regulated secretory protein , BRCA0 appears to function by a mechanism not previously described for tumour suppressor gene products . .", "entities": [{"start": 17, "end": 18, "span": "tumour", "e_type": "Disease"}]}
{"idx": 7, "sentence": "Ovarian cancer risk in BRCA0 carriers is modified by the HRAS0 variable number of tandem repeat ( VNTR ) locus .", "entities": [{"start": 0, "end": 2, "span": "Ovarian cancer", "e_type": "Disease"}]}
{"idx": 8, "sentence": "Women who carry a mutation in the BRCA0 gene ( on chromosome 00q00 ) , have an 0 % risk of breast cancer and a 0 % risk of ovarian cancer by the age of 0 ( ref . 0 ) .", "entities": [{"start": 21, "end": 23, "span": "breast cancer", "e_type": "Disease"}, {"start": 29, "end": 31, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 9, "sentence": "The variable penetrance of BRCA0 suggests that other genetic and non - genetic factors play a role in tumourigenesis in these individuals .", "entities": []}
{"idx": 10, "sentence": "The HRAS0 variable number of tandem repeats ( VNTR ) polymorphism , located 0 kilobase ( kb ) downstream of the HRAS0 proto - oncogene ( chromosome 00p00 . 0 ) is one possible genetic modifier of cancer penetrance .", "entities": [{"start": 37, "end": 38, "span": "cancer", "e_type": "Disease"}]}
{"idx": 11, "sentence": "Individuals who have rare alleles of the VNTR have an increased risk of certain types of cancers , including breast cancer ( 0 - 0 ) .", "entities": [{"start": 16, "end": 17, "span": "cancers", "e_type": "Disease"}, {"start": 19, "end": 21, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 12, "sentence": "To investigate whether the presence of rare HRAS0 alleles increases susceptibility to hereditary breast and ovarian cancer , we have typed a panel of 0 female BRCA0 carriers at this locus using a PCR - based technique .", "entities": [{"start": 12, "end": 17, "span": "hereditary breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 13, "sentence": "The risk for ovarian cancer was 0 .", "entities": [{"start": 3, "end": 5, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 14, "sentence": "0 times greater for BRCA0 carriers harbouring one or two rare HRAS0 alleles , compared to carriers with only common alleles ( P = 0 . 0 ) .", "entities": []}
{"idx": 15, "sentence": "The magnitude of the relative risk associated with a rare HRAS0 allele was not altered by adjusting for the other known risk factors for hereditary ovarian cancer ( 0 ) .", "entities": [{"start": 24, "end": 27, "span": "hereditary ovarian cancer", "e_type": "Disease"}]}
{"idx": 16, "sentence": "Susceptibility to breast cancer did not appear to be affected by the presence of rare HRAS0 alleles .", "entities": [{"start": 2, "end": 4, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 17, "sentence": "This study is the first to show the effect of a modifying gene on the penetrance of an inherited cancer syndrome", "entities": [{"start": 18, "end": 21, "span": "inherited cancer syndrome", "e_type": "Disease"}]}
{"idx": 18, "sentence": "A novel homeodomain - encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable ( CTG ) n repeat .", "entities": [{"start": 16, "end": 18, "span": "myotonic dystrophy", "e_type": "Disease"}]}
{"idx": 19, "sentence": "Myotonic dystrophy ( DM ) is associated with a ( CTG ) n trinucleotide repeat expansion in the 0 - untranslated region of a protein kinase - encoding gene , DMPK , which maps to chromosome 00q00 .", "entities": [{"start": 0, "end": 2, "span": "Myotonic dystrophy", "e_type": "Disease"}, {"start": 3, "end": 4, "span": "DM", "e_type": "Disease"}]}
{"idx": 20, "sentence": "0 .", "entities": []}
{"idx": 21, "sentence": "Characterisation of the expression of this gene in patient tissues has thus far generated conflicting data on alterations in the steady state levels of DMPK mRNA , and on the final DMPK protein levels in the presence of the expansion .", "entities": []}
{"idx": 22, "sentence": "The DM region of chromosome 0 is gene rich , and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity , perhaps as a consequence of chromatin disruption .", "entities": [{"start": 1, "end": 2, "span": "DM", "e_type": "Disease"}]}
{"idx": 23, "sentence": "We have searched for genes associated with a CpG island at the 0 end of DMPK .", "entities": []}
{"idx": 24, "sentence": "Sequencing of this region shows that the island extends over 0 .", "entities": []}
{"idx": 25, "sentence": "0 kb and is interrupted by the ( CTG ) n repeat .", "entities": []}
{"idx": 26, "sentence": "Comparison of genomic sequences downstream ( centromeric ) of the repeat in human and mouse identified regions of significant homology .", "entities": []}
{"idx": 27, "sentence": "These correspond to exons of a gene predicted to encode a homeodomain protein .", "entities": []}
{"idx": 28, "sentence": "RT - PCR analysis shows that this gene , which we have called DM locus - associated homeodomain protein ( DMAHP ) , is expressed in a number of human tissues , including skeletal muscle , heart and brain .", "entities": [{"start": 13, "end": 14, "span": "DM", "e_type": "Disease"}]}
{"idx": 29, "sentence": "Germline mutations in the RB0 gene in patients with hereditary retinoblastoma .", "entities": [{"start": 9, "end": 11, "span": "hereditary retinoblastoma", "e_type": "Disease"}]}
{"idx": 30, "sentence": "We have analyzed the 0 exons and the promoter region of the RB0 gene in familial or sporadic bilateral retinoblastoma by using single - strand conformation polymorphism analysis .", "entities": [{"start": 15, "end": 20, "span": "familial or sporadic bilateral retinoblastoma", "e_type": "Disease"}]}
{"idx": 31, "sentence": "For improvement over previous studies , a new set of primers has been designed , which allow for amplification of the coding and splicing sequences only .", "entities": []}
{"idx": 32, "sentence": "The positioning of the polymerase chain reaction ( PCR ) primers was such that the resulting PCR products were of different sizes , which enabled us to analyze two different exons simultaneously and still distinguish between the banding profiles for both ( biplex analysis ) .", "entities": []}
{"idx": 33, "sentence": "By using this approach , we were able to identify mutation in 0 new patients , but the overall efficiency of the procedure when we used a single - pass regimen was only 0 % .", "entities": []}
{"idx": 34, "sentence": "The mutations were small insertions and deletions and point mutations in roughly equal proportions . .", "entities": []}
{"idx": 35, "sentence": "Type II human complement C2 deficiency .", "entities": [{"start": 0, "end": 6, "span": "Type II human complement C2 deficiency", "e_type": "Disease"}]}
{"idx": 36, "sentence": "Allele - specific amino acid substitutions ( Ser000 - - > Phe ; Gly000 - - > Arg ) cause impaired C0 secretion .", "entities": []}
{"idx": 37, "sentence": "Type II complement protein C2 deficiency is characterized by a selective block in C0 secretion .", "entities": [{"start": 0, "end": 6, "span": "Type II complement protein C2 deficiency", "e_type": "Disease"}]}
{"idx": 38, "sentence": "The Type II C0 null allele ( C0Q0 ) is linked to two major histocompatibility haplotypes ( MHC ) that differ from the MHC of the more common Type I C2 deficiency .", "entities": [{"start": 28, "end": 32, "span": "Type I C2 deficiency", "e_type": "Disease"}]}
{"idx": 39, "sentence": "To determine the molecular basis of Type II deficiency the two Type II C0Q0 genes were isolated and transfected separately into L - cells .", "entities": [{"start": 6, "end": 9, "span": "Type II deficiency", "e_type": "Disease"}]}
{"idx": 40, "sentence": "Subsequent molecular biology , biosynthetic , and immunofluorescence studies demonstrated that C0 secretion is impaired in Type II C2 deficiency because of different missense mutations at highly conserved residues in each of the C0Q0 alleles .", "entities": [{"start": 16, "end": 20, "span": "Type II C2 deficiency", "e_type": "Disease"}]}
{"idx": 41, "sentence": "One is in exon 0 ( nucleotide C000 - - > T ; Ser000 - - > Phe ) of the C0Q0 gene linked to the MHC haplotype A00 , B00 , DRw0 , BFS , C0A0B0 .", "entities": []}
{"idx": 42, "sentence": "The other is in exon 0 ( G0000 - - > A ; Gly000 - - > Arg ) of the C0Q0 gene linked to the MHC haplotype A0 , B0 , DRw0 , BFS , C0A0B0 .", "entities": []}
{"idx": 43, "sentence": "Each mutant C0 gene product is retained early in the secretory pathway .", "entities": []}
{"idx": 44, "sentence": "These mutants provide models for elucidating the C0 secretory pathway . .", "entities": []}
{"idx": 45, "sentence": "Defective dimerization of von Willebrand factor subunits due to a Cys - > Arg mutation in type IID von Willebrand disease .", "entities": [{"start": 3, "end": 5, "span": "von Willebrand", "e_type": "Disease"}, {"start": 16, "end": 21, "span": "type IID von Willebrand disease", "e_type": "Disease"}]}
{"idx": 46, "sentence": "The same heterozygous T - > C transition at nt 0 of the von Willebrand factor ( vWF ) transcript was found in two unrelated patients with type IID von Willebrand disease , with no other apparent abnormality .", "entities": [{"start": 13, "end": 15, "span": "von Willebrand", "e_type": "Disease"}, {"start": 27, "end": 32, "span": "type IID von Willebrand disease", "e_type": "Disease"}]}
{"idx": 47, "sentence": "In one family , both alleles were normal in the parents and one sister ; thus , the mutation originated de novo in the proposita .", "entities": []}
{"idx": 48, "sentence": "The second patient also had asymptomatic parents who , however , were not available for study .", "entities": []}
{"idx": 49, "sentence": "The structural consequences of the identified mutation , resulting in the CyS0000 - > Arg substitution , were evaluated by expression of the vWF carboxyl - terminal domain containing residues 0 - 0 .", "entities": []}
{"idx": 50, "sentence": "Insect cells infected with recombinant baculovirus expressing normal vWF sequence secreted a disulfide linked dimeric molecule with an apparent molecular mass of 0 kDa before reduction , yielding a single band of 0 kDa after disulfide bond reduction .", "entities": []}
{"idx": 51, "sentence": "In contrast , cells expressing the mutant fragment secreted a monomeric molecule of apparent molecular mass of 0 kDa , which remained unchanged after reduction .", "entities": []}
{"idx": 52, "sentence": "We conclude that CyS0000 is essential for normal dimerization of vWF subunits through disulfide bonding of carboxyl - terminal domains and that a heterozygous mutation in the corresponding codon is responsible for defective multimer formation in type IID von Willebrand disease . .", "entities": [{"start": 36, "end": 41, "span": "type IID von Willebrand disease", "e_type": "Disease"}]}
{"idx": 53, "sentence": "Wiskott - Aldrich syndrome protein , a novel effector for the GTPase CDC00Hs , is implicated in actin polymerization .", "entities": [{"start": 0, "end": 4, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 54, "sentence": "The Rho family of GTPases control diverse biological processes , including cell morphology and mitogenesis .", "entities": []}
{"idx": 55, "sentence": "We have identified WASP , the protein that is defective in Wiskott - Aldrich syndrome ( WAS ) , as a novel effector for CDC00Hs , but not for the other Rho family members , Rac and Rho .", "entities": [{"start": 11, "end": 15, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}, {"start": 16, "end": 17, "span": "WAS", "e_type": "Disease"}]}
{"idx": 56, "sentence": "This interaction is dependent on the presence of the G protein - binding domain .", "entities": []}
{"idx": 57, "sentence": "Cellular expression of epitope - tagged WASP produces clusters of WASP that are highly enriched in polymerized actin .", "entities": []}
{"idx": 58, "sentence": "This clustering is not observed with a C - terminally deleted WASP and is inhibited by coexpression with dominant negative CDC00Hs - N00 , but not with dominant negative forms of Rac or Rho .", "entities": []}
{"idx": 59, "sentence": "Thus , WASP provides a novel link between CDC00Hs and the actin cytoskeleton , which suggests a molecular mechanism for many of the cellular abnormalities in WAS .", "entities": [{"start": 26, "end": 27, "span": "WAS", "e_type": "Disease"}]}
{"idx": 60, "sentence": "The WASP sequence contains two novel domains that are homologous to other proteins involved in action organization . .", "entities": []}
{"idx": 61, "sentence": "X - linked adrenoleukodystrophy is a frequent cause of idiopathic Addison ' s disease in young adult male patients .", "entities": [{"start": 0, "end": 4, "span": "X - linked adrenoleukodystrophy", "e_type": "Disease"}, {"start": 10, "end": 14, "span": "Addison ' s disease", "e_type": "Disease"}]}
{"idx": 62, "sentence": "X - Linked adrenoleukodystrophy ( ALD ) is a genetic disease associated with demyelination of the central nervous system , adrenal insufficiency , and accumulation of very long chain fatty acids in tissue and body fluids .", "entities": [{"start": 0, "end": 4, "span": "X - Linked adrenoleukodystrophy", "e_type": "Disease"}, {"start": 5, "end": 6, "span": "ALD", "e_type": "Disease"}, {"start": 9, "end": 11, "span": "genetic disease", "e_type": "Disease"}, {"start": 13, "end": 19, "span": "demyelination of the central nervous system", "e_type": "Disease"}, {"start": 20, "end": 22, "span": "adrenal insufficiency", "e_type": "Disease"}]}
{"idx": 63, "sentence": "ALD is due to mutation of a gene located in Xq00 that encodes a peroxisomal transporter protein of unknown function .", "entities": [{"start": 0, "end": 1, "span": "ALD", "e_type": "Disease"}]}
{"idx": 64, "sentence": "The most common phenotype of ALD is the cerebral form ( 0 % ) that develops in boys between 0 - 0 yr .", "entities": [{"start": 5, "end": 6, "span": "ALD", "e_type": "Disease"}]}
{"idx": 65, "sentence": "Adrenomyeloneuropathy ( AMN ) involves the spinal cord and peripheral nerves in young adults ( 0 % ) .", "entities": [{"start": 0, "end": 1, "span": "Adrenomyeloneuropathy", "e_type": "Disease"}, {"start": 2, "end": 3, "span": "AMN", "e_type": "Disease"}]}
{"idx": 66, "sentence": "Adrenal insufficiency ( Addisons disease ) is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD ( 0 % of cases ) .", "entities": [{"start": 0, "end": 2, "span": "Adrenal insufficiency", "e_type": "Disease"}, {"start": 3, "end": 5, "span": "Addisons disease", "e_type": "Disease"}, {"start": 10, "end": 11, "span": "AMN", "e_type": "Disease"}, {"start": 12, "end": 14, "span": "cerebral ALD", "e_type": "Disease"}, {"start": 22, "end": 23, "span": "ALD", "e_type": "Disease"}]}
{"idx": 67, "sentence": "The prevalence of ALD among adults with Addisons disease remains unknown .", "entities": [{"start": 3, "end": 4, "span": "ALD", "e_type": "Disease"}, {"start": 7, "end": 9, "span": "Addisons disease", "e_type": "Disease"}]}
{"idx": 68, "sentence": "To evaluate this prevalence , we performed biochemical analysis of very long chain fatty acids in 0 male patients ( age ranging from 0 - 0 yr at diagnosis ) previously diagnosed as having primary idiopathic adrenocortical insufficiency .", "entities": [{"start": 36, "end": 38, "span": "adrenocortical insufficiency", "e_type": "Disease"}]}
{"idx": 69, "sentence": "In 0 of 0 patients ( 0 % ) , elevated plasma concentrations of very long chain fatty acids were detected .", "entities": []}
{"idx": 70, "sentence": "None of these patients had adrenocortical antibodies .", "entities": []}
{"idx": 71, "sentence": "By electrophysiological tests and magnetic resonance imaging it was determined that two patients had cerebral ALD , one had adrenomyeloneuropathy with cerebral involvement , and two had preclinical AMN .", "entities": [{"start": 14, "end": 16, "span": "cerebral ALD", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "adrenomyeloneuropathy", "e_type": "Disease"}, {"start": 28, "end": 29, "span": "AMN", "e_type": "Disease"}]}
{"idx": 72, "sentence": "Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults . .", "entities": [{"start": 6, "end": 7, "span": "ALD", "e_type": "Disease"}, {"start": 13, "end": 15, "span": "Addisons disease", "e_type": "Disease"}]}
{"idx": 73, "sentence": "Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 00pter - q00 .", "entities": [{"start": 0, "end": 1, "span": "Tumor", "e_type": "Disease"}, {"start": 6, "end": 8, "span": "prostate carcinoma", "e_type": "Disease"}]}
{"idx": 74, "sentence": "Prostate cancer is the second leading cause of male cancer deaths in the United States .", "entities": [{"start": 0, "end": 2, "span": "Prostate cancer", "e_type": "Disease"}, {"start": 9, "end": 10, "span": "cancer", "e_type": "Disease"}]}
{"idx": 75, "sentence": "Yet , despite a large international effort , little is known about the molecular mechanisms that underlie this devastating disease .", "entities": []}
{"idx": 76, "sentence": "Prostate secretory epithelial cells and androgen - dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and , furthermore , most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression .", "entities": [{"start": 8, "end": 10, "span": "prostate carcinomas", "e_type": "Disease"}, {"start": 22, "end": 24, "span": "prostate carcinomas", "e_type": "Disease"}]}
{"idx": 77, "sentence": "Definition of the genetic events that trigger apoptosis in the prostate could provide important insights into critical pathways in normal development as well as elucidate the perturbations of those key pathways in neoplastic transformation .", "entities": []}
{"idx": 78, "sentence": "We report the functional definition of a novel genetic locus within human chromosome 00pter - q00 that mediates both in vivo tumor suppression and in vitro apoptosis of prostatic adenocarcinoma cells .", "entities": [{"start": 28, "end": 30, "span": "prostatic adenocarcinoma", "e_type": "Disease"}]}
{"idx": 79, "sentence": "A defined fragment of human chromosome 0 was transferred via microcell fusion into a prostate adenocarcinoma cell line .", "entities": [{"start": 14, "end": 16, "span": "prostate adenocarcinoma", "e_type": "Disease"}]}
{"idx": 80, "sentence": "Microcell hybrids containing only the region 00pter - q00 were suppressed for tumorigenicity following injection of microcell hybrids into nude mice .", "entities": []}
{"idx": 81, "sentence": "Furthermore , the complemented hybrids undergo programmed cell death in vitro via a mechanism that does not require nuclear localization of p00 .", "entities": []}
{"idx": 82, "sentence": "These data functionally define a novel genetic locus , designated PAC0 , for prostate adenocarcinoma 0 , involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma . .", "entities": [{"start": 23, "end": 25, "span": "prostate carcinoma", "e_type": "Disease"}, {"start": 39, "end": 41, "span": "prostatic adenocarcinoma", "e_type": "Disease"}]}
{"idx": 83, "sentence": "Low incidence of BRCA0 mutations in breast carcinoma and other cancers .", "entities": [{"start": 6, "end": 8, "span": "breast carcinoma", "e_type": "Disease"}, {"start": 10, "end": 11, "span": "cancers", "e_type": "Disease"}]}
{"idx": 84, "sentence": "Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer .", "entities": [{"start": 5, "end": 6, "span": "tumour", "e_type": "Disease"}, {"start": 14, "end": 15, "span": "cancer", "e_type": "Disease"}]}
{"idx": 85, "sentence": "In addition to an involvement in inherited susceptibility to cancer , these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms .", "entities": [{"start": 9, "end": 10, "span": "cancer", "e_type": "Disease"}, {"start": 12, "end": 13, "span": "tumour", "e_type": "Disease"}, {"start": 21, "end": 23, "span": "sporadic cancers", "e_type": "Disease"}]}
{"idx": 86, "sentence": "An exception is BRCA0 , which contributes to a significant fraction of familial breast and ovarian cancer , but undergoes mutation at very low rates in sporadic breast and ovarian cancers .", "entities": [{"start": 12, "end": 17, "span": "familial breast and ovarian cancer", "e_type": "Disease"}, {"start": 26, "end": 31, "span": "sporadic breast and ovarian cancers", "e_type": "Disease"}]}
{"idx": 87, "sentence": "This finding suggests that other genes may be the principal targets for somatic mutation in breast carcinoma .", "entities": [{"start": 15, "end": 17, "span": "breast carcinoma", "e_type": "Disease"}]}
{"idx": 88, "sentence": "A second , recently identified familial breast cancer gene , BRCA0 ( refs 0 - 0 ) , accounts for a proportion of breast cancer roughly equal to BRCA0 .", "entities": [{"start": 5, "end": 8, "span": "familial breast cancer", "e_type": "Disease"}, {"start": 23, "end": 25, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 89, "sentence": "Like BRCA0 , BRCA0 behaves as a dominantly inherited tumour suppressor gene .", "entities": [{"start": 9, "end": 10, "span": "tumour", "e_type": "Disease"}]}
{"idx": 90, "sentence": "Individuals who inherit one mutant allele are at increased risk for breast cancer , and the tumours they develop lose the wild - type allele by heterozygous deletion .", "entities": [{"start": 11, "end": 13, "span": "breast cancer", "e_type": "Disease"}, {"start": 16, "end": 17, "span": "tumours", "e_type": "Disease"}]}
{"idx": 91, "sentence": "The BRCA0 coding sequence is huge , composed of 0 exons that span 0 , 0 bp .", "entities": []}
{"idx": 92, "sentence": "Here we investigate the rate of BRCA0 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types .", "entities": [{"start": 9, "end": 12, "span": "sporadic breast cancers", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "tumour", "e_type": "Disease"}]}
{"idx": 93, "sentence": "Surprisingly , mutations in BRCA0 are infrequent in cancers including breast carcinoma .", "entities": [{"start": 8, "end": 9, "span": "cancers", "e_type": "Disease"}, {"start": 10, "end": 12, "span": "breast carcinoma", "e_type": "Disease"}]}
{"idx": 94, "sentence": "However , a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA0 in susceptibility to pancreatic cancer . .", "entities": [{"start": 8, "end": 10, "span": "pancreatic tumour", "e_type": "Disease"}, {"start": 20, "end": 22, "span": "pancreatic cancer", "e_type": "Disease"}]}
{"idx": 95, "sentence": "Founding BRCA0 mutations in hereditary breast and ovarian cancer in southern Sweden .", "entities": [{"start": 4, "end": 9, "span": "hereditary breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 96, "sentence": "Nine different germ - line mutations in the BRCA0 breast and ovarian cancer susceptibility gene were identified in 0 of 0 kindreds from southern Sweden , by use of SSCP and heteroduplex analysis of all exons and flanking intron region and by a protein - truncation test for exon 0 , followed by direct sequencing .", "entities": [{"start": 9, "end": 13, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 97, "sentence": "All but one of the mutations are predicted to give rise to premature translation termination and include seven frameshift insertions or deletions , a nonsense mutation , and a splice acceptor site mutation .", "entities": []}
{"idx": 98, "sentence": "The remaining mutation is a missense mutation ( Cys00Gly ) in the zinc - binding motif .", "entities": []}
{"idx": 99, "sentence": "Four novel Swedish founding mutations were identified the nucleotide 0 deletion A was found in five families , the C 0 T nonsense mutation in three families , the 0 insertion TGAGA in three families , and the nucleotide 0 deletion 0 in two families .", "entities": []}
{"idx": 100, "sentence": "Analysis of the intragenic polymorphism D00S000 supports common origins of the mutations .", "entities": []}
{"idx": 101, "sentence": "Eleven of the 0 kindreds manifesting BRCA0 mutations were breast - ovarian cancer families , several of them with a predominant ovarian cancer phenotype .", "entities": [{"start": 9, "end": 13, "span": "breast - ovarian cancer", "e_type": "Disease"}, {"start": 21, "end": 23, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 102, "sentence": "The set of 0 families in which no BRCA0 alterations were detected included 0 breast - ovarian cancer kindred manifesting clear linkage to the BRCA0 region and loss of the wild - type chromosome in associated tumors .", "entities": [{"start": 14, "end": 18, "span": "breast - ovarian cancer", "e_type": "Disease"}, {"start": 36, "end": 37, "span": "tumors", "e_type": "Disease"}]}
{"idx": 103, "sentence": "Other tumor types found in BRCA0 mutation / haplotype carriers included prostatic , pancreas , skin , and lung cancer , a malignant melanoma , an oligodendroglioma , and a carcinosarcoma .", "entities": [{"start": 1, "end": 2, "span": "tumor", "e_type": "Disease"}, {"start": 11, "end": 20, "span": "prostatic , pancreas , skin , and lung cancer", "e_type": "Disease"}, {"start": 22, "end": 24, "span": "malignant melanoma", "e_type": "Disease"}, {"start": 26, "end": 27, "span": "oligodendroglioma", "e_type": "Disease"}, {"start": 30, "end": 31, "span": "carcinosarcoma", "e_type": "Disease"}]}
{"idx": 104, "sentence": "In all , 0 of 0 kindreds manifesting BRCA0 mutation or linkage contained ovarian cancer , as compared with only 0 of the remaining 0 families ( P < . 0 ) .", "entities": [{"start": 13, "end": 15, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 105, "sentence": "The present study confirms the involvement of BRCA0 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers .", "entities": [{"start": 15, "end": 18, "span": "hereditary breast cancer", "e_type": "Disease"}, {"start": 22, "end": 24, "span": "ovarian cancers", "e_type": "Disease"}]}
{"idx": 106, "sentence": "Rapid detection of regionally clustered germ - line BRCA0 mutations by multiplex heteroduplex analysis .", "entities": []}
{"idx": 107, "sentence": "UKCCCR Familial Ovarian Cancer Study Group .", "entities": [{"start": 2, "end": 4, "span": "Ovarian Cancer", "e_type": "Disease"}]}
{"idx": 108, "sentence": "Germ - line mutations of the BRCA0 gene are responsible for a substantial proportion of families with multiple cases of early - onset breast and / or ovarian cancer .", "entities": [{"start": 23, "end": 29, "span": "breast and / or ovarian cancer", "e_type": "Disease"}]}
{"idx": 109, "sentence": "Since the isolation of BRCA0 last year , > 0 distinct mutations scattered throughout the coding region have been detected , making analysis of the gene time consuming and technically challenging .", "entities": []}
{"idx": 110, "sentence": "We have developed a multiplex heteroduplex analysis that is designed to analyze one - quarter of the coding sequence in a single - step screening procedure and that will detect approximately 0 % of all BRCA0 mutations so far reported in breast / ovarian cancer families .", "entities": [{"start": 41, "end": 45, "span": "breast / ovarian cancer", "e_type": "Disease"}]}
{"idx": 111, "sentence": "We have used this technique to analyze BRCA0 in 0 families with a history of breast and / or ovarian cancer and identified 0 distinct mutations in 0 families . .", "entities": [{"start": 15, "end": 21, "span": "breast and / or ovarian cancer", "e_type": "Disease"}]}
{"idx": 112, "sentence": "A previously undescribed mutation within the tetramerisation domain of TP00 in a family with Li - Fraumeni syndrome .", "entities": [{"start": 14, "end": 18, "span": "Li - Fraumeni syndrome", "e_type": "Disease"}]}
{"idx": 113, "sentence": "We report details of a family with classic Li - Fraumeni syndrome in which there is a mutation in codon 0 of the tumour suppressor gene TP00 .", "entities": [{"start": 8, "end": 12, "span": "Li - Fraumeni syndrome", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "tumour", "e_type": "Disease"}]}
{"idx": 114, "sentence": "Codon 0 is a key residue within the tetramerisation domain , and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding .", "entities": []}
{"idx": 115, "sentence": "This is the first report of a mutation at this residue in either sporadic tumours or in the germline and the first report of a germline mutation within the tetramerisation domain .", "entities": [{"start": 13, "end": 15, "span": "sporadic tumours", "e_type": "Disease"}]}
{"idx": 116, "sentence": "The family does not appear to be remarkable in the spectrum of tumours , and there is loss of the wild - type allele in a leiomyosarcoma from the proband .", "entities": [{"start": 12, "end": 13, "span": "tumours", "e_type": "Disease"}, {"start": 26, "end": 27, "span": "leiomyosarcoma", "e_type": "Disease"}]}
{"idx": 117, "sentence": "A cell line has been established from the tumour of the proband and cytogenetic and molecular studies carried out , providing an extensive analysis in this family . .", "entities": [{"start": 8, "end": 9, "span": "tumour", "e_type": "Disease"}]}
{"idx": 118, "sentence": "The spectrum of RB0 germ - line mutations in hereditary retinoblastoma .", "entities": [{"start": 9, "end": 11, "span": "hereditary retinoblastoma", "e_type": "Disease"}]}
{"idx": 119, "sentence": "We have searched for germ - line RB0 mutations in 0 patients with hereditary retinoblastoma .", "entities": [{"start": 13, "end": 15, "span": "hereditary retinoblastoma", "e_type": "Disease"}]}
{"idx": 120, "sentence": "Previous investigations by Southern blot hybridization and PCR fragment - length analysis had revealed mutations in 0 patients .", "entities": []}
{"idx": 121, "sentence": "Here we report on the analysis of the remaining 0 patients .", "entities": []}
{"idx": 122, "sentence": "By applying heteroduplex analysis , nonisotopic SSCP , and direct sequencing , we detected germ - line mutations resulting in premature termination codons or disruption of splice signals in 0 ( 0 % ) of the 0 patients .", "entities": []}
{"idx": 123, "sentence": "Four patients also showed rare sequence variants .", "entities": []}
{"idx": 124, "sentence": "No region of the RB0 gene was preferentially involved in single base substitutions .", "entities": []}
{"idx": 125, "sentence": "Recurrent transitions were observed at most of the 0 codons within the RB0 .", "entities": []}
{"idx": 126, "sentence": "No mutation was observed in exons 0 - 0 , although this region contains two CGA codons .", "entities": []}
{"idx": 127, "sentence": "This suggests that mutations within the 0 - terminal region of the RB0 gene may not be oncogenic .", "entities": []}
{"idx": 128, "sentence": "When these data were combined with the results of our previous investigations , mutations were identified in a total of 0 ( 0 % ) of 0 patients .", "entities": []}
{"idx": 129, "sentence": "The spectrum comprises 0 % large deletions , 0 % small length alterations , and 0 % base substitutions .", "entities": []}
{"idx": 130, "sentence": "No correlation between the location of frameshift or nonsense mutations and phenotypic features , including age at diagnosis , the number of tumor foci , and manifestation of nonocular tumors was observed . .", "entities": [{"start": 22, "end": 23, "span": "tumor", "e_type": "Disease"}, {"start": 28, "end": 30, "span": "nonocular tumors", "e_type": "Disease"}]}
{"idx": 131, "sentence": "Phenotypic characterization of individuals with 0 - 0 CAG repeats in the Huntington disease ( HD ) gene reveals HD cases with 0 repeats and apparently normal elderly individuals with 0 - 0 repeats .", "entities": [{"start": 12, "end": 14, "span": "Huntington disease", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "HD", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "HD", "e_type": "Disease"}]}
{"idx": 132, "sentence": "Abnormal CAG expansions in the IT - 0 gene are associated with Huntington disease ( HD ) .", "entities": [{"start": 12, "end": 14, "span": "Huntington disease", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "HD", "e_type": "Disease"}]}
{"idx": 133, "sentence": "In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and HD - associated chromosomes .", "entities": [{"start": 19, "end": 20, "span": "HD", "e_type": "Disease"}]}
{"idx": 134, "sentence": "Most large analyses that defined the limits of the normal and pathological size ranges employed PCR assays , which included the CAG repeats and a CCG repeat tract that was thought to be invariant .", "entities": []}
{"idx": 135, "sentence": "Many of these experiments found an overlap between the normal and disease size ranges .", "entities": []}
{"idx": 136, "sentence": "Subsequent findings that the CCG repeats vary by 0 trinucleotide lengths suggested that the limits of the normal and disease size ranges should be reevaluated with assays that exclude the CCG polymorphism .", "entities": []}
{"idx": 137, "sentence": "Since patients with between 0 and 0 repeats are rare , a consortium was assembled to collect such individuals .", "entities": []}
{"idx": 138, "sentence": "All 0 samples were reanalyzed in Cambridge by using assays specific for the CAG repeats .", "entities": []}
{"idx": 139, "sentence": "We have optimized methods for reliable sizing of CAG repeats and show cases that demonstrate the dangers of using PCR assays that include both the CAG and CCG polymorphisms .", "entities": []}
{"idx": 140, "sentence": "Seven HD patients had 0 repeats , which confirms that this allele is associated with disease .", "entities": [{"start": 1, "end": 2, "span": "HD", "e_type": "Disease"}]}
{"idx": 141, "sentence": "Individuals without apparent symptoms or signs of HD were found at 0 repeats ( aged 0 , 0 , 0 , and 0 years ) , 0 repeats ( aged 0 years ) , 0 repeats ( aged 0 and 0 years ) , and 0 repeats ( aged 0 , 0 , and 0 years ) .", "entities": [{"start": 7, "end": 8, "span": "HD", "e_type": "Disease"}]}
{"idx": 142, "sentence": "The detailed case histories of an exceptional case from this series will be presented a 0 - year - old man with 0 repeats who did not have classical features of HD .", "entities": [{"start": 31, "end": 32, "span": "HD", "e_type": "Disease"}]}
{"idx": 143, "sentence": "The apparently healthy survival into old age of some individuals with 0 - 0 repeats suggests that the HD mutation may not always be fully penetrant . .", "entities": [{"start": 18, "end": 19, "span": "HD", "e_type": "Disease"}]}
{"idx": 144, "sentence": "Identification and expression of eight novel mutations among non - Jewish patients with Canavan disease .", "entities": [{"start": 13, "end": 15, "span": "Canavan disease", "e_type": "Disease"}]}
{"idx": 145, "sentence": "Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase ( ASPA ) .", "entities": [{"start": 0, "end": 2, "span": "Canavan disease", "e_type": "Disease"}, {"start": 14, "end": 17, "span": "deficiency of aspartoacylase", "e_type": "Disease"}]}
{"idx": 146, "sentence": "The majority of patients with Canavan disease are from an Ashkenazi Jewish background .", "entities": [{"start": 5, "end": 7, "span": "Canavan disease", "e_type": "Disease"}]}
{"idx": 147, "sentence": "Mutations in ASPA that lead to loss of enzymatic activity have been identified , and E000A and Y000X are the two predominant mutations that account for 0 % of the mutant chromosomes in Ashkenazi Jewish patients .", "entities": []}
{"idx": 148, "sentence": "The current study was aimed at finding the molecular basis of Canavan disease in 0 independent patients of non - Jewish background .", "entities": [{"start": 11, "end": 13, "span": "Canavan disease", "e_type": "Disease"}]}
{"idx": 149, "sentence": "Eight novel and three previously characterized mutations accounted for 0 % ( 0 / 0 ) of mutant chromosomes .", "entities": []}
{"idx": 150, "sentence": "The A000E missense mutation accounted for 0 % ( 0 / 0 ) of mutant chromosomes in patients of western European descent , while the two predominant Jewish mutations each accounted for a single mutant chromosome .", "entities": []}
{"idx": 151, "sentence": "The eight novel mutations identified included 0 - and 0 - bp deletions ( 0 deltaT and 0 deltaAGAA , respectively ) and I00T , G00R , D000E , G000E , C000Y , and R000C missense mutations .", "entities": []}
{"idx": 152, "sentence": "The homozygous 0 deltaT deletion was identified in the only known patient of African - American origin with Canavan disease .", "entities": [{"start": 18, "end": 20, "span": "Canavan disease", "e_type": "Disease"}]}
{"idx": 153, "sentence": "The heterozygosity for 0 deltaAGAA mutation was identified in three independent patients from England .", "entities": []}
{"idx": 154, "sentence": "Six single - base changes leading to missense mutations were identified in patients from Turkey ( D000E , R000C ) , The Netherlands ( I00T ) , Germany ( G00R ) , Ireland ( C000Y ) , and Canada ( G000E ) .", "entities": []}
{"idx": 155, "sentence": "A PCR - based protocol is described that was used to introduce mutations in wild - type cDNA .", "entities": []}
{"idx": 156, "sentence": "In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a deficiency of ASPA and should therefore result in Canavan disease . .", "entities": [{"start": 16, "end": 19, "span": "deficiency of ASPA", "e_type": "Disease"}, {"start": 24, "end": 26, "span": "Canavan disease", "e_type": "Disease"}]}
{"idx": 157, "sentence": "Identification and chromosomal localization of Atm , the mouse homolog of the ataxia - telangiectasia gene .", "entities": [{"start": 12, "end": 15, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 158, "sentence": "Atm , the mouse homolog of the human ATM gene defective in ataxia - telangiectasia ( A - T ) , has been identified .", "entities": [{"start": 12, "end": 15, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 16, "end": 19, "span": "A - T", "e_type": "Disease"}]}
{"idx": 159, "sentence": "The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a protein of 0 amino acids with 0 % overall identity and 0 % similarity to the human ATM protein .", "entities": []}
{"idx": 160, "sentence": "Variable levels of expression of Atm were observed in different tissues .", "entities": []}
{"idx": 161, "sentence": "Fluorescence in situ hybridization and linkage analysis located the Atm gene on mouse chromosome 0 , band 0C , in a region homologous to the ATM region on human chromosome 00q00 - q00 . .", "entities": []}
{"idx": 162, "sentence": "The mouse homolog of the Wiskott - Aldrich syndrome protein ( WASP ) gene is highly conserved and maps near the scurfy ( sf ) mutation on the X chromosome .", "entities": [{"start": 5, "end": 9, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 163, "sentence": "The mouse WASP gene , the homolog of the gene mutated in Wiskott - Aldrich syndrome , has been isolated and sequenced . the predicted amino acid sequence is 0 % identical to the human WASP sequence .", "entities": [{"start": 12, "end": 16, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 164, "sentence": "A distinct feature of the mouse gene is an expanded polymorphic GGA trinucleotide repeat that codes for polyglycine and varies from 0 to 0 triplets in different Mus musculus strains .", "entities": []}
{"idx": 165, "sentence": "The genomic structure of the mouse WASP gene is expressed as an approximately 0 .", "entities": []}
{"idx": 166, "sentence": "0 - kb mRNA in thymus and spleen .", "entities": []}
{"idx": 167, "sentence": "Chromosomal mapping in an interspecific M .", "entities": []}
{"idx": 168, "sentence": "Musculus / M . spretus backcross placed the Wasp locus near the centromere of the mouse X chromosome , inseparable from Gata0 , Tcfe0 , and scurfy ( sf ) .", "entities": []}
{"idx": 169, "sentence": "This localization makes Wasp a candidate for involvement in scurfy , a T cell - mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of Wiskott - Aldrich syndrome .", "entities": [{"start": 16, "end": 19, "span": "fatal lymphoreticular disease", "e_type": "Disease"}, {"start": 31, "end": 35, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 170, "sentence": "Northern analysis of sf tissue samples indicated the presence of WASP mRNA in liver and skin , presumably as a consequence of lymphocytic infiltration , but non abnormalities in the amount or size of mRNA present .", "entities": []}
{"idx": 171, "sentence": "Colchicine in breast milk of patients with familial Mediterranean fever .", "entities": [{"start": 7, "end": 10, "span": "familial Mediterranean fever", "e_type": "Disease"}]}
{"idx": 172, "sentence": "OBJECTIVE .", "entities": []}
{"idx": 173, "sentence": "To clarify whether colchicine is excreted in breast milk , and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever ( FMF ) .", "entities": [{"start": 26, "end": 29, "span": "familial Mediterranean fever", "e_type": "Disease"}, {"start": 30, "end": 31, "span": "FMF", "e_type": "Disease"}]}
{"idx": 174, "sentence": "METHODS .", "entities": []}
{"idx": 175, "sentence": "Using a specific radioimmunoassay , we determined colchicine concentrations in the serum and breast milk of 0 patients at various time points , following oral administration of the drug .", "entities": []}
{"idx": 176, "sentence": "The study evaluated 0 patients with FMF who had been taking colchicine on a long - term basis .", "entities": [{"start": 6, "end": 7, "span": "FMF", "e_type": "Disease"}]}
{"idx": 177, "sentence": "RESULTS .", "entities": []}
{"idx": 178, "sentence": "Colchicine was found to be excreted in breast milk .", "entities": []}
{"idx": 179, "sentence": "Its levels ranged between 0 .", "entities": []}
{"idx": 180, "sentence": "0 and 0 .", "entities": []}
{"idx": 181, "sentence": "0 ng / ml , which were similar to those found in the serum ( parallel concentration time curves ) .", "entities": []}
{"idx": 182, "sentence": "However , there appeared to be a considerable variation in colchicine milk concentration among the different patients , which might be related to individual breast milk composition and , possibly , to other nutritional or metabolic factors .", "entities": []}
{"idx": 183, "sentence": "CONCLUSION .", "entities": []}
{"idx": 184, "sentence": "The extensive peripheral tissue binding and relatively low concentration of colchicine in breast milk suggests that the amount ingested by the infant is small .", "entities": []}
{"idx": 185, "sentence": "Furthermore , based on our clinical experience , nursing appears to be safe for lactating women with FMF who continue to take colchicine .", "entities": [{"start": 17, "end": 18, "span": "FMF", "e_type": "Disease"}]}
{"idx": 186, "sentence": "Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice .", "entities": [{"start": 1, "end": 3, "span": "myotonic dystrophy", "e_type": "Disease"}, {"start": 9, "end": 10, "span": "myopathy", "e_type": "Disease"}]}
{"idx": 187, "sentence": "Myotonic dystrophy ( DM ) is commonly associated with CTG repeat expansions within the gene for DM - protein kinase ( DMPK ) .", "entities": [{"start": 0, "end": 2, "span": "Myotonic dystrophy", "e_type": "Disease"}, {"start": 3, "end": 4, "span": "DM", "e_type": "Disease"}]}
{"idx": 188, "sentence": "The effect of altered expression levels of DMPK , which is ubiquitously expressed in all muscle cell lineages during development , was examined by disrupting the endogenous Dmpk gene and overexpressing a normal human DMPK transgene in mice .", "entities": []}
{"idx": 189, "sentence": "Nullizygous ( - / - ) mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age , animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality .", "entities": [{"start": 32, "end": 34, "span": "hypertrophic cardiomyopathy", "e_type": "Disease"}]}
{"idx": 190, "sentence": "However , both models lack other frequent DM symptoms including the fibre - type dependent atrophy , myotonia , cataract and male - infertility .", "entities": [{"start": 7, "end": 8, "span": "DM", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "atrophy", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "myotonia", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "cataract", "e_type": "Disease"}, {"start": 21, "end": 24, "span": "male - infertility", "e_type": "Disease"}]}
{"idx": 191, "sentence": "These results strengthen the contention that simple loss - or gain - of - expression of DMPK is not the only crucial requirement for development of the disease . .", "entities": []}
{"idx": 192, "sentence": "Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy .", "entities": [{"start": 3, "end": 5, "span": "myotonic dystrophy", "e_type": "Disease"}, {"start": 12, "end": 13, "span": "myopathy", "e_type": "Disease"}]}
{"idx": 193, "sentence": "Myotonic dystrophy ( DM ) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 0 untranslated region of a putative protein kinase ( DMPK ) .", "entities": [{"start": 0, "end": 2, "span": "Myotonic dystrophy", "e_type": "Disease"}, {"start": 3, "end": 4, "span": "DM", "e_type": "Disease"}, {"start": 7, "end": 10, "span": "autosomal dominant disorder", "e_type": "Disease"}]}
{"idx": 194, "sentence": "To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient ( Dmpk - / - ) mice .", "entities": [{"start": 7, "end": 8, "span": "DM", "e_type": "Disease"}, {"start": 12, "end": 14, "span": "Dmpk deficient", "e_type": "Disease"}]}
{"idx": 195, "sentence": "Dmpk - / - mice develop a late - onset , progressive skeletal myopathy that shares some pathological features with DM .", "entities": [{"start": 11, "end": 14, "span": "progressive skeletal myopathy", "e_type": "Disease"}, {"start": 20, "end": 21, "span": "DM", "e_type": "Disease"}]}
{"idx": 196, "sentence": "Muscles from mature mice show variation in fibre size , increased fibre degeneration and fibrosis .", "entities": [{"start": 11, "end": 13, "span": "fibre degeneration", "e_type": "Disease"}, {"start": 14, "end": 15, "span": "fibrosis", "e_type": "Disease"}]}
{"idx": 197, "sentence": "Adult Dmpk - / - mice show ultrastructural changes in muscle and a 0 % decrease in force generation compared to young mice .", "entities": []}
{"idx": 198, "sentence": "Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology . .", "entities": [{"start": 28, "end": 29, "span": "DM", "e_type": "Disease"}]}
{"idx": 199, "sentence": "The tumor suppressor gene Brca0 is required for embryonic cellular proliferation in the mouse .", "entities": [{"start": 1, "end": 2, "span": "tumor", "e_type": "Disease"}]}
{"idx": 200, "sentence": "Mutations of the BRCA0 gone in humans are associated with predisposition to breast and ovarian cancers .", "entities": [{"start": 12, "end": 16, "span": "breast and ovarian cancers", "e_type": "Disease"}]}
{"idx": 201, "sentence": "We show here that Brca0 + / - mice are normal and fertile and lack tumors by age eleven months .", "entities": [{"start": 15, "end": 16, "span": "tumors", "e_type": "Disease"}]}
{"idx": 202, "sentence": "Homozygous Brca0 ( 0 - 0 ) mutant mice die before day 0 .", "entities": []}
{"idx": 203, "sentence": "0 of embryogenesis .", "entities": []}
{"idx": 204, "sentence": "Mutant embryos are poorly developed , with no evidence of mesoderm formation .", "entities": []}
{"idx": 205, "sentence": "The extraembryonic region is abnormal , but aggregation with wild - type tetraploid embryos does not rescue the lethality .", "entities": []}
{"idx": 206, "sentence": "In vivo , mutant embryos do not exhibit increased apoptosis but show reduced cell proliferation accompanied by decreased expression of cyclin E and mdm - 0 , a regulator of p00 activity .", "entities": []}
{"idx": 207, "sentence": "The expression of cyclin - dependent kinase inhibitor p00 is dramatically increased in the mutant embryos .", "entities": []}
{"idx": 208, "sentence": "Buttressing these in vivo observations is the fact that mutant blastocyst growth is grossly impaired in vitro .", "entities": []}
{"idx": 209, "sentence": "Thus , the death of Brca0 ( 0 - 0 ) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers .", "entities": []}
{"idx": 210, "sentence": "Increased coronary heart disease in Japanese - American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels .", "entities": [{"start": 1, "end": 4, "span": "coronary heart disease", "e_type": "Disease"}]}
{"idx": 211, "sentence": "Plasma high density lipoprotein ( HDL ) levels are strongly genetically determined and show a general inverse relationship with coronary heart disease ( CHD ) .", "entities": [{"start": 19, "end": 22, "span": "coronary heart disease", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "CHD", "e_type": "Disease"}]}
{"idx": 212, "sentence": "The cholesteryl ester transfer protein ( CETP ) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver .", "entities": []}
{"idx": 213, "sentence": "A high prevalence of two different CETP gene mutations ( D000G , 0 . 0 % ; intron 00G A , 0 . 0 % ) , was found in 0 , 0 men of Japanese ancestry in the Honolulu Heart Program and mutations were associated with decreased CETP ( - 0 % ) and increased HDL chol levels ( + 0 % for D000G ) .", "entities": []}
{"idx": 214, "sentence": "However , the overall prevalence of definite CHD was 0 % in men with mutations and 0 % in men without mutations .", "entities": [{"start": 7, "end": 8, "span": "CHD", "e_type": "Disease"}]}
{"idx": 215, "sentence": "The relative risk ( RR ) of CHD was 0 .", "entities": [{"start": 7, "end": 8, "span": "CHD", "e_type": "Disease"}]}
{"idx": 216, "sentence": "0 in men with mutations ( P < . 0 ) ; after adjustment for CHD risk factors , the RR was 0 .", "entities": [{"start": 15, "end": 16, "span": "CHD", "e_type": "Disease"}]}
{"idx": 217, "sentence": "0 ( P = . 0 ) ; after additional adjustment for HDL levels , the RR was 0 .", "entities": []}
{"idx": 218, "sentence": "0 ( P = . 0 ) .", "entities": []}
{"idx": 219, "sentence": "Similar RR values were obtained for the D000G mutation alone .", "entities": []}
{"idx": 220, "sentence": "Increased CHD in men with mutations was primarily observed for HDL chol 0 - 0 mg / dl ; for HDL chol > 0 mg / dl men with and without mutations had low CHD prevalence .", "entities": [{"start": 1, "end": 2, "span": "CHD", "e_type": "Disease"}, {"start": 34, "end": 35, "span": "CHD", "e_type": "Disease"}]}
{"idx": 221, "sentence": "Thus , genetic CETP deficiency appears to be an independent risk factor for CHD , primarily due to increased CHD prevalence in men with the D000G mutation and HDL cholesterol between 0 and 0 mg / dl .", "entities": [{"start": 3, "end": 5, "span": "CETP deficiency", "e_type": "Disease"}, {"start": 13, "end": 14, "span": "CHD", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "CHD", "e_type": "Disease"}]}
{"idx": 222, "sentence": "The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL ( i . e . , reverse cholesterol transport ) determine the anti - atherogenicity of the HDL fraction .", "entities": []}
{"idx": 223, "sentence": "Mapping the homolog of the human Rb0 gene to chromosome 0 of higher primates .", "entities": []}
{"idx": 224, "sentence": "The Rb0 gene has been implicated with retinoblastoma and is located on human Chromosome ( Chr ) 00q00 .", "entities": [{"start": 7, "end": 8, "span": "retinoblastoma", "e_type": "Disease"}]}
{"idx": 225, "sentence": "0 0 .", "entities": []}
{"idx": 226, "sentence": "A unique sequence human Rb0 cosmid DNA probe has been used to localize this region on apes Chr 0 by the FISH technique .", "entities": []}
{"idx": 227, "sentence": "The conservation of the Rb0 gene in higher primates at the corresponding equivalent chromosome locus ( 00q00 ) of the human may serve as a phylogenetic marker to further trace the evolutionary pathway of human descent .", "entities": []}
{"idx": 228, "sentence": "Wiskott - Aldrich syndrome : no strict genotype - phenotype correlations but clustering of missense mutations in the amino - terminal part of the WASP gene product .", "entities": [{"start": 0, "end": 4, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 229, "sentence": "The Wiskott - Aldrich syndrome protein ( WASP ) gene was found to be mutated in patients presenting with WAS and in patients showing X - linked thrombocytopenia .", "entities": [{"start": 1, "end": 5, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "WAS", "e_type": "Disease"}, {"start": 24, "end": 28, "span": "X - linked thrombocytopenia", "e_type": "Disease"}]}
{"idx": 230, "sentence": "Mutation analysis in 0 families of German , Swiss and Turkish descent by single - strand conformation polymorphism and sequencing resulted in the detection of seven novel and 0 known mutations .", "entities": []}
{"idx": 231, "sentence": "A striking clustering of missense mutations in the first four exons contrasted with a random distribution of nonsense mutations .", "entities": []}
{"idx": 232, "sentence": "More than 0 % of all known missense mutations were localized in the amino - terminal stretch of the WASP gene product ; this region contained a mutational hot spot at codon 0 .", "entities": []}
{"idx": 233, "sentence": "No genotype - phenotype correlation emerged after a comparison of the identified mutations with the resulting clinical picture for a classical WAS phenotype .", "entities": [{"start": 21, "end": 22, "span": "WAS", "e_type": "Disease"}]}
{"idx": 234, "sentence": "A substitution at codon 0 resulted in an extremely variable expression of the disease in a large Swiss family .", "entities": []}
{"idx": 235, "sentence": "An extended homology search revealed a distant relationship of this stretch to the vasodilator - stimulated phosphoprotein ( VASP ) , which is involved in the maintenance of cyto - architecture by interacting with actin - like filaments . .", "entities": []}
{"idx": 236, "sentence": "Influence of PAX0 gene dosage on development : overexpression causes severe eye abnormalities .", "entities": [{"start": 11, "end": 13, "span": "eye abnormalities", "e_type": "Disease"}]}
{"idx": 237, "sentence": "Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX0 .", "entities": [{"start": 0, "end": 1, "span": "Aniridia", "e_type": "Disease"}, {"start": 9, "end": 12, "span": "semidominant developmental disorders", "e_type": "Disease"}]}
{"idx": 238, "sentence": "Whereas heterozygotes suffer from iris hypoplasia , homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities .", "entities": [{"start": 4, "end": 6, "span": "iris hypoplasia", "e_type": "Disease"}, {"start": 16, "end": 18, "span": "brain abnormalities", "e_type": "Disease"}]}
{"idx": 239, "sentence": "To investigate the role of gene dosage in more detail , we have generated yeast artificial chromosome transgenic mice carrying the human PAX0 locus .", "entities": []}
{"idx": 240, "sentence": "When crossed onto the Small eye background , the transgene rescues the mutant phenotype .", "entities": []}
{"idx": 241, "sentence": "Strikingly , mice carrying multiple copies on a wild - type background show specific developmental abnormalities of the eye , but not of other tissues expressing the gene .", "entities": [{"start": 14, "end": 19, "span": "developmental abnormalities of the eye", "e_type": "Disease"}]}
{"idx": 242, "sentence": "Thus , at least five different eye phenotypes are associated with changes in PAX0 expression .", "entities": []}
{"idx": 243, "sentence": "We provide evidence that not only reduced , but also increased levels of transcriptional regulators can cause developmental defects . .", "entities": [{"start": 17, "end": 19, "span": "developmental defects", "e_type": "Disease"}]}
{"idx": 244, "sentence": "Heterodimer formation and activity in the human enzyme galactose - 0 - phosphate uridylyltransferase .", "entities": []}
{"idx": 245, "sentence": "One of the fundamental questions concerning expression and function of dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity .", "entities": []}
{"idx": 246, "sentence": "This question is of particular interest for the human enzyme galactose - l - phosphate uridylyl - transferase ( GALT ) , impairment of which results in the inherited metabolic disorder galactosemia , because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes .", "entities": [{"start": 28, "end": 31, "span": "inherited metabolic disorder", "e_type": "Disease"}, {"start": 31, "end": 32, "span": "galactosemia", "e_type": "Disease"}]}
{"idx": 247, "sentence": "Furthermore , the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination , not just allelic constitution , may play some role in determining outcome .", "entities": []}
{"idx": 248, "sentence": "In the work described herein , we have selected two distinct naturally occurring null mutations of GALT , Q000R and R000W , and asked the questions ( i ) what are the impacts of these mutations on subunit assembly , and ( ii ) if heterodimers do form , are they active ?", "entities": []}
{"idx": 249, "sentence": "To answer these questions , we have established a yeast system for the coexpression of epitope - tagged alleles of human GALT and investigated both the extent of specific GALT subunit interactions and the activity of defined heterodimer pools .", "entities": []}
{"idx": 250, "sentence": "We have found that both homodimers and heterodimers do form involving each of the mutant subunits tested and that both heterodimer pools retain substantial enzymatic activity .", "entities": []}
{"idx": 251, "sentence": "These results are significant not only in terms of their implications for furthering our understanding of galactosemia and GALT holoenzyme structure - function relationships but also because the system described may serve as a model for similar studies of other complexes composed of multiple subunits . .", "entities": [{"start": 16, "end": 17, "span": "galactosemia", "e_type": "Disease"}]}
{"idx": 252, "sentence": "Cleavage of huntingtin by apopain , a proapoptotic cysteine protease , is modulated by the polyglutamine tract .", "entities": []}
{"idx": 253, "sentence": "Apoptosis has recently been recognized as a mode of cell death in Huntington disease ( HD ) .", "entities": [{"start": 12, "end": 14, "span": "Huntington disease", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "HD", "e_type": "Disease"}]}
{"idx": 254, "sentence": "Apopain , a human counterpart of the nematode cysteine protease death - gene product , CED - 0 , has a key role in proteolytic events leading to apoptosis .", "entities": []}
{"idx": 255, "sentence": "Here we show that apoptotic extracts and apopain itself specifically cleave the HD gene product , huntingtin .", "entities": [{"start": 12, "end": 13, "span": "HD", "e_type": "Disease"}]}
{"idx": 256, "sentence": "The rate of cleavage increases with the length of the huntingtin polyglutamine tract , providing an explanation for the gain - of - function associated with CAG expansion .", "entities": []}
{"idx": 257, "sentence": "Our results show that huntingtin is cleaved by cysteine proteases and suggest that HD might be a disorder of inappropriate apoptosis . .", "entities": [{"start": 13, "end": 14, "span": "HD", "e_type": "Disease"}, {"start": 17, "end": 21, "span": "disorder of inappropriate apoptosis", "e_type": "Disease"}]}
{"idx": 258, "sentence": "The 0 ' end of the BRCA0 gene lies within a duplicated region of human chromosome 00q00 .", "entities": []}
{"idx": 259, "sentence": "To begin to address the hypothesis that abnormal regulation of the breast / ovarian cancer susceptibility gene BRCA0 is a critical step in sporadic breast / ovarian tumorigenesis , we have determined the detailed structure of the BRCA0 genomic region .", "entities": [{"start": 11, "end": 15, "span": "breast / ovarian cancer", "e_type": "Disease"}]}
{"idx": 260, "sentence": "We show that this region of the genome contains a tandem duplication of approximately 0 kilobases , which results in two copies of BRCA0 exons 0 and 0 , of exons 0 and 0 of the adjacent 0A0 - 0B gene and of the previously reported 0 base pair intergenic region .", "entities": []}
{"idx": 261, "sentence": "Sequence analysis of the duplicated exons of BRCA0 and 0A0 - 0B and flanking genomic DNA reveals maintenance of the intron - exon structure and a high degree of nucleotide sequence identity , suggesting that these are non - processed pseudogenes and that the duplication is a recent event in evolutionary terms .", "entities": []}
{"idx": 262, "sentence": "We also show that a processed pseudogene of the acidic ribosomal phosphoprotein P0 ( ARPP0 ) is inserted directly upstream of pseudo - BRCA0 exon 0A .", "entities": []}
{"idx": 263, "sentence": "We believe that these findings could not only confound BRCA0 mutation analysis , but could have implications for the normal and abnormal regulation of BRCA0 transcription , translation and function . .", "entities": []}
{"idx": 264, "sentence": "Deletion of small nuclear ribonucleoprotein polypeptide N ( SNRPN ) in Prader - Willi syndrome detected by fluorescence in situ hybridization : two sibs with the typical phenotype without a cytogenetic deletion in chromosome 00q .", "entities": [{"start": 11, "end": 15, "span": "Prader - Willi syndrome", "e_type": "Disease"}]}
{"idx": 265, "sentence": "The small nuclear ribonucleoprotein polypeptide N ( SNRPN ) gene is regarded as one of the candidates for Prader - Willi syndrome ( PWS ) .", "entities": [{"start": 18, "end": 22, "span": "Prader - Willi syndrome", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "PWS", "e_type": "Disease"}]}
{"idx": 266, "sentence": "We describe two sibs with typical PWS presenting deletion of SNRPN detected by fluorescence in situ hybridization ( FISH ) .", "entities": [{"start": 6, "end": 7, "span": "PWS", "e_type": "Disease"}]}
{"idx": 267, "sentence": "Neither a cytogenetically detectable 00q00 deletion nor a deletion for the D00S00 , D00S00 , and GABRB0 cosmid probes were found in either patient .", "entities": []}
{"idx": 268, "sentence": "This implies a smaller deletion limited to the PWS critical region .", "entities": [{"start": 8, "end": 9, "span": "PWS", "e_type": "Disease"}]}
{"idx": 269, "sentence": "FISH with a SNRPN probe will permit analysis of PWS patients with limited deletions not detectable with other probes . .", "entities": [{"start": 9, "end": 10, "span": "PWS", "e_type": "Disease"}]}
{"idx": 270, "sentence": "Expression of the von Hippel - Lindau disease tumour suppressor gene during human embryogenesis .", "entities": [{"start": 3, "end": 9, "span": "von Hippel - Lindau disease tumour", "e_type": "Disease"}]}
{"idx": 271, "sentence": "The von Hippel - Lindau ( VHL ) disease product is thought to down - regulate transcription by antagonizing elongin - enhanced transcriptional elongation .", "entities": [{"start": 1, "end": 9, "span": "von Hippel - Lindau ( VHL ) disease", "e_type": "Disease"}]}
{"idx": 272, "sentence": "Germline VHL gene mutations predispose to the development of retinal , cerebellar and spinal haemangioblastomas , renal cell carcinoma and phaeochromocytoma .", "entities": [{"start": 1, "end": 2, "span": "VHL", "e_type": "Disease"}, {"start": 9, "end": 15, "span": "retinal , cerebellar and spinal haemangioblastomas", "e_type": "Disease"}, {"start": 16, "end": 19, "span": "renal cell carcinoma", "e_type": "Disease"}, {"start": 20, "end": 21, "span": "phaeochromocytoma", "e_type": "Disease"}]}
{"idx": 273, "sentence": "In addition , somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma .", "entities": [{"start": 7, "end": 8, "span": "VHL", "e_type": "Disease"}, {"start": 12, "end": 16, "span": "sporadic renal cell carcinoma", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "haemangioblastoma", "e_type": "Disease"}]}
{"idx": 274, "sentence": "Regulation of transcript elongation is an important control mechanism for gene expression and the VHL gene might modify the expression of proto - oncogenes and growth suppressor genes during embryogenesis .", "entities": [{"start": 14, "end": 15, "span": "VHL", "e_type": "Disease"}]}
{"idx": 275, "sentence": "We therefore investigated the expression of VHL mRNA during human embryogenesis by in situ hybridization studies at 0 , 0 and 0 weeks post conception .", "entities": [{"start": 6, "end": 7, "span": "VHL", "e_type": "Disease"}]}
{"idx": 276, "sentence": "Although VHL mRNA was expressed in all three germ layers , strong expression was noted in the central nervous system , kidneys , testis and lung .", "entities": [{"start": 1, "end": 2, "span": "VHL", "e_type": "Disease"}]}
{"idx": 277, "sentence": "Within the kidney , VHL mRNA was differentially expressed within renal tubules suggesting that the VHL gene product may have a specific role in kidney development .", "entities": [{"start": 4, "end": 5, "span": "VHL", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "VHL", "e_type": "Disease"}]}
{"idx": 278, "sentence": "Two alternatively spliced VHL mRNAs characterized by inclusion ( isoform I ) or exclusion ( isoform II ) of exon 0 are transcribed in adult tissues .", "entities": [{"start": 3, "end": 4, "span": "VHL", "e_type": "Disease"}]}
{"idx": 279, "sentence": "To investigate if the two isoforms are differentially expressed during embryogenesis , VHL mRNA was reverse transcribed from 0 fetal tissues ( 0 - 0 weeks gestation ) .", "entities": [{"start": 12, "end": 13, "span": "VHL", "e_type": "Disease"}]}
{"idx": 280, "sentence": "The quantitative distribution of VHL mRNA within fetal tissues reflected that seen by in situ hybridization and the ratio of the two VHL isoforms was similar between tissues .", "entities": [{"start": 4, "end": 5, "span": "VHL", "e_type": "Disease"}, {"start": 22, "end": 23, "span": "VHL", "e_type": "Disease"}]}
{"idx": 281, "sentence": "Although the genes regulated by the VHL gene product have not yet been identified , our findings are compatible with the hypothesis that VHL - mediated control of transcriptional elongation may have a role in normal human development . .", "entities": [{"start": 6, "end": 7, "span": "VHL", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "VHL", "e_type": "Disease"}]}
{"idx": 282, "sentence": "Genetic heterogeneity in hereditary breast cancer : role of BRCA0 and BRCA0 .", "entities": [{"start": 3, "end": 6, "span": "hereditary breast cancer", "e_type": "Disease"}]}
{"idx": 283, "sentence": "The common hereditary forms of breast cancer have been largely attributed to the inheritance of mutations in the BRCA0 or BRCA0 genes .", "entities": [{"start": 5, "end": 7, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 284, "sentence": "However , it is not yet clear what proportion of hereditary breast cancer is explained by BRCA0 and BRCA0 or by some other unidentified susceptibility gene ( s ) .", "entities": [{"start": 10, "end": 13, "span": "hereditary breast cancer", "e_type": "Disease"}]}
{"idx": 285, "sentence": "We describe the proportion of hereditary breast cancer explained by BRCA0 or BRCA0 in a sample of North American hereditary breast cancers and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk .", "entities": [{"start": 5, "end": 8, "span": "hereditary breast cancer", "e_type": "Disease"}, {"start": 19, "end": 22, "span": "hereditary breast cancers", "e_type": "Disease"}, {"start": 33, "end": 38, "span": "hereditary breast or ovarian cancer", "e_type": "Disease"}]}
{"idx": 286, "sentence": "Twenty - three families were identified through two high - risk breast cancer research programs .", "entities": [{"start": 11, "end": 13, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 287, "sentence": "Genetic analysis was undertaken to establish linkage between the breast or ovarian cancer cases and markers on chromosomes 00q ( BRCA0 ) and 00q ( BRCA0 ) .", "entities": [{"start": 9, "end": 13, "span": "breast or ovarian cancer", "e_type": "Disease"}]}
{"idx": 288, "sentence": "Mutation analysis in the BRCA0 and BRCA0 genes was also undertaken in all families .", "entities": []}
{"idx": 289, "sentence": "The pattern of hereditary cancer in 0 ( 0 % ) of the 0 families studied was attributed to BRCA0 by a combination of linkage and mutation analyses .", "entities": [{"start": 3, "end": 5, "span": "hereditary cancer", "e_type": "Disease"}]}
{"idx": 290, "sentence": "No families were attributed to BRCA0 .", "entities": []}
{"idx": 291, "sentence": "Five families ( 0 % ) provided evidence against linkage to both BRCA0 and BRCA0 .", "entities": []}
{"idx": 292, "sentence": "No BRCA0 or BRCA0 mutations were detected in these five families .", "entities": []}
{"idx": 293, "sentence": "The BRCA0 or BRCA0 status of four families ( 0 % ) could not be determined .", "entities": []}
{"idx": 294, "sentence": "BRCA0 and BRCA0 probably explain the majority of hereditary breast cancer that exists in the North American population .", "entities": [{"start": 8, "end": 11, "span": "hereditary breast cancer", "e_type": "Disease"}]}
{"idx": 295, "sentence": "However , one or more additional genes may yet be found that explain some proportion of hereditary breast cancer . .", "entities": [{"start": 16, "end": 19, "span": "hereditary breast cancer", "e_type": "Disease"}]}
{"idx": 296, "sentence": "An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder ( fish - eye disease ) .", "entities": [{"start": 14, "end": 17, "span": "inherited human disorder", "e_type": "Disease"}, {"start": 18, "end": 22, "span": "fish - eye disease", "e_type": "Disease"}]}
{"idx": 297, "sentence": "The first step in the splicing of an intron from nuclear precursors of mRNA results in the formation of a lariat structure .", "entities": []}
{"idx": 298, "sentence": "A distinct intronic nucleotide sequence , known as the branchpoint region , plays a central role in this process .", "entities": []}
{"idx": 299, "sentence": "We here describe a point mutation in such a sequence .", "entities": []}
{"idx": 300, "sentence": "Three sisters were shown to suffer from fish - eye disease ( FED ) , a disorder which is caused by mutations in the gene coding for lecithin cholesterol acyltransferase ( LCAT ) .", "entities": [{"start": 7, "end": 11, "span": "fish - eye disease", "e_type": "Disease"}, {"start": 12, "end": 13, "span": "FED", "e_type": "Disease"}]}
{"idx": 301, "sentence": "Sequencing of the LCAT gene of all three probands revealed compound heterozygosity for a missense mutation in exon 0 which is reported to underlie the FED phenotype , and a point mutation located in intron 0 ( IVS0 T - 00C ) .", "entities": [{"start": 25, "end": 26, "span": "FED", "e_type": "Disease"}]}
{"idx": 302, "sentence": "By performing in vitro expression of LCAT minigenes and reverse transcriptase PCR on mRNA isolated from leukocytes of the patient , this gene defect was shown to cause a null allele as the result of complete intron retention .", "entities": []}
{"idx": 303, "sentence": "In conclusion , we demonstrated that a point mutation in a lariat branchpoint consensus sequence causes a null allele in a patient with FED .", "entities": [{"start": 23, "end": 24, "span": "FED", "e_type": "Disease"}]}
{"idx": 304, "sentence": "In addition , our finding illustrates the importance of this sequence for normal human mRNA processing .", "entities": []}
{"idx": 305, "sentence": "Finally , this report provides a widely applicable strategy which ensures fast and effective screening for intronic defects that underlie differential gene expression . .", "entities": []}
{"idx": 306, "sentence": "Mutations associated with variant phenotypes in ataxia - telangiectasia .", "entities": [{"start": 6, "end": 9, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 307, "sentence": "We have identified 0 families with ataxia - telangiectasia ( A - T ) in which mutation of the ATM gene is associated with a less severe clinical and cellular phenotype ( approximately 0 % - 0 % of A - T families identified in the United Kingdom ) .", "entities": [{"start": 6, "end": 9, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 10, "end": 13, "span": "A - T", "e_type": "Disease"}, {"start": 39, "end": 42, "span": "A - T", "e_type": "Disease"}]}
{"idx": 308, "sentence": "In 0 of these families , all the homozygotes have a 0 - bp insertion in their cDNA caused by a point mutation in a sequence resembling a splice - donor site .", "entities": []}
{"idx": 309, "sentence": "The second A - T allele has a different mutation in each patient .", "entities": [{"start": 2, "end": 5, "span": "A - T", "e_type": "Disease"}]}
{"idx": 310, "sentence": "We show that the less severe phenotype in these patients is caused by some degree of normal splicing , which occurs as an alternative product from the insertion - containing allele .", "entities": []}
{"idx": 311, "sentence": "The level of the 0 - bp PCR product containing the insertion was lowest in two patients who showed a later onset of cerebellar ataxia .", "entities": [{"start": 23, "end": 25, "span": "cerebellar ataxia", "e_type": "Disease"}]}
{"idx": 312, "sentence": "A further four families who do not have this insertion have been identified .", "entities": []}
{"idx": 313, "sentence": "Mutations detected in two of four of these are missense mutations , normally rare in A - T patients .", "entities": [{"start": 15, "end": 18, "span": "A - T", "e_type": "Disease"}]}
{"idx": 314, "sentence": "The demonstration of mutations giving rise to a slightly milder phenotype in A - T raises the interesting question of what range of phenotypes might occur in individuals in whom both mutations are milder .", "entities": [{"start": 12, "end": 15, "span": "A - T", "e_type": "Disease"}]}
{"idx": 315, "sentence": "One possibility might be that individuals who are compound heterozygotes for ATM mutations are more common than we realize . .", "entities": []}
{"idx": 316, "sentence": "Mutation of the VHL gene is associated exclusively with the development of non - papillary renal cell carcinomas .", "entities": [{"start": 12, "end": 18, "span": "non - papillary renal cell carcinomas", "e_type": "Disease"}]}
{"idx": 317, "sentence": "To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas , 0 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism ( SSCP ) and / or heteroduplex ( HD ) techniques .", "entities": [{"start": 7, "end": 8, "span": "VHL", "e_type": "Disease"}, {"start": 13, "end": 17, "span": "sporadic renal cell carcinomas", "e_type": "Disease"}, {"start": 20, "end": 25, "span": "parenchymal tumours of the kidney", "e_type": "Disease"}, {"start": 32, "end": 33, "span": "VHL", "e_type": "Disease"}]}
{"idx": 318, "sentence": "Chromosome 0p deletion was detected in 0 per cent of non - papillary renal cell carcinomas and in 0 per cent of chromophobe renal cell carcinomas .", "entities": [{"start": 10, "end": 16, "span": "non - papillary renal cell carcinomas", "e_type": "Disease"}, {"start": 23, "end": 26, "span": "renal cell carcinomas", "e_type": "Disease"}]}
{"idx": 319, "sentence": "In 0 of the 0 non - papillary renal cell carcinomas , abnormally migrating DNA bands were detected by SSCP and / or HD analysis .", "entities": [{"start": 5, "end": 11, "span": "non - papillary renal cell carcinomas", "e_type": "Disease"}]}
{"idx": 320, "sentence": "No mobility shift was seen in any of the 0 chromophobe renal cell carcinomas .", "entities": [{"start": 11, "end": 14, "span": "renal cell carcinomas", "e_type": "Disease"}]}
{"idx": 321, "sentence": "In addition , 0 papillary renal cell tumours and ten renal oncocytomas , which are characterized by genetic changes other than loss of chromosome 0p sequences , were analysed for mutation of the VHL gene .", "entities": [{"start": 4, "end": 8, "span": "papillary renal cell tumours", "e_type": "Disease"}, {"start": 10, "end": 12, "span": "renal oncocytomas", "e_type": "Disease"}, {"start": 33, "end": 34, "span": "VHL", "e_type": "Disease"}]}
{"idx": 322, "sentence": "None of these tumours showed abnormal migration patterns .", "entities": [{"start": 3, "end": 4, "span": "tumours", "e_type": "Disease"}]}
{"idx": 323, "sentence": "The results indicate that mutation of the VHL gene is associated exclusively with the development of non - papillary renal cell carcinoma . .", "entities": [{"start": 7, "end": 8, "span": "VHL", "e_type": "Disease"}, {"start": 16, "end": 22, "span": "non - papillary renal cell carcinoma", "e_type": "Disease"}]}
{"idx": 324, "sentence": "The Emery - Dreifuss muscular dystrophy protein , emerin , is a nuclear membrane protein .", "entities": [{"start": 1, "end": 6, "span": "Emery - Dreifuss muscular dystrophy", "e_type": "Disease"}]}
{"idx": 325, "sentence": "A large fragment of emerin cDNA was prepared by PCR and expressed as a recombinant protein in Escherichia coli .", "entities": []}
{"idx": 326, "sentence": "Using this as immunogen , we prepared a panel of 0 monoclonal antibodies which recognise at least four different epitopes on emerin in order to ensure that emerin can be distinguished from non - specific cross - reacting proteins .", "entities": []}
{"idx": 327, "sentence": "All the mAbs recognised a 0 kDa protein in all tissues tested , though minor emerin - related bands were also detected in some tissues .", "entities": []}
{"idx": 328, "sentence": "Immunofluorescence microscopy showed that emerin is located at the nuclear rim in all tissues examined .", "entities": []}
{"idx": 329, "sentence": "A muscle biopsy from an Emery - Dreifuss muscular dystrophy ( EMDM ) patient showed complete absence of emerin by both Western blotting and immunohistochemistry , suggesting a simple diagnostic antibody test for EDMD families .", "entities": [{"start": 5, "end": 10, "span": "Emery - Dreifuss muscular dystrophy", "e_type": "Disease"}, {"start": 11, "end": 12, "span": "EMDM", "e_type": "Disease"}, {"start": 33, "end": 34, "span": "EDMD", "e_type": "Disease"}]}
{"idx": 330, "sentence": "Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through 0 % sucrose and was absent from soluble fractions ( post - 0 , 0 g ) .", "entities": []}
{"idx": 331, "sentence": "From these results , together with sequence and structural homologies between emerin , thymopoietins and the nuclear lamina - associated protein , LAP0 , we suggest that emerin will prove to be one member of a family of inner nuclear membrane proteins . .", "entities": []}
{"idx": 332, "sentence": "Mutation of MSH0 in endometrial cancer and evidence for its functional role in heteroduplex repair .", "entities": [{"start": 4, "end": 6, "span": "endometrial cancer", "e_type": "Disease"}]}
{"idx": 333, "sentence": "Many human tumours have length alterations in repetitive sequence elements .", "entities": [{"start": 2, "end": 3, "span": "tumours", "e_type": "Disease"}]}
{"idx": 334, "sentence": "Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer ( HNPCC ) kindreds , many sporadic tumours exhibit instability but no detectable mutations in these genes .", "entities": [{"start": 2, "end": 4, "span": "microsatellite instability", "e_type": "Disease"}, {"start": 16, "end": 20, "span": "hereditary nonpolyposis colorectal cancer", "e_type": "Disease"}, {"start": 21, "end": 22, "span": "HNPCC", "e_type": "Disease"}, {"start": 26, "end": 28, "span": "sporadic tumours", "e_type": "Disease"}]}
{"idx": 335, "sentence": "It is therefore of interest to identify other genes that contribute to this instability .", "entities": []}
{"idx": 336, "sentence": "In yeast , mutations in several genes , including RTH and MSH0 , cause microsatellite instability .", "entities": []}
{"idx": 337, "sentence": "Thus , we screened 0 endometrial carcinomas with microsatellite instability for alterations in FEN0 ( the human homolog of RTH ) and in MSH0 ( refs 0 - 0 ) .", "entities": [{"start": 5, "end": 7, "span": "endometrial carcinomas", "e_type": "Disease"}]}
{"idx": 338, "sentence": "Although we found no FEN0 mutations , a frameshift mutation in MSH0 was observed in an endometrial carcinoma and in an endometrial carcinoma cell line .", "entities": [{"start": 16, "end": 18, "span": "endometrial carcinoma", "e_type": "Disease"}, {"start": 21, "end": 23, "span": "endometrial carcinoma", "e_type": "Disease"}]}
{"idx": 339, "sentence": "Extracts of the cell line were deficient in repair of DNA substrates containing mismatches or extra nucleotides .", "entities": []}
{"idx": 340, "sentence": "Introducing chromosome 0 , encoding the MSH0 gene , into the mutant cell line increased the stability of some but not all microsatellites .", "entities": []}
{"idx": 341, "sentence": "Extracts of these cells repaired certain substrates containing extra nucleotides , but were deficient in repair of those containing mismatches or other extra nucleotides .", "entities": []}
{"idx": 342, "sentence": "A subsequent search revealed a second gene mutation in HHUA cells , a missense mutation in the MSH0 gene .", "entities": []}
{"idx": 343, "sentence": "Together the data suggest that the MSH0 gene encodes a product that functions in repair of some but not all pre - mutational intermediates , its mutation in tumours can result in genomic instability and , as in yeast , MSH0 and MSH0 are partially redundant for mismatch repair . .", "entities": [{"start": 28, "end": 29, "span": "tumours", "e_type": "Disease"}]}
{"idx": 344, "sentence": "Comparative genome mapping of the ataxia - telangiectasia region in mouse , rat , and Syrian hamster .", "entities": [{"start": 5, "end": 8, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 345, "sentence": "Chromosomal locations of the Atm ( ataxia - telangiectasia ( AT ) - mutated ) and Acat0 ( mitochondrial acetoacetyl - CoA thiolase ) genes in mouse , rat , and Syrian hamster were determined by direct R - banding FISH .", "entities": [{"start": 6, "end": 9, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 10, "end": 11, "span": "AT", "e_type": "Disease"}]}
{"idx": 346, "sentence": "Both genes were colocalized to the C - D band of mouse chromosome 0 , the proximal end of q00 .", "entities": []}
{"idx": 347, "sentence": "0 of rat chromosome 0 , and qa0 - qa0 of Syrian hamster chromosome 0 .", "entities": []}
{"idx": 348, "sentence": "The regions in the mouse and rat were homologous to human chromosome 00q .", "entities": []}
{"idx": 349, "sentence": "Fine genetic linkage mapping of the mouse AT region was performed using the interspecific backcross mice .", "entities": [{"start": 7, "end": 8, "span": "AT", "e_type": "Disease"}]}
{"idx": 350, "sentence": "Atm , Acat0 , and Npat , which is a new gene isolated from the AT region , and 0 flanking microsatellite DNA markers were examined .", "entities": []}
{"idx": 351, "sentence": "No recombinations were found among the Atm , Npat , Acat0 , and D0Mit0 loci , and these loci were mapped 0 .", "entities": []}
{"idx": 352, "sentence": "0 cM distal to D0Mit00 and 0 .", "entities": []}
{"idx": 353, "sentence": "0 cM proximal to D0Mit000 .", "entities": []}
{"idx": 354, "sentence": "Comparison of the linkage map of mouse chromosome 0 ( MMU0 ) and that of human chromosome 0 ( HSA00 ) indicates that there is a chromosomal rearrangement due to an inversion between Ets0 and Atm - Npat - Acat0 and that the inversion of MMU0 originated from the chromosomal breakage at the boundary between Gria0 and Atm - Npat - Acat0 on HSA00 .", "entities": []}
{"idx": 355, "sentence": "This type of inversion appeared to be conserved in the three rodent species , mouse , rat , and Syrian hamster , using additional comparative mapping data with the Rck gene", "entities": []}
{"idx": 356, "sentence": "An animal model for Norrie disease ( ND ) : gene targeting of the mouse ND gene .", "entities": [{"start": 4, "end": 6, "span": "Norrie disease", "e_type": "Disease"}, {"start": 7, "end": 8, "span": "ND", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "ND", "e_type": "Disease"}]}
{"idx": 357, "sentence": "In order to elucidate the cellular and molecular processes which are involved in Norrie disease ( ND ) , we have used gene targeting technology to generate ND mutant mice .", "entities": [{"start": 13, "end": 15, "span": "Norrie disease", "e_type": "Disease"}, {"start": 16, "end": 17, "span": "ND", "e_type": "Disease"}, {"start": 27, "end": 28, "span": "ND", "e_type": "Disease"}]}
{"idx": 358, "sentence": "The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 0 % of the amino acid sequence with its human counterpart .", "entities": [{"start": 5, "end": 6, "span": "ND", "e_type": "Disease"}]}
{"idx": 359, "sentence": "RNA in situ hybridization revealed expression in retina , brain and the olfactory bulb and epithelium of 0 week old mice .", "entities": []}
{"idx": 360, "sentence": "Hemizygous mice carrying a replacement mutation in exon 0 of the ND gene developed retrolental structures in the vitreous body and showed an overall disorganization of the retinal ganglion cell layer .", "entities": [{"start": 11, "end": 12, "span": "ND", "e_type": "Disease"}]}
{"idx": 361, "sentence": "The outer plexiform layer disappears occasionally , resulting in a juxtaposed inner and outer nuclear layer .", "entities": []}
{"idx": 362, "sentence": "At the same regions , the outer segments of the photoreceptor cell layer are no longer present .", "entities": []}
{"idx": 363, "sentence": "These ocular findings are consistent with observations in ND patients and the generated mouse line provides a faithful model for study of early pathogenic events in this severe X - linked recessive neurological disorder . .", "entities": [{"start": 8, "end": 9, "span": "ND", "e_type": "Disease"}, {"start": 28, "end": 34, "span": "X - linked recessive neurological disorder", "e_type": "Disease"}]}
{"idx": 364, "sentence": "The hybrid PAX0 - FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture .", "entities": [{"start": 8, "end": 10, "span": "alveolar rhabdomyosarcoma", "e_type": "Disease"}]}
{"idx": 365, "sentence": "Pediatric alveolar rhabdomyosarcoma is characterized by a chromosomal translocation that fuses parts of the PAX0 and FKHR genes .", "entities": [{"start": 0, "end": 3, "span": "Pediatric alveolar rhabdomyosarcoma", "e_type": "Disease"}]}
{"idx": 366, "sentence": "PAX0 codes for a transcriptional regulator that controls developmental programs , and FKHR codes for a forkhead - winged helix protein , also a likely transcription factor .", "entities": []}
{"idx": 367, "sentence": "The PAX0 - FKHR fusion product retains the DNA binding domains of the PAX0 protein and the putative activator domain of the FKHR protein .", "entities": []}
{"idx": 368, "sentence": "The PAX0 - FKHR protein has been shown to function as a transcriptional activator .", "entities": []}
{"idx": 369, "sentence": "Using the RCAS retroviral vector , we have introduced the PAX0 - FKHR gene into chicken embryo fibroblasts .", "entities": []}
{"idx": 370, "sentence": "Expression of the PAX0 - FKHR protein in these cells leads to transformation the cells become enlarged , grow tightly packed and in multiple layers , and acquire the ability for anchorage - independent growth .", "entities": []}
{"idx": 371, "sentence": "This cellular transformation in vitro will facilitate studies on the mechanism of PAX0 - FKHR - induced oncogenesis . .", "entities": []}
{"idx": 372, "sentence": "Somatic - cell selection is a major determinant of the blood - cell phenotype in heterozygotes for glucose - 0 - phosphate dehydrogenase mutations causing severe enzyme deficiency .", "entities": [{"start": 26, "end": 28, "span": "enzyme deficiency", "e_type": "Disease"}]}
{"idx": 373, "sentence": "X - chromosome inactivation in mammals is regarded as an essentially random process , but the resulting somatic - cell mosaicism creates the opportunity for cell selection .", "entities": []}
{"idx": 374, "sentence": "In most people with red - blood - cell glucose - 6 - phosphate dehydrogenase ( G6PD ) deficiency , the enzyme - deficient phenotype is only moderately expressed in nucleated cells .", "entities": [{"start": 9, "end": 19, "span": "glucose - 6 - phosphate dehydrogenase ( G6PD ) deficiency", "e_type": "Disease"}]}
{"idx": 375, "sentence": "However , in a small subset of hemizygous males who suffer from chronic nonspherocytic hemolytic anemia , the underlying mutations ( designated class I ) cause more - severe G6PD deficiency , and this might provide an opportunity for selection in heterozygous females during development .", "entities": [{"start": 12, "end": 16, "span": "chronic nonspherocytic hemolytic anemia", "e_type": "Disease"}, {"start": 29, "end": 31, "span": "G6PD deficiency", "e_type": "Disease"}]}
{"idx": 376, "sentence": "In order to test this possibility we have analyzed four heterozygotes for class I G0PD mutations two with G0PD Portici ( 0000G - - > A ) and two with G0PD Bari ( 0000C - - > T ) .", "entities": []}
{"idx": 377, "sentence": "We found that in fractionated blood cell types ( including erythroid , myeloid , and lymphoid cell lineages ) there was a significant excess of G0PD - normal cells .", "entities": []}
{"idx": 378, "sentence": "The significant concordance that we have observed in the degree of imbalance in the different blood - cell lineages indicates that a selective mechanism is likely to operate at the level of pluripotent blood stem cells .", "entities": []}
{"idx": 379, "sentence": "Thus , it appears that severe G6PD deficiency affects adversely the proliferation or the survival of nucleated blood cells and that this phenotypic characteristic is critical during hematopoiesis . .", "entities": [{"start": 6, "end": 8, "span": "G6PD deficiency", "e_type": "Disease"}]}
{"idx": 380, "sentence": "Analysis of meiotic segregation , using single - sperm typing : meiotic drive at the myotonic dystrophy locus .", "entities": [{"start": 15, "end": 17, "span": "myotonic dystrophy", "e_type": "Disease"}]}
{"idx": 381, "sentence": "Meiotic drive at the myotonic dystrophy ( DM ) locus has recently been suggested as being responsible for maintaining the frequency , in the human population , of DM chromosomes capable of expansion to the disease state .", "entities": [{"start": 4, "end": 6, "span": "myotonic dystrophy", "e_type": "Disease"}, {"start": 7, "end": 8, "span": "DM", "e_type": "Disease"}, {"start": 28, "end": 29, "span": "DM", "e_type": "Disease"}]}
{"idx": 382, "sentence": "In order to test this hypothesis , we have studied samples of single sperm from three individuals heterozygous at the DM locus , each with one allele larger and one allele smaller than 0 CTG repeats .", "entities": [{"start": 20, "end": 21, "span": "DM", "e_type": "Disease"}]}
{"idx": 383, "sentence": "To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles , the sperm were also typed at another closely linked marker whose allele size was unrelated to the allele size at the DM locus .", "entities": [{"start": 40, "end": 41, "span": "DM", "e_type": "Disease"}]}
{"idx": 384, "sentence": "Using statistical models specifically designed to study single - sperm segregation data , we find no evidence of meiotic segregation distortion .", "entities": []}
{"idx": 385, "sentence": "The upper limit of the two - sided 0 % confidence interval for the estimate of the common segregation probability for the three donors is at or below .", "entities": []}
{"idx": 386, "sentence": "0 for all models considered , and no statistically significant difference from .", "entities": []}
{"idx": 387, "sentence": "0 is detected in any of the models .", "entities": []}
{"idx": 388, "sentence": "This suggests that any greater amount of segregation distortion at the myotonic dystrophy locus must result from events following sperm ejaculation .", "entities": [{"start": 11, "end": 13, "span": "myotonic dystrophy", "e_type": "Disease"}]}
{"idx": 389, "sentence": "LPP , the preferred fusion partner gene of HMGIC in lipomas , is a novel member of the LIM protein gene family .", "entities": [{"start": 10, "end": 11, "span": "lipomas", "e_type": "Disease"}]}
{"idx": 390, "sentence": "A major cytogenetic subgroup of lipomas is characterized by recurrent chromosome aberrations , mainly translocations , that involve chromosome segment 00q00 - q00 .", "entities": [{"start": 5, "end": 6, "span": "lipomas", "e_type": "Disease"}]}
{"idx": 391, "sentence": "Multiple chromosomes have been found as the translocation partners of chromosome 0 but 0q00 - q00 is preferentially involved .", "entities": []}
{"idx": 392, "sentence": "In previous studies , it has been shown that the high mobility group ( HMG ) protein gene HMGIC at 00q00 is consistently rearranged as a consequence of these translocations .", "entities": []}
{"idx": 393, "sentence": "Here , we report the identification and characterization of the chromosome 0 - derived translocation partner gene , which we have designated LPP ( lipoma preferred partner gene ) .", "entities": [{"start": 24, "end": 25, "span": "lipoma", "e_type": "Disease"}]}
{"idx": 394, "sentence": "Using 0 - RACE analysis of HMGIC fusion transcripts in lipoma cell line Li - 0 / SV00 , ectopic genetic sequences were obtained , which by CASH ( chromosome assignment using somatic cell hybrids ) and FISH ( fluorescence in situ hybridization ) analysis were found to originate from chromosome segment 0q00 - q00 .", "entities": [{"start": 10, "end": 11, "span": "lipoma", "e_type": "Disease"}]}
{"idx": 395, "sentence": "In Northern blot analysis , an mRNA of over 0 kb was detected by these ectopic sequences in a variety of human tissues but not in brain and peripheral blood leukocytes .", "entities": []}
{"idx": 396, "sentence": "Upon partial cDNA cloning , features of the genetic organization of LPP were established .", "entities": []}
{"idx": 397, "sentence": "The gene was found to span a genomic region of over 0 kb .", "entities": []}
{"idx": 398, "sentence": "Nucleotide sequence analysis of a composite cDNA of LPP revealed an open reading frame of 0 nucleotides encoding a proline - rich protein containing a leucine - zipper motif in its amino - terminal region and three LIM domains in its carboxy - terminal region .", "entities": []}
{"idx": 399, "sentence": "The LPP - encoded protein should be classified as a novel member of the group 0 proteins of the LIM protein gene family .", "entities": []}
{"idx": 400, "sentence": "Using reverse transcriptase combined with polymerase chain reactions in the analysis of a number of lipoma cell lines and primary lipomas , it appeared that LPP is frequently rearranged also in cases without a cytogenetically detectable involvement of 0q00 - q00 .", "entities": [{"start": 15, "end": 16, "span": "lipoma", "e_type": "Disease"}, {"start": 19, "end": 21, "span": "primary lipomas", "e_type": "Disease"}]}
{"idx": 401, "sentence": "Two alternative HMGIC / LPP hybrid transcripts have been detected ; the difference between them is mainly the presence of either two or three LIM domains in the predicted HMGI - C / LPP fusion proteins . .", "entities": []}
{"idx": 402, "sentence": "Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript .", "entities": [{"start": 17, "end": 19, "span": "Huntington disease", "e_type": "Disease"}]}
{"idx": 403, "sentence": "The mutation underlying Huntington disease ( HD ) is CAG expansion in the first exon of the HD gene .", "entities": [{"start": 3, "end": 5, "span": "Huntington disease", "e_type": "Disease"}, {"start": 6, "end": 7, "span": "HD", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "HD", "e_type": "Disease"}]}
{"idx": 404, "sentence": "In order to investigate the role of CAG expansion in the pathogenesis of HD , we have produced transgenic mice containing the full length human HD cDNA with 0 CAG repeats .", "entities": [{"start": 13, "end": 14, "span": "HD", "e_type": "Disease"}, {"start": 25, "end": 26, "span": "HD", "e_type": "Disease"}]}
{"idx": 405, "sentence": "By 0 year , these mice have no behavioral abnormalities and morphometric analysis at 0 ( one animal ) and 0 ( two animals ) months age revealed no changes .", "entities": [{"start": 8, "end": 10, "span": "behavioral abnormalities", "e_type": "Disease"}]}
{"idx": 406, "sentence": "Despite high levels of mRNA expression , there was no evidence of the HD gene product in any of these transgenic mice .", "entities": [{"start": 13, "end": 14, "span": "HD", "e_type": "Disease"}]}
{"idx": 407, "sentence": "In vitro transfection studies indicated that the inclusion of 0 bp of the 0 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 0 prevented expression of the HD cDNA .", "entities": [{"start": 33, "end": 34, "span": "HD", "e_type": "Disease"}]}
{"idx": 408, "sentence": "These findings suggest that the pathogenesis of HD is not mediated through DNA - protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease .", "entities": [{"start": 7, "end": 8, "span": "HD", "e_type": "Disease"}]}
{"idx": 409, "sentence": "Rather , translation of the CAG is crucial for the pathogenesis of HD .", "entities": [{"start": 12, "end": 13, "span": "HD", "e_type": "Disease"}]}
{"idx": 410, "sentence": "In contrast to that seen in humans , the CAG repeat in these mice was remarkably stable in 0 meioses .", "entities": []}
{"idx": 411, "sentence": "This suggests that genomic sequences may play a critical role in influencing repeat instability . .", "entities": []}
{"idx": 412, "sentence": "FISH studies in a patient with sporadic aniridia and t ( 0 ; 0 ) ( q00 . 0 ; p00 ) .", "entities": [{"start": 6, "end": 8, "span": "sporadic aniridia", "e_type": "Disease"}]}
{"idx": 413, "sentence": "A 0 year old female presenting with bilateral sporadic aniridia was found to have an apparently balanced reciprocal translocation with a chromosome 0 breakpoint within band p00 .", "entities": [{"start": 7, "end": 10, "span": "bilateral sporadic aniridia", "e_type": "Disease"}]}
{"idx": 414, "sentence": "Fluorescence in situ hybridisation ( FISH ) studies with distal 00p00 specific cosmids showed that the chromosome 0 breakpoint lay between the aniridia ( PAX0 ) locus and a region approximately 0 kb distal to PAX0 defined by the cosmid FO0000 .", "entities": [{"start": 22, "end": 23, "span": "aniridia", "e_type": "Disease"}]}
{"idx": 415, "sentence": "Although this patient did not have a detectable deletion within PAX0 , her aniridia may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX0 .", "entities": [{"start": 13, "end": 14, "span": "aniridia", "e_type": "Disease"}]}
{"idx": 416, "sentence": "This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 00p00 breakpoints . .", "entities": [{"start": 8, "end": 9, "span": "aniridia", "e_type": "Disease"}, {"start": 19, "end": 21, "span": "familial aniridia", "e_type": "Disease"}, {"start": 28, "end": 30, "span": "chromosome abnormalities", "e_type": "Disease"}]}
{"idx": 417, "sentence": "Muscle expression of glucose - 6 - phosphate dehydrogenase deficiency in different variants .", "entities": [{"start": 3, "end": 10, "span": "glucose - 6 - phosphate dehydrogenase deficiency", "e_type": "Disease"}]}
{"idx": 418, "sentence": "Muscle expression of G6PD deficiency has been investigated in Mediterranean , Seattle - like and A - variants .", "entities": [{"start": 3, "end": 5, "span": "G6PD deficiency", "e_type": "Disease"}]}
{"idx": 419, "sentence": "G0PD activity was detected in samples obtained from biopsies on the quadriceps muscle of seven males and one female .", "entities": []}
{"idx": 420, "sentence": "The type of genetic variant was determined by molecular analysis of DNA , extracted from blood samples .", "entities": []}
{"idx": 421, "sentence": "All variants showed the enzyme defect in muscle .", "entities": []}
{"idx": 422, "sentence": "A statistically significant relationship was found in the activity of G0PD between erythrocytes and muscle of the male subjects ( r = 0 . 0 ; p = 0 . 0 ) .", "entities": []}
{"idx": 423, "sentence": "The equation for the best fit line was Y = 0 .", "entities": []}
{"idx": 424, "sentence": "000X + 0 .", "entities": []}
{"idx": 425, "sentence": "0 0 .", "entities": []}
{"idx": 426, "sentence": "The results suggest that , for a given variant , the extent of the enzyme defect in muscle may be determined , using this equation , from the G0PD activity of erythrocytes", "entities": []}
{"idx": 427, "sentence": "Gene therapy for phenylketonuria .", "entities": [{"start": 3, "end": 4, "span": "phenylketonuria", "e_type": "Disease"}]}
{"idx": 428, "sentence": "Classical phenylketonuria ( PKU ) is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase ( PAH ) .", "entities": [{"start": 1, "end": 2, "span": "phenylketonuria", "e_type": "Disease"}, {"start": 3, "end": 4, "span": "PKU", "e_type": "Disease"}, {"start": 7, "end": 10, "span": "autosomal recessive disorder", "e_type": "Disease"}, {"start": 13, "end": 18, "span": "deficiency of hepatic phenylalanine hydroxylase", "e_type": "Disease"}]}
{"idx": 429, "sentence": "Limitations of the current dietary treatment for PKU have led to the development of potential treatments based on somatic gene transfer .", "entities": [{"start": 7, "end": 8, "span": "PKU", "e_type": "Disease"}]}
{"idx": 430, "sentence": "Three different vector systems have been examined .", "entities": []}
{"idx": 431, "sentence": "Vectors derived from a recombinant retrovirus or a DNA / protein complex can efficiently transduce the PAH cDNA into PAH - deficient hepatocytes in vitro , but the application of these vector systems is presently limited by their low transduction efficiency in vivo .", "entities": [{"start": 19, "end": 22, "span": "PAH - deficient", "e_type": "Disease"}]}
{"idx": 432, "sentence": "In contrast , a vector derived from a recombinant adenovirus can restore 0 % - 0 % of normal hepatic PAH activity into PAH - deficient mice , which completely normalizes serum phenylalanine levels .", "entities": [{"start": 23, "end": 26, "span": "PAH - deficient", "e_type": "Disease"}]}
{"idx": 433, "sentence": "This treatment is transient and cannot be effectively re - administered due to the presence of neutralizing antibodies directed against the recombinant adenoviral vector .", "entities": []}
{"idx": 434, "sentence": "However , these findings suggest that PKU can be completely corrected by somatic gene therapy , and provide some direction for the future development of adenoviral vectors . .", "entities": [{"start": 6, "end": 7, "span": "PKU", "e_type": "Disease"}]}
{"idx": 435, "sentence": "Exon - intron structure of the human neuronal nicotinic acetylcholine receptor alpha 0 subunit ( CHRNA0 ) .", "entities": []}
{"idx": 436, "sentence": "The human neuronal nicotinic acetylcholine receptor alpha 0 subunit gene ( CHRNA0 ) is located in the candidate region for three different phenotypes benign familial neonatal convulsions , autosomal dominant nocturnal frontal lobe epilepsy , and low - voltage EEG .", "entities": [{"start": 23, "end": 27, "span": "benign familial neonatal convulsions", "e_type": "Disease"}, {"start": 28, "end": 34, "span": "autosomal dominant nocturnal frontal lobe epilepsy", "e_type": "Disease"}]}
{"idx": 437, "sentence": "Recently , a missense mutation in transmembrane domain 0 of CHRNA0 was found to be associated with autosomal dominant nocturnal frontal lobe epilepsy in one extended pedigree .", "entities": [{"start": 17, "end": 23, "span": "autosomal dominant nocturnal frontal lobe epilepsy", "e_type": "Disease"}]}
{"idx": 438, "sentence": "We have determined the genomic organization of CHRNA0 , which consists of six exons distributed over approximately 0 kb of genomic DNA .", "entities": []}
{"idx": 439, "sentence": "The nucleotide sequence obtained from the genomic regions adjacent to the exon boundaries enabled us to develop a set of primer pairs for PCR amplification of the complete coding region .", "entities": []}
{"idx": 440, "sentence": "The sequence analysis provides the basis for a comprehensive mutation screening of CHRNA0 in the above - mentioned phenotypes and possibly in other types of idiopathic epilepsies . .", "entities": [{"start": 25, "end": 27, "span": "idiopathic epilepsies", "e_type": "Disease"}]}
{"idx": 441, "sentence": "Ashkenazi Jewish population frequencies for common mutations in BRCA0 and BRCA0 .", "entities": []}
{"idx": 442, "sentence": "BRCA0 and BRCA0 are the two major identified causes of inherited breast cancer , with mutations in either gene conferring up to 0 - 0 % lifetime risk of breast cancer in carrier females .", "entities": [{"start": 10, "end": 13, "span": "inherited breast cancer", "e_type": "Disease"}, {"start": 29, "end": 31, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 443, "sentence": "Mutations in BRCA0 account for approximately 0 % of familial breast cancer and 0 % of inherited breast / ovarian cancer , whereas mutations in BRCA0 account for a comparable percentage of inherited breast cancer cases .", "entities": [{"start": 9, "end": 12, "span": "familial breast cancer", "e_type": "Disease"}, {"start": 16, "end": 21, "span": "inherited breast / ovarian cancer", "e_type": "Disease"}, {"start": 32, "end": 35, "span": "inherited breast cancer", "e_type": "Disease"}]}
{"idx": 444, "sentence": "Over 0 distinct BRCA0 mutations and a growing list of BRCA0 mutations have been identified , with the majority resulting in protein truncation .", "entities": []}
{"idx": 445, "sentence": "A specific BRCA0 mutation , 000delAG , has a reported increased carrier frequency of approximately 0 .", "entities": []}
{"idx": 446, "sentence": "0 % in the Ashkenazi Jewish population , but is also found in rare non - Jewish patients with a different haplotype .", "entities": []}
{"idx": 447, "sentence": "The 0000delT mutation in BRCA0 was recently identified as a frequent mutation in 0 out of 0 Ashkenazi Jewish women diagnosed with breast cancer by age 0 ( ref . 0 ) , as well as in three Ashkenazi male breast cancer patients .", "entities": [{"start": 22, "end": 24, "span": "breast cancer", "e_type": "Disease"}, {"start": 39, "end": 42, "span": "male breast cancer", "e_type": "Disease"}]}
{"idx": 448, "sentence": "We have conducted a large - scale population study to investigate the prevalence of specific BRCA0 and BRCA0 mutations in Ashkenazi Jewish individuals who were unselected for breast cancer .", "entities": [{"start": 27, "end": 29, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 449, "sentence": "BRCA0 mutation screening on approximately 0 , 0 Ashkenazi Jewish samples determined a carrier frequency of 0 .", "entities": []}
{"idx": 450, "sentence": "0 % for the 000delAG mutation and 0 .", "entities": []}
{"idx": 451, "sentence": "0 % for the 0000insC mutation .", "entities": []}
{"idx": 452, "sentence": "BRCA0 analysis on 0 , 0 individuals from the same population showed a carrier frequency of 0 .", "entities": []}
{"idx": 453, "sentence": "0 % for the 0000delT mutation .", "entities": []}
{"idx": 454, "sentence": "This expanded population - based study confirms that the BRCA0 000delAG mutation and the BRCA0 0000delT mutation constitute the two most frequent mutation alleles predisposing to hereditary breast cancer among the Ashkenazim , and suggests a relatively lower penetrance for the 0000delT mutation in BRCA0", "entities": [{"start": 26, "end": 29, "span": "hereditary breast cancer", "e_type": "Disease"}]}
{"idx": 455, "sentence": "Dual roles of ATM in the cellular response to radiation and in cell growth control .", "entities": []}
{"idx": 456, "sentence": "The gene mutated in ataxia - telangiectasia ( AT ) patients , denoted ATM , encodes a putative protein or lipid kinase .", "entities": [{"start": 4, "end": 7, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 8, "end": 9, "span": "AT", "e_type": "Disease"}]}
{"idx": 457, "sentence": "To elucidate the functions of ATM , we disrupted the mouse ATM gene through homologous recombination in mice .", "entities": []}
{"idx": 458, "sentence": "Consistent with cellular defects of AT patients , the ATM - / - cells are hypersensitive to gamma - irradiation and defective in cell - cycle arrest following radiation , correlating with a defective up - regulation of p00 .", "entities": [{"start": 5, "end": 6, "span": "AT", "e_type": "Disease"}]}
{"idx": 459, "sentence": "In addition , ATM - / - mouse thymocytes are more resistant to apoptosis induced by gamma - irradiation than normal thymocytes .", "entities": []}
{"idx": 460, "sentence": "ATM - / - fibroblasts are inefficient in G0 to S - phase progression following serum stimulation and senesce after only a few passages in culture .", "entities": []}
{"idx": 461, "sentence": "They have an increased constitutive level of p00CP0 / WAF0 .", "entities": []}
{"idx": 462, "sentence": "The ATM protein is therefore critical both for cellular responses to ionizing radiation and for normal cell - cycle progression .", "entities": []}
{"idx": 463, "sentence": "ATM + / - fibroblasts and thymocytes showed intermediately defective responses to irradiation but no growth defect , suggesting that the increased cancer risk of AT heterozygotes could be attributable to poor checkpoint function . .", "entities": [{"start": 22, "end": 23, "span": "cancer", "e_type": "Disease"}, {"start": 25, "end": 26, "span": "AT", "e_type": "Disease"}]}
{"idx": 464, "sentence": "Targeted disruption of ATM leads to growth retardation , chromosomal fragmentation during meiosis , immune defects , and thymic lymphoma .", "entities": [{"start": 6, "end": 8, "span": "growth retardation", "e_type": "Disease"}, {"start": 9, "end": 13, "span": "chromosomal fragmentation during meiosis", "e_type": "Disease"}, {"start": 14, "end": 16, "span": "immune defects", "e_type": "Disease"}, {"start": 18, "end": 20, "span": "thymic lymphoma", "e_type": "Disease"}]}
{"idx": 465, "sentence": "ATM , the gene mutated in the inherited human disease ataxia - telangiectasia , is a member of a family of kinases involved in DNA metabolism and cell - cycle checkpoint control .", "entities": [{"start": 7, "end": 10, "span": "inherited human disease", "e_type": "Disease"}, {"start": 10, "end": 13, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 466, "sentence": "To help clarify the physiological roles of the ATM protein , we disrupted the ATM gene in mice through homologous recombination .", "entities": []}
{"idx": 467, "sentence": "Initial evaluation of the ATM knockout animals indicates that inactivation of the mouse ATM gene recreates much of the phenotype of ataxia - telangiectasia .", "entities": [{"start": 21, "end": 24, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 468, "sentence": "The homozygous mutant ( ATM - / - ) mice are viable , growth - retarded , and infertile .", "entities": []}
{"idx": 469, "sentence": "The infertility of ATM - / - mice results from meiotic failure .", "entities": [{"start": 1, "end": 2, "span": "infertility", "e_type": "Disease"}]}
{"idx": 470, "sentence": "Meiosis is arrested at the zygotene / pachytene stage of prophase I as a result of abnormal chromosomal synapsis and subsequent chromosome fragmentation .", "entities": []}
{"idx": 471, "sentence": "Immune defects also are evident in ATM - / - mice , including reduced numbers of B000 + CD00 - pre - B cells , thymocytes , and peripheral T cells , as well as functional impairment of T - cell - dependent immune responses .", "entities": [{"start": 0, "end": 2, "span": "Immune defects", "e_type": "Disease"}]}
{"idx": 472, "sentence": "The cerebella of ATM - / - mice appear normal by histologic examination at 0 to 0 months and the mice have no gross behavioral abnormalities .", "entities": [{"start": 24, "end": 26, "span": "behavioral abnormalities", "e_type": "Disease"}]}
{"idx": 473, "sentence": "The majority of mutant mice rapidly develop thymic lymphomas and die before 0 months of age .", "entities": [{"start": 7, "end": 9, "span": "thymic lymphomas", "e_type": "Disease"}]}
{"idx": 474, "sentence": "These findings indicate that the ATM gene product plays an essential role in a diverse group of cellular processes , including meiosis , the normal growth of somatic tissues , immune development , and tumor suppression . .", "entities": [{"start": 34, "end": 35, "span": "tumor", "e_type": "Disease"}]}
{"idx": 475, "sentence": "Cloning and characterization of human very - long - chain acyl - CoA dehydrogenase cDNA , chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene .", "entities": []}
{"idx": 476, "sentence": "Very - long - chain acyl - CoA dehydrogenase ( VLCAD ) is one of four straight - chain acyl - CoA dehydrogenase ( ACD ) enzymes , which are all nuclear encoded mitochondrial flavoproteins catalyzing the initial step in fatty acid beta - oxidation .", "entities": []}
{"idx": 477, "sentence": "We have used the very fast , Rapid Amplification of cDNA Ends ( RACE ) based strategy to obtain the sequence of cDNAs encoding human VLCAD from placenta and fibroblasts .", "entities": []}
{"idx": 478, "sentence": "Alignment of the predicted amino acid sequence of human VLCAD with those of the other human ACD enzymes revealed extensive sequence homology .", "entities": []}
{"idx": 479, "sentence": "Moreover , human VLCAD and human acyl - CoA oxidase showed extensive sequence homology corroborating the notion that these genes are evolutionarily related .", "entities": []}
{"idx": 480, "sentence": "Southern blot analysis of genomic DNA from hybrid cell lines was used to localize the VLCAD gene to human chromosome 00p00 .", "entities": []}
{"idx": 481, "sentence": "0 - p00 .", "entities": []}
{"idx": 482, "sentence": "0 .", "entities": []}
{"idx": 483, "sentence": "Using Northern and Western blot analysis to investigate the tissue specific distribution of VLCAD mRNA and protein in several human tissues we showed that VLCAD is most abundant in heart and skeletal muscle .", "entities": []}
{"idx": 484, "sentence": "This agrees well with the fact that cardiac and muscle symptoms are characteristic for patients with VLCAD deficiency .", "entities": [{"start": 16, "end": 18, "span": "VLCAD deficiency", "e_type": "Disease"}]}
{"idx": 485, "sentence": "Northern blot analysis and sequencing of cloned PCR amplified VLCAD cDNA from four unrelated patients with VLCAD deficiency showed that VLCAD mRNA was undetectable in one patient and that the other three have mutations in both VLCAD alleles .", "entities": [{"start": 16, "end": 18, "span": "VLCAD deficiency", "e_type": "Disease"}]}
{"idx": 486, "sentence": "Western blot analysis of patient fibroblasts showed that the identified mutations result in severely reduced amounts of VLCAD protein .", "entities": []}
{"idx": 487, "sentence": "Molecular bases of combined subtotal deficiencies of C6 and C7 : their effects in combination with other C6 and C7 deficiencies .", "entities": [{"start": 3, "end": 10, "span": "combined subtotal deficiencies of C6 and C7", "e_type": "Disease"}, {"start": 17, "end": 21, "span": "C6 and C7 deficiencies", "e_type": "Disease"}]}
{"idx": 488, "sentence": "Combined subtotal deficiency of C6 and C7 , in which both proteins are expressed at very low levels , has been observed in homozygous form in two families .", "entities": [{"start": 0, "end": 7, "span": "Combined subtotal deficiency of C6 and C7", "e_type": "Disease"}]}
{"idx": 489, "sentence": "A defect at the 0 splice donor site of intron 0 of the C0 gene explains the low molecular weight of the C0 protein and is probably responsible for its low expressed concentration .", "entities": []}
{"idx": 490, "sentence": "The C0 defect is more enigmatic the protein is of normal molecular weight , low circulating concentration , and altered isoelectric point .", "entities": []}
{"idx": 491, "sentence": "An Arg > Ser codon substitution in exon 0 is the only molecular alteration within the mature C0 protein .", "entities": []}
{"idx": 492, "sentence": "These defects are associated with a characteristic set of polymorphic DNA markers in the C0 / C0 region , forming a distinct haplotype .", "entities": []}
{"idx": 493, "sentence": "The haplotype has been found in combination with a number of other haplotypes containing defective genes that lead either to C6 or C7 deficiency , but with different consequences .", "entities": [{"start": 20, "end": 24, "span": "C6 or C7 deficiency", "e_type": "Disease"}]}
{"idx": 494, "sentence": "Where it is combined with a C6 - deficient gene , the serum C0 levels can be surprisingly high , possibly because there is no C0 generating C00 to consume the C0 .", "entities": [{"start": 6, "end": 9, "span": "C6 - deficient", "e_type": "Disease"}]}
{"idx": 495, "sentence": "In contrast , where the C0 genes are both defective ( but still partially functional ) , there may be a profound deficit of circulating C0 because there is ample C0 to produce C00 and consume the already small amount of C0 .", "entities": []}
{"idx": 496, "sentence": "Each molecular defect has also been found in isolation and has the expected effect . .", "entities": []}
{"idx": 497, "sentence": "Genetic bases of human complement C7 deficiency .", "entities": [{"start": 4, "end": 7, "span": "complement C7 deficiency", "e_type": "Disease"}]}
{"idx": 498, "sentence": "Complement C7 deficiency ( C7D ) is associated frequently with recurrent bacterial infections , especially meningitis caused by Neisseria meningitidis .", "entities": [{"start": 0, "end": 3, "span": "Complement C7 deficiency", "e_type": "Disease"}, {"start": 4, "end": 5, "span": "C7D", "e_type": "Disease"}, {"start": 11, "end": 13, "span": "bacterial infections", "e_type": "Disease"}, {"start": 15, "end": 16, "span": "meningitis", "e_type": "Disease"}, {"start": 18, "end": 20, "span": "Neisseria meningitidis", "e_type": "Disease"}]}
{"idx": 499, "sentence": "We report in this work the molecular bases of C7D in two unrelated Japanese males .", "entities": [{"start": 9, "end": 10, "span": "C7D", "e_type": "Disease"}]}
{"idx": 500, "sentence": "We used exon - specific PCR / single - strand conformation polymorphism analysis as a screening step for mutations .", "entities": []}
{"idx": 501, "sentence": "Subsequent direct sequencing of the target exons identified homozygous mutations in exon 0 of case 0 and in exon 0 of case 0 .", "entities": []}
{"idx": 502, "sentence": "The mutation of case 0 was a homozygous T to A transversion at nucleotide 0 , the third nucleotide of the codon TGT for Cys000 , leading to a stop codon TGA ( C000X ) .", "entities": []}
{"idx": 503, "sentence": "In case 0 , a homozygous 0 - bp deletion ( 0000delTG / 0000delGT / 0000delTG ) caused a frameshift , generating a premature termination codon 0 to 0 nucleotides downstream .", "entities": []}
{"idx": 504, "sentence": "Family study in case 0 confirmed the genetic nature of the defect .", "entities": []}
{"idx": 505, "sentence": "Moreover , we detected a novel polymorphism in intron 0 that presumably is linked to the mutation responsible for C7D in case 0 .", "entities": [{"start": 19, "end": 20, "span": "C7D", "e_type": "Disease"}]}
{"idx": 506, "sentence": "Our results indicate that the pathogenesis of C7D is heterogeneous like most of the other deficiencies of complement components . .", "entities": [{"start": 7, "end": 8, "span": "C7D", "e_type": "Disease"}, {"start": 15, "end": 19, "span": "deficiencies of complement components", "e_type": "Disease"}]}
{"idx": 507, "sentence": "HPRT - APRT - deficient mice are not a model for lesch - nyhan syndrome .", "entities": [{"start": 0, "end": 5, "span": "HPRT - APRT - deficient", "e_type": "Disease"}, {"start": 11, "end": 15, "span": "lesch - nyhan syndrome", "e_type": "Disease"}]}
{"idx": 508, "sentence": "Complete hypoxanthine - guanine phosphoribosyl - transferase ( HPRT ) deficiency in humans results in the Lesch - Nyhan syndrome which is characterized , among other features , by compulsive self - injurious behavior .", "entities": [{"start": 0, "end": 11, "span": "Complete hypoxanthine - guanine phosphoribosyl - transferase ( HPRT ) deficiency", "e_type": "Disease"}, {"start": 16, "end": 20, "span": "Lesch - Nyhan syndrome", "e_type": "Disease"}]}
{"idx": 509, "sentence": "HPRT - deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch - Nyhan syndrome .", "entities": [{"start": 0, "end": 3, "span": "HPRT - deficient", "e_type": "Disease"}, {"start": 19, "end": 23, "span": "Lesch - Nyhan syndrome", "e_type": "Disease"}]}
{"idx": 510, "sentence": "Administration of drugs that inhibit adenine phosphoribosyltransferase ( APRT ) in HPRT - deficient mice has produced the suggestion that deficiency of APRT in combination with HPRT - deficiency in mice may lead to self - mutilation behavior [ C . L . Wu and D . W . Melton ( 0 ) Nature Genet . 0 , 0 - 0 ] .", "entities": [{"start": 11, "end": 14, "span": "HPRT - deficient", "e_type": "Disease"}, {"start": 20, "end": 23, "span": "deficiency of APRT", "e_type": "Disease"}, {"start": 26, "end": 29, "span": "HPRT - deficiency", "e_type": "Disease"}]}
{"idx": 511, "sentence": "To test this proposition , we bred HPRT - APRT - deficient mice .", "entities": [{"start": 7, "end": 12, "span": "HPRT - APRT - deficient", "e_type": "Disease"}]}
{"idx": 512, "sentence": "Although the doubly - deficient mice excrete adenine and its highly insoluble derivative , 0 , 0 - dihydroxyadenine , which are also associated with human APRT deficiency , additional abnormalities or any self - injurious behavior were not detected .", "entities": [{"start": 26, "end": 28, "span": "APRT deficiency", "e_type": "Disease"}]}
{"idx": 513, "sentence": "Thus , APRT - HPRT - deficient mice , which are devoid of any purine salvage pathways , show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch - Nyhan syndrome as previously suggested", "entities": [{"start": 2, "end": 7, "span": "APRT - HPRT - deficient", "e_type": "Disease"}, {"start": 29, "end": 31, "span": "behavioral abnormalities", "e_type": "Disease"}, {"start": 34, "end": 38, "span": "Lesch - Nyhan syndrome", "e_type": "Disease"}]}
{"idx": 514, "sentence": "Somatic alterations of the DPC0 gene in human colorectal cancers in vivo .", "entities": [{"start": 8, "end": 10, "span": "colorectal cancers", "e_type": "Disease"}]}
{"idx": 515, "sentence": "BACKGROUND & AIMS The chromosome region 00q00 has been shown to be frequently deleted in colorectal cancers , and such frequent allelic loss is a hallmark of the presence of a tumor - suppressor gene .", "entities": [{"start": 15, "end": 17, "span": "colorectal cancers", "e_type": "Disease"}]}
{"idx": 516, "sentence": "The DPC0 gene , which is located at 00q00 , has been identified as a tumor - suppressor gene from examination of pancreatic cancers .", "entities": [{"start": 22, "end": 24, "span": "pancreatic cancers", "e_type": "Disease"}]}
{"idx": 517, "sentence": "The aim of the present study was to determine if it might also be altered in colorectal cancers .", "entities": [{"start": 16, "end": 18, "span": "colorectal cancers", "e_type": "Disease"}]}
{"idx": 518, "sentence": "METHODS Mutation analyses of the DPC0 gene were performed on complementary DNA samples from 0 primary colorectal cancer specimens using a combination of polymerase chain reaction , single - strand conformation polymorphism , and DNA sequencing .", "entities": [{"start": 16, "end": 18, "span": "colorectal cancer", "e_type": "Disease"}]}
{"idx": 519, "sentence": "RESULTS Four missense mutations producing amino acid substitutions and a somatic 0 - base pair deletion in the coding region of the DPC0 gene were detected in the 0 cancers ( 0 % ; 0 of 0 ) .", "entities": [{"start": 29, "end": 30, "span": "cancers", "e_type": "Disease"}]}
{"idx": 520, "sentence": "CONCLUSIONS The DPC0 gene may play a role as a tumor - suppressor gene in a fraction of colorectal cancers ; however , while allelic loss at 00q00 is very often seen in colorectal cancers , only a minority show DPC0 mutations , suggesting that there might be another tumor - suppressor gene in this chromosome region . .", "entities": [{"start": 18, "end": 20, "span": "colorectal cancers", "e_type": "Disease"}, {"start": 33, "end": 35, "span": "colorectal cancers", "e_type": "Disease"}]}
{"idx": 521, "sentence": "Pleiotropic defects in ataxia - telangiectasia protein - deficient mice .", "entities": [{"start": 3, "end": 6, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 522, "sentence": "We have generated a mouse model for ataxia - telangiectasia by using gene targeting to generate mice that do not express the Atm protein .", "entities": [{"start": 7, "end": 10, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 523, "sentence": "Atm - deficient mice are retarded in growth , do not produce mature sperm , and exhibit severe defects in T cell maturation while going on to develop thymomas .", "entities": [{"start": 28, "end": 29, "span": "thymomas", "e_type": "Disease"}]}
{"idx": 524, "sentence": "Atm - deficient fibroblasts grow poorly in culture and display a high level of double - stranded chromosome breaks .", "entities": []}
{"idx": 525, "sentence": "Atm - deficient thymocytes undergo spontaneous apoptosis in vitro significantly more than controls .", "entities": []}
{"idx": 526, "sentence": "Atm - deficient mice then exhibit many of the same symptoms found in ataxia - telangiectasia patients and in cells derived from them .", "entities": [{"start": 13, "end": 16, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 527, "sentence": "Furthermore , we demonstrate that the Atm protein exists as two discrete molecular species , and that loss of one or of both of these can lead to the development of the disease . .", "entities": []}
{"idx": 528, "sentence": "The DCC protein and prognosis in colorectal cancer .", "entities": [{"start": 6, "end": 8, "span": "colorectal cancer", "e_type": "Disease"}]}
{"idx": 529, "sentence": "BACKGROUND Allelic loss of chromosome 00q predicts a poor outcome in patients with stage II colorectal cancer .", "entities": [{"start": 13, "end": 17, "span": "stage II colorectal cancer", "e_type": "Disease"}]}
{"idx": 530, "sentence": "Although the specific gene inactivated by this allelic loss has not been elucidated , the DCC ( deleted in colorectal cancer ) gene is a candidate .", "entities": [{"start": 19, "end": 21, "span": "colorectal cancer", "e_type": "Disease"}]}
{"idx": 531, "sentence": "We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma .", "entities": [{"start": 10, "end": 11, "span": "tumor", "e_type": "Disease"}, {"start": 17, "end": 19, "span": "colorectal carcinoma", "e_type": "Disease"}]}
{"idx": 532, "sentence": "METHODS The expression of DCC was evaluated immunohistochemically in 0 paraffin - embedded samples from patients with curatively resected stage II and III colorectal carcinomas .", "entities": [{"start": 19, "end": 25, "span": "stage II and III colorectal carcinomas", "e_type": "Disease"}]}
{"idx": 533, "sentence": "The Cox proportional - hazards model was used to adjust for covariates including age , sex , tumor site , degree of tumor differentiation , and use of adjuvant therapy .", "entities": [{"start": 17, "end": 18, "span": "tumor", "e_type": "Disease"}, {"start": 22, "end": 23, "span": "tumor", "e_type": "Disease"}]}
{"idx": 534, "sentence": "RESULTS The expression of DCC was a strong positive predictive factor for survival in both stage II and stage III colorectal carcinomas .", "entities": [{"start": 15, "end": 22, "span": "stage II and stage III colorectal carcinomas", "e_type": "Disease"}]}
{"idx": 535, "sentence": "In patients with stage II disease whose tumors expressed DCC , the five - year survival rate was 0 .", "entities": [{"start": 7, "end": 8, "span": "tumors", "e_type": "Disease"}]}
{"idx": 536, "sentence": "0 percent , whereas in patients with DCC - negative tumors , the survival rate was 0 .", "entities": [{"start": 7, "end": 11, "span": "DCC - negative tumors", "e_type": "Disease"}]}
{"idx": 537, "sentence": "0 percent ( P < 0 . 0 ) .", "entities": []}
{"idx": 538, "sentence": "In patients with stage III disease , the respective survival rates were 0 .", "entities": [{"start": 3, "end": 6, "span": "stage III disease", "e_type": "Disease"}]}
{"idx": 539, "sentence": "0 percent and 0 .", "entities": []}
{"idx": 540, "sentence": "0 percent ( P = 0 . 0 ) .", "entities": []}
{"idx": 541, "sentence": "CONCLUSIONS DCC is a prognostic marker in patients with stage II or stage III colorectal cancer .", "entities": [{"start": 9, "end": 16, "span": "stage II or stage III colorectal cancer", "e_type": "Disease"}]}
{"idx": 542, "sentence": "In stage II colorectal carcinomas , the absence of DCC identifies a subgroup of patients with lesions that behave like stage III cancers .", "entities": [{"start": 1, "end": 5, "span": "stage II colorectal carcinomas", "e_type": "Disease"}, {"start": 20, "end": 23, "span": "stage III cancers", "e_type": "Disease"}]}
{"idx": 543, "sentence": "These findings may thus have therapeutic implications in this group of patients", "entities": []}
{"idx": 544, "sentence": "Association of anxiety - related traits with a polymorphism in the serotonin transporter gene regulatory region .", "entities": [{"start": 2, "end": 6, "span": "anxiety - related traits", "e_type": "Disease"}]}
{"idx": 545, "sentence": "Transporter - facilitated uptake of serotonin ( 0 - hydroxytryptamine or 0 - HT ) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake - inhibiting antidepressant and antianxiety drugs .", "entities": [{"start": 19, "end": 20, "span": "anxiety", "e_type": "Disease"}]}
{"idx": 546, "sentence": "Human 0 - HT transporter ( 0 - HTT ) gene transcription is modulated by a common polymorphism in its upstream regulatory region .", "entities": []}
{"idx": 547, "sentence": "The short variant of the polymorphism reduces the transcriptional efficiency of the 0 - HTT gene promoter , resulting in decreased 0 - HTT expression and 0 - HT uptake in lymphoblasts .", "entities": []}
{"idx": 548, "sentence": "Association studies in two independent samples totaling 0 individuals revealed that the 0 - HTT polymorphism accounts for 0 to 0 percent of total variation and 0 to 0 percent of inherited variance in anxiety - related personality traits in individuals as well as sibships . .", "entities": [{"start": 34, "end": 39, "span": "anxiety - related personality traits", "e_type": "Disease"}]}
{"idx": 549, "sentence": "Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia .", "entities": [{"start": 5, "end": 8, "span": "atelosteogenesis type 2", "e_type": "Disease"}, {"start": 9, "end": 11, "span": "diastrophic dysplasia", "e_type": "Disease"}]}
{"idx": 550, "sentence": "Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises , in order of increasing severity , diastrophic dysplasia ( DTD ) , atelosteogenesis type 2 ( AO2 ) , and achondrogenesis type 1B ( ACG1B ) .", "entities": [{"start": 3, "end": 5, "span": "diastrophic dysplasia", "e_type": "Disease"}, {"start": 16, "end": 17, "span": "chondrodysplasias", "e_type": "Disease"}, {"start": 26, "end": 28, "span": "diastrophic dysplasia", "e_type": "Disease"}, {"start": 29, "end": 30, "span": "DTD", "e_type": "Disease"}, {"start": 32, "end": 35, "span": "atelosteogenesis type 2", "e_type": "Disease"}, {"start": 36, "end": 37, "span": "AO2", "e_type": "Disease"}, {"start": 40, "end": 43, "span": "achondrogenesis type 1B", "e_type": "Disease"}, {"start": 44, "end": 45, "span": "ACG1B", "e_type": "Disease"}]}
{"idx": 551, "sentence": "To learn more about the molecular basis of DTDST chondrodysplasias and about genotype - phenotype correlations , we studied fibroblast cultures of three new patients one with AO - 2 , one with DTD , and one with an intermediate phenotype ( AO2 / DTD ) .", "entities": [{"start": 8, "end": 10, "span": "DTDST chondrodysplasias", "e_type": "Disease"}, {"start": 27, "end": 30, "span": "AO - 2", "e_type": "Disease"}, {"start": 33, "end": 34, "span": "DTD", "e_type": "Disease"}, {"start": 42, "end": 43, "span": "AO2", "e_type": "Disease"}, {"start": 44, "end": 45, "span": "DTD", "e_type": "Disease"}]}
{"idx": 552, "sentence": "Reduced incorporation of inorganic sulfate into macromolecules was found in all three .", "entities": []}
{"idx": 553, "sentence": "Each of the three patients was found to be heterozygous for a c000t transition predicting a R000W substitution in the third extracellular loop of DTDST .", "entities": []}
{"idx": 554, "sentence": "In two patients ( DTD and AO2 / DTD ) , no other structural mutation was found , but polymerase chain reaction amplification and single - strand conformation polymorphism analysis of fibroblast cDNA showed reduced mRNA levels of the wild - type DTDST allele these two patients may be compound heterozygotes for the \" Finnish \" mutation ( as yet uncharacterized at the DNA level ) , which causes reduced expression of DTDST .", "entities": [{"start": 4, "end": 5, "span": "DTD", "e_type": "Disease"}, {"start": 6, "end": 7, "span": "AO2", "e_type": "Disease"}, {"start": 8, "end": 9, "span": "DTD", "e_type": "Disease"}]}
{"idx": 555, "sentence": "The third patient ( with AO2 ) had the R000W mutation compounded with a novel mutation , the deletion of cytosine 0 ( delta c000 ) , predicting a frameshift with premature termination .", "entities": [{"start": 5, "end": 6, "span": "AO2", "e_type": "Disease"}]}
{"idx": 556, "sentence": "Also the delta c000 allele was underrepresented in the cDNA , in accordance with previous observations that premature stop codons reduce mRNA levels .", "entities": []}
{"idx": 557, "sentence": "The presence of the DTDST R000W mutation in a total of 0 patients with AO2 or DTD emphasizes the overlap between these conditions .", "entities": [{"start": 14, "end": 15, "span": "AO2", "e_type": "Disease"}, {"start": 16, "end": 17, "span": "DTD", "e_type": "Disease"}]}
{"idx": 558, "sentence": "This mutation has not been found so far in 0 analyzed ACG1B patients , suggesting that it allows some residual activity of the sulfate transporter . .", "entities": [{"start": 11, "end": 12, "span": "ACG1B", "e_type": "Disease"}]}
{"idx": 559, "sentence": "Identification of WASP mutations , mutation hotspots and genotype - phenotype disparities in 0 patients with the Wiskott - Aldrich syndrome .", "entities": [{"start": 17, "end": 21, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}]}
{"idx": 560, "sentence": "The Wiskott - Aldrich syndrome ( WAS ) , an X - linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein ( WASP ) , is known to be associated with extensive clinical heterogeneity .", "entities": [{"start": 1, "end": 5, "span": "Wiskott - Aldrich syndrome", "e_type": "Disease"}, {"start": 6, "end": 7, "span": "WAS", "e_type": "Disease"}, {"start": 10, "end": 15, "span": "X - linked immunodeficiency disease", "e_type": "Disease"}, {"start": 24, "end": 25, "span": "WAS", "e_type": "Disease"}]}
{"idx": 561, "sentence": "Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients , but the relationship of phenotype with genotype in this disease remains unclear .", "entities": [{"start": 13, "end": 14, "span": "WAS", "e_type": "Disease"}]}
{"idx": 562, "sentence": "To address this issue we characterized WASP mutations in 0 unrelated WAS patients , including 0 boys with severe classical WAS and 0 boys expressing mild forms of the disease , and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity .", "entities": [{"start": 11, "end": 12, "span": "WAS", "e_type": "Disease"}, {"start": 20, "end": 21, "span": "WAS", "e_type": "Disease"}]}
{"idx": 563, "sentence": "By analysis of these compiled mutation data , we demonstrated clustering of WASP mutations within the four most N - terminal exons of the gene and also identified several sites within this region as hotspots for WASP mutation .", "entities": []}
{"idx": 564, "sentence": "These characteristics were observed , however , in both severe and mild cases of the disease .", "entities": []}
{"idx": 565, "sentence": "Similarly , while the cumulative data revealed a predominance of missense mutations among the WASP gene lesions observed in boys with isolated thrombocytopenia , missense mutations were not exclusively associated with milder WAS phenotypes , but also comprised a substantial portion ( 0 % ) of the WASP gene defects found in patients with severe disease .", "entities": [{"start": 21, "end": 23, "span": "isolated thrombocytopenia", "e_type": "Disease"}, {"start": 32, "end": 33, "span": "WAS", "e_type": "Disease"}]}
{"idx": 566, "sentence": "These findings , as well as the detection of identical WASP mutations in patients with disparate phenotypes , reveal a lack of phenotype concordance with genotype in WAS and thus imply that phenotypic outcome in this disease cannot be reliably predicted solely on the basis of WASP genotypes . .", "entities": [{"start": 27, "end": 28, "span": "WAS", "e_type": "Disease"}]}
{"idx": 567, "sentence": "Germline mutations in the 0 ' part of APC exon 0 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli .", "entities": [{"start": 8, "end": 9, "span": "APC", "e_type": "Disease"}, {"start": 22, "end": 25, "span": "adenomatous polyposis coli", "e_type": "Disease"}]}
{"idx": 568, "sentence": "Familial adenomatous polyposis ( FAP ) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region .", "entities": [{"start": 0, "end": 3, "span": "Familial adenomatous polyposis", "e_type": "Disease"}, {"start": 4, "end": 5, "span": "FAP", "e_type": "Disease"}, {"start": 11, "end": 13, "span": "colorectal cancer", "e_type": "Disease"}, {"start": 19, "end": 21, "span": "adenomatous polyps", "e_type": "Disease"}]}
{"idx": 569, "sentence": "Germline mutations in the adenomatous polyposis coli ( APC ) gene are responsible for most cases of FAP .", "entities": [{"start": 4, "end": 7, "span": "adenomatous polyposis coli", "e_type": "Disease"}, {"start": 8, "end": 9, "span": "APC", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "FAP", "e_type": "Disease"}]}
{"idx": 570, "sentence": "Mutations at the 0 end of APC are known to be associated with a relatively mild form of the disease , called attenuated adenomatous polyposis coli ( AAPC ) .", "entities": [{"start": 6, "end": 7, "span": "APC", "e_type": "Disease"}, {"start": 22, "end": 26, "span": "attenuated adenomatous polyposis coli", "e_type": "Disease"}, {"start": 27, "end": 28, "span": "AAPC", "e_type": "Disease"}]}
{"idx": 571, "sentence": "We identified a frameshift mutation in the 0 part of exon 0 , resulting in a stop codon at 0 , in a large Dutch kindred with AAPC .", "entities": [{"start": 27, "end": 28, "span": "AAPC", "e_type": "Disease"}]}
{"idx": 572, "sentence": "Western blot analysis of lymphoblastoid cell lines derived from affected family members from this kindred , as well as from a previously reported Swiss family carrying a frameshift mutation at codon 0 and displaying a similar attenuated phenotype , showed only the wild - type APC protein .", "entities": [{"start": 45, "end": 46, "span": "APC", "e_type": "Disease"}]}
{"idx": 573, "sentence": "Our study indicates that chain - terminating mutations located in the 0 part of APC do not result in detectable truncated polypeptides and we hypothesize that this is likely to be the basis for the observed AAPC phenotype . .", "entities": [{"start": 14, "end": 15, "span": "APC", "e_type": "Disease"}, {"start": 36, "end": 37, "span": "AAPC", "e_type": "Disease"}]}
{"idx": 574, "sentence": "Complete genomic sequence and analysis of 0 kb of human DNA containing the gene BRCA0 .", "entities": []}
{"idx": 575, "sentence": "Over 0 distinct disease - associated mutations have been identified in the breast - ovarian cancer susceptibility gene BRCA0 .", "entities": [{"start": 12, "end": 16, "span": "breast - ovarian cancer", "e_type": "Disease"}]}
{"idx": 576, "sentence": "Loss of the wild - type allele in > 0 % of tumors from patients with inherited BRCA0 mutations indicates tumor suppressive function .", "entities": [{"start": 12, "end": 13, "span": "tumors", "e_type": "Disease"}, {"start": 20, "end": 21, "span": "tumor", "e_type": "Disease"}]}
{"idx": 577, "sentence": "The low incidence of somatic mutations suggests that BRCA0 inactivation in sporadic tumors occurs by alternative mechanisms , such as interstitial chromosomal deletion or reduced transcription .", "entities": [{"start": 12, "end": 13, "span": "tumors", "e_type": "Disease"}]}
{"idx": 578, "sentence": "To identify possible features of the BRCA0 genomic region that may contribute to chromosomal instability as well as potential transcriptional regulatory elements , a 0 , 0 - bp DNA sequence encompassing BRCA0 was obtained by random sequencing of four cosmids identified from a human chromosome 0 specific library .", "entities": []}
{"idx": 579, "sentence": "The 0 exons of BRCA0 span an 0 - kb region that has an unusually high density of Alu repetitive DNA ( 0 . 0 % ) , but relatively low density ( 0 . 0 % ) of other repetitive sequences .", "entities": []}
{"idx": 580, "sentence": "BRCA0 intron lengths range in size from 0 bp to 0 .", "entities": []}
{"idx": 581, "sentence": "0 kb and contain the intragenic microsatellite markers D00S0000 , D00S0000 , and D00S000 , which localize to introns 0 , 0 , and 0 , respectively .", "entities": []}
{"idx": 582, "sentence": "In addition to BRCA0 , the contig contains two complete genes Rho0 , a member of the rho family of GTP binding proteins , and VAT0 , an abundant membrane protein of cholinergic synaptic vesicles .", "entities": []}
{"idx": 583, "sentence": "Partial sequences of the 0A0 - 0B B - box protein pseudogene and IFP 0 , an interferon induced leucine zipper protein , reside within the contig .", "entities": []}
{"idx": 584, "sentence": "An L00 ribosomal protein pseudogene is embedded in BRCA0 intron 0 .", "entities": []}
{"idx": 585, "sentence": "The order of genes on the chromosome is centromere - 0FP 0 - VAT0 - Rho0 - BRCA0 - 0A0 - 0B - telomere", "entities": []}
{"idx": 586, "sentence": "Identification of a RING protein that can interact in vivo with the BRCA0 gene product .", "entities": []}
{"idx": 587, "sentence": "The hereditary breast and ovarian cancer gene , BRCA0 , encodes a large polypeptide that contains the cysteine - rich RING motif , a zinc - binding domain found in a variety of regulatory proteins .", "entities": [{"start": 1, "end": 6, "span": "hereditary breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 588, "sentence": "Here we describe a novel protein that interacts in vivo with the N - terminal region of BRCA0 .", "entities": []}
{"idx": 589, "sentence": "This BRCA0 - associated RING domain ( BARD0 ) protein contains an N - terminal RING motif , three tandem ankyrin repeats , and a C - terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA0 .", "entities": []}
{"idx": 590, "sentence": "The BARD0 / BRCA0 interaction is disrupted by BRCA0 missense mutations that segregate with breast cancer susceptibility , indicating that BARD0 may be involved in mediating tumour suppression by BRCA0 . .", "entities": [{"start": 14, "end": 16, "span": "breast cancer", "e_type": "Disease"}, {"start": 26, "end": 27, "span": "tumour", "e_type": "Disease"}]}
{"idx": 591, "sentence": "Detection of heterozygous mutations in BRCA0 using high density oligonucleotide arrays and two - colour fluorescence analysis .", "entities": []}
{"idx": 592, "sentence": "The ability to scan a large gene rapidly and accurately for all possible heterozygous mutations in large numbers of patient samples will be critical for the future of medicine .", "entities": []}
{"idx": 593, "sentence": "We have designed high - density arrays consisting of over 0 , 0 oligonucleotides 0 - nucleotides ( nt ) in length to screen for a wide range of heterozygous mutations in the 0 .", "entities": []}
{"idx": 594, "sentence": "0 - kilobases ( kb ) exon 0 of the hereditary breast and ovarian cancer gene BRCA0 .", "entities": [{"start": 10, "end": 15, "span": "hereditary breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 595, "sentence": "Reference and test samples were co - hybridized to these arrays and differences in hybridization patterns quantitated by two - colour analysis .", "entities": []}
{"idx": 596, "sentence": "Fourteen of fifteen patient samples with known mutations were accurately diagnosed , and no false positive mutations were identified in 0 control samples .", "entities": []}
{"idx": 597, "sentence": "Eight single nucleotide polymorphisms were also readily detected .", "entities": []}
{"idx": 598, "sentence": "DNA chip - based assays may provide a valuable new technology for high - throughput cost - efficient detection of genetic alterations .", "entities": []}
{"idx": 599, "sentence": "Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease : linkage to 0q00 - q00 and loss of the wild type allele in renal hamartomas .", "entities": [{"start": 3, "end": 8, "span": "hyperparathyroidism and jaw tumor syndrome", "e_type": "Disease"}, {"start": 10, "end": 12, "span": "renal hamartomas", "e_type": "Disease"}, {"start": 13, "end": 16, "span": "cystic kidney disease", "e_type": "Disease"}, {"start": 30, "end": 32, "span": "renal hamartomas", "e_type": "Disease"}]}
{"idx": 600, "sentence": "Hereditary hyperparathyroidism - jaw tumor syndrome ( HPT - JT ) is an autosomal dominant disease ( OMIM 0 ) that has recently been mapped to chromosomal region 0q00 - q00 ( HRPT0 ) .", "entities": [{"start": 0, "end": 6, "span": "Hereditary hyperparathyroidism - jaw tumor syndrome", "e_type": "Disease"}, {"start": 7, "end": 10, "span": "HPT - JT", "e_type": "Disease"}, {"start": 13, "end": 16, "span": "autosomal dominant disease", "e_type": "Disease"}]}
{"idx": 601, "sentence": "Here we report two families with HPT - JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features , possibly representing a new phenotypic variant of the HPT - JT syndrome .", "entities": [{"start": 6, "end": 10, "span": "HPT - JT syndrome", "e_type": "Disease"}, {"start": 12, "end": 15, "span": "adult renal hamartomas", "e_type": "Disease"}, {"start": 16, "end": 19, "span": "cystic kidney disease", "e_type": "Disease"}, {"start": 32, "end": 36, "span": "HPT - JT syndrome", "e_type": "Disease"}]}
{"idx": 602, "sentence": "In the first family , renal lesions were present in five out of six affected individuals , whereas HPT and JT were seen in four and two cases , respectively .", "entities": [{"start": 5, "end": 7, "span": "renal lesions", "e_type": "Disease"}, {"start": 18, "end": 19, "span": "HPT", "e_type": "Disease"}, {"start": 20, "end": 21, "span": "JT", "e_type": "Disease"}]}
{"idx": 603, "sentence": "In the second family , JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease .", "entities": [{"start": 5, "end": 6, "span": "JT", "e_type": "Disease"}, {"start": 21, "end": 24, "span": "polycystic kidney disease", "e_type": "Disease"}]}
{"idx": 604, "sentence": "The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out .", "entities": []}
{"idx": 605, "sentence": "A sex - dependent penetrance of primary HPT , resulting in predominantly male - affected cases was evident in the two families .", "entities": [{"start": 6, "end": 8, "span": "primary HPT", "e_type": "Disease"}]}
{"idx": 606, "sentence": "Twenty microsatellite markers in the HRPT0 region were typed , in addition to markers in the multiple endocrine neoplasia ( MEN ) types 1 and 2 regions at 00q00 and 00q00 .", "entities": [{"start": 16, "end": 26, "span": "multiple endocrine neoplasia ( MEN ) types 1 and 2", "e_type": "Disease"}]}
{"idx": 607, "sentence": "The disease in these two kindreds was linked to five markers in the 0q00 - q00 region ( logarithm - of - odds scores 0 . 0 - 0 0 - 0 . 0 ) , whereas linkage to the MEN1 and MEN2 regions was excluded .", "entities": [{"start": 40, "end": 41, "span": "MEN1", "e_type": "Disease"}, {"start": 42, "end": 43, "span": "MEN2", "e_type": "Disease"}]}
{"idx": 608, "sentence": "Meiotic recombinations detected in affected individuals placed the locus telomeric of D0S000 , thus narrowing the HRPT0 region from > 0 to approximately 0 centimorgans .", "entities": []}
{"idx": 609, "sentence": "Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family , as well as in a jaw tumor and a parathyroid tumor from the second family .", "entities": [{"start": 7, "end": 9, "span": "renal hamartomas", "e_type": "Disease"}, {"start": 23, "end": 25, "span": "jaw tumor", "e_type": "Disease"}, {"start": 27, "end": 29, "span": "parathyroid tumor", "e_type": "Disease"}]}
{"idx": 610, "sentence": "All renal hamartomas showed loss of heterozygosity at the 0q00 - q00 region .", "entities": [{"start": 1, "end": 3, "span": "renal hamartomas", "e_type": "Disease"}]}
{"idx": 611, "sentence": "The losses invariably involved the wild type allele derived from the unaffected parent , suggesting the inactivation of a tumor suppressor gene in this region", "entities": [{"start": 19, "end": 20, "span": "tumor", "e_type": "Disease"}]}
{"idx": 612, "sentence": "Independent origin of single and double mutations in the human glucose 0 - phosphate dehydrogenase gene .", "entities": []}
{"idx": 613, "sentence": "The vast majority of both polymorphic and sporadic G0PD variants are due to single missense mutations .", "entities": []}
{"idx": 614, "sentence": "In the four polymorphic variants that have two point mutations , one of the mutations is always 0 A - - > G ( 0 Asn - - > Asp ) , which on its own gives rise to the nondeficient polymorphic variant , G0PD A .", "entities": []}
{"idx": 615, "sentence": "In a study of G6PD deficient patients who presented with clinical favism in Spain , we have found a new polymorphic variant that we have called G0PD Malaga , whose only abnormality is a 0 A - - > T ( 0 Asp - - > Val ) mutation .", "entities": [{"start": 4, "end": 6, "span": "G6PD deficient", "e_type": "Disease"}, {"start": 11, "end": 12, "span": "favism", "e_type": "Disease"}]}
{"idx": 616, "sentence": "This is the same mutation as previously found in association with the mutation of G0PD A in the double mutant , G0PD Santamaria .", "entities": []}
{"idx": 617, "sentence": "G0PD Malaga is associated with enzyme deficiency ( class III ) , and the enzymic properties of G0PD Malaga and G0PD Santamaria are quite similar , indicating that in this case the effects of the two mutations are additive rather than synergistic .", "entities": [{"start": 5, "end": 7, "span": "enzyme deficiency", "e_type": "Disease"}]}
{"idx": 618, "sentence": "G0PD Santamaria might have been produced by recombination between G0PD A and G0PD Malaga ; however haplotype analysis , including the use of a new silent polymorphism , suggests that the same 0 A - - > T mutation has taken place independently in a G0PD B gene to give G0PD Malaga and in a G0PD A gene to give G0PD Santamaria .", "entities": []}
{"idx": 619, "sentence": "These findings help to outline the relationship and evolution of mutations in the human G0PD locus . .", "entities": []}
{"idx": 620, "sentence": "BRCA0 R000W : a strong candidate for a common mutation with moderate phenotype .", "entities": []}
{"idx": 621, "sentence": "BRCA0 mutations cause increased risk for breast and ovarian cancer , frequently of early onset .", "entities": [{"start": 6, "end": 10, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 622, "sentence": "Many different mutations occur in BRCA0 , including several examples of recurrent mutations , each of which accounts for a significant number of families with heritable cancer predisposition .", "entities": [{"start": 26, "end": 27, "span": "cancer", "e_type": "Disease"}]}
{"idx": 623, "sentence": "These common mutations have an etiological role in many breast and ovarian cancer cases and provide the opportunity to examine genotype - phenotype correlations and genotype - environment interactions in individuals with the identical BRCA0 lesion .", "entities": [{"start": 9, "end": 13, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 624, "sentence": "We report a novel missense change in BRCA0 , 0 C - - > T ( R000W ) , found in 0 cases from a subject group of 0 breast and 79 ovarian cancer cases from Orange County , CA .", "entities": [{"start": 29, "end": 34, "span": "breast and 79 ovarian cancer", "e_type": "Disease"}]}
{"idx": 625, "sentence": "These are consecutive , population - based cases not selected for age or family history .", "entities": []}
{"idx": 626, "sentence": "In all three cases , there is a strong family history of breast , ovarian , or other cancers possibly related to a BRCA0 defect and family members showed a high concordance of cancer incidence with the presence of R000W .", "entities": [{"start": 12, "end": 19, "span": "breast , ovarian , or other cancers", "e_type": "Disease"}, {"start": 33, "end": 34, "span": "cancer", "e_type": "Disease"}]}
{"idx": 627, "sentence": "The age of cancer onset was not always distinct from typical sporadic cases .", "entities": [{"start": 3, "end": 4, "span": "cancer", "e_type": "Disease"}]}
{"idx": 628, "sentence": "Testing of a sample of 0 unrelated individuals to examine the hypothesis that R000W might be a rare polymorphism detected one additional instance in a woman with breast cancer diagnosed at age 0 years , and cancer in one parent .", "entities": [{"start": 27, "end": 29, "span": "breast cancer", "e_type": "Disease"}, {"start": 36, "end": 37, "span": "cancer", "e_type": "Disease"}]}
{"idx": 629, "sentence": "R000W is likely to be an etiologically significant lesion with involvement in close to 0 % ( 0 % confidence interval of 0 - 0 . 0 % ) of all breast and ovarian cancers in this population .", "entities": [{"start": 31, "end": 35, "span": "breast and ovarian cancers", "e_type": "Disease"}]}
{"idx": 630, "sentence": "Ataxia - telangiectasia : founder effect among north African Jews .", "entities": [{"start": 0, "end": 3, "span": "Ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 631, "sentence": "The ATM gene is responsible for the autosomal recessive disorder ataxia - telangiectasia ( A - T ) , characterized by cerebellar degeneration , immunodeficiency and cancer predisposition .", "entities": [{"start": 7, "end": 10, "span": "autosomal recessive disorder", "e_type": "Disease"}, {"start": 10, "end": 13, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 14, "end": 17, "span": "A - T", "e_type": "Disease"}, {"start": 21, "end": 23, "span": "cerebellar degeneration", "e_type": "Disease"}, {"start": 24, "end": 25, "span": "immunodeficiency", "e_type": "Disease"}, {"start": 26, "end": 28, "span": "cancer predisposition", "e_type": "Disease"}]}
{"idx": 632, "sentence": "A - T carriers were reported to be moderately cancer - prone .", "entities": [{"start": 0, "end": 3, "span": "A - T", "e_type": "Disease"}, {"start": 9, "end": 12, "span": "cancer - prone", "e_type": "Disease"}]}
{"idx": 633, "sentence": "A wide variety of A - T mutations , most of which are unique to single families , were identified in various ethnic groups , precluding carrier screening with mutation - specific assays .", "entities": [{"start": 4, "end": 7, "span": "A - T", "e_type": "Disease"}]}
{"idx": 634, "sentence": "However , a single mutation was observed in 0 / 0 defective ATM alleles in Jewish A - T families of North African origin , coming from various regions of Morocco and Tunisia .", "entities": [{"start": 16, "end": 19, "span": "A - T", "e_type": "Disease"}]}
{"idx": 635, "sentence": "This mutation , 000C - - > T , results in a stop codon at position 0 of the ATM protein .", "entities": []}
{"idx": 636, "sentence": "In keeping with the nature of this mutation , various antibodies directed against the ATM protein failed to defect this protein in patient cells .", "entities": []}
{"idx": 637, "sentence": "A rapid carrier detection assay detected this mutation in three out of 0 ATM alleles of Jewish Moroccan or Tunisian origin .", "entities": []}
{"idx": 638, "sentence": "This founder effect provides a unique opportunity for population - based screening for A - T carriers in a large Jewish community . .", "entities": [{"start": 13, "end": 16, "span": "A - T", "e_type": "Disease"}]}
{"idx": 639, "sentence": "Mutation analysis of BRCA0 and BRCA0 in a male breast cancer population .", "entities": [{"start": 8, "end": 11, "span": "male breast cancer", "e_type": "Disease"}]}
{"idx": 640, "sentence": "A population - based series of 0 male breast cancer cases from Southern California were analyzed for germ - line mutations in the inherited breast / ovarian cancer genes , BRCA0 and BRCA0 .", "entities": [{"start": 7, "end": 10, "span": "male breast cancer", "e_type": "Disease"}, {"start": 23, "end": 28, "span": "inherited breast / ovarian cancer", "e_type": "Disease"}]}
{"idx": 641, "sentence": "Nine ( 0 % ) of the patients had a family history of breast and / or ovarian cancer in at least one first - degree relative .", "entities": [{"start": 13, "end": 19, "span": "breast and / or ovarian cancer", "e_type": "Disease"}]}
{"idx": 642, "sentence": "A further seven ( 0 % ) of the patients reported breast / ovarian cancer in at least one second - degree relative and in no first - degree relatives .", "entities": [{"start": 11, "end": 15, "span": "breast / ovarian cancer", "e_type": "Disease"}]}
{"idx": 643, "sentence": "No germ - line BRCA0 mutations were found .", "entities": []}
{"idx": 644, "sentence": "Two male breast cancer patients ( 0 % of the total ) were found to carry novel truncating mutations in the BRCA0 gene .", "entities": [{"start": 1, "end": 4, "span": "male breast cancer", "e_type": "Disease"}]}
{"idx": 645, "sentence": "Only one of the two male breast cancer patients carrying a BRCA0 mutation had a family history of cancer , with one case of ovarian cancer in a first - degree relative .", "entities": [{"start": 5, "end": 8, "span": "male breast cancer", "e_type": "Disease"}, {"start": 18, "end": 19, "span": "cancer", "e_type": "Disease"}, {"start": 24, "end": 26, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 646, "sentence": "The remaining eight cases ( 0 % ) of male breast cancer with a family history of breast / ovarian cancer in first - degree relatives remain unaccounted for by mutations in either the BRCA0 gene or the BRCA0 gene . .", "entities": [{"start": 9, "end": 12, "span": "male breast cancer", "e_type": "Disease"}, {"start": 17, "end": 21, "span": "breast / ovarian cancer", "e_type": "Disease"}]}
{"idx": 647, "sentence": "Molecular basis for Duarte and Los Angeles variant galactosemia .", "entities": [{"start": 3, "end": 9, "span": "Duarte and Los Angeles variant galactosemia", "e_type": "Disease"}]}
{"idx": 648, "sentence": "Human orythrocytes that are homozygous for the Duarte enzyme variant of galactosemia ( D / D ) have a characteristic isoform on isoelectric focusing and 0 % reduction in galactose - 0 - phosphate uridyltransferase ( GALT ) enzyme activity .", "entities": [{"start": 7, "end": 12, "span": "Duarte enzyme variant of galactosemia", "e_type": "Disease"}]}
{"idx": 649, "sentence": "The Duarte biochemical phenotype has a molecular genotype of N000D / N000D .", "entities": []}
{"idx": 650, "sentence": "The characteristic Duarte isoform is also associated with a variant called the \" Los Angeles ( LA ) phenotype , \" which has increased GALT enzyme activity .", "entities": []}
{"idx": 651, "sentence": "We evaluated GALT enzyme activity and screened the GALT genes of 0 patients with one or more N000D - containing alleles .", "entities": []}
{"idx": 652, "sentence": "We found seven with the LA biochemical phenotype , and all had a 0000C - - > T transition in exon 0 in cis with the N000D missense mutation .", "entities": []}
{"idx": 653, "sentence": "The 0000C - - > T transition is a neutral polymorphism for leucine at amino acid 0 ( L000L ) .", "entities": []}
{"idx": 654, "sentence": "In pedigree analyses , this 0000C - - > T transition segregated with the LA phenotype of increased GALT activity in three different biochemical phenotypes ( LA / N , LA / G , and LA / D ) .", "entities": []}
{"idx": 655, "sentence": "To determine the mechanism for increased activity of the LA variant , we compared GALT mRNA , protein abundance , and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes .", "entities": []}
{"idx": 656, "sentence": "GALT protein abundance was increased in LA compared to D alleles , but mRNA was similar among all genotypes .", "entities": []}
{"idx": 657, "sentence": "When LA / D and D / D GALT biochemical phenotypes were compared to N / N GALT phenotypes , both had 0 % , as compared to 0 % , reduction in GALT activity in the wild type ( N / N ) after exposure at identical initial enzyme activity to 0 degrees C for 0 min .", "entities": []}
{"idx": 658, "sentence": "We conclude that the codon change N000D in cis with the base - pair transition 0000C - - > T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability .", "entities": [{"start": 22, "end": 26, "span": "LA variant of galactosemia", "e_type": "Disease"}]}
{"idx": 659, "sentence": "A favorable codon bias for the mutated codon with consequently increased translation rates is postulated as the mechanism . .", "entities": []}
{"idx": 660, "sentence": "The TSG000 tumor susceptibility gene is located in chromosome 0 band p00 and is mutated in human breast cancer .", "entities": [{"start": 2, "end": 3, "span": "tumor", "e_type": "Disease"}, {"start": 17, "end": 19, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 661, "sentence": "Recent work has identified a mouse gene ( tsg000 ) whose inactivation in fibroblasts results in cellular transformation and the ability to produce metastatic tumors in nude mice .", "entities": [{"start": 23, "end": 25, "span": "metastatic tumors", "e_type": "Disease"}]}
{"idx": 662, "sentence": "Here , we report that the human homolog , TSG000 , which we isolated and mapped to chromosome 0 , bands 0 .", "entities": []}
{"idx": 663, "sentence": "0 - 0 0 - 0 .", "entities": []}
{"idx": 664, "sentence": "0 , a region proposed to contain tumor suppressor gene ( s ) , is mutated at high frequency in human breast cancer .", "entities": [{"start": 7, "end": 8, "span": "tumor", "e_type": "Disease"}, {"start": 21, "end": 23, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 665, "sentence": "In 0 of 0 uncultured primary human breast carcinomas , intragenic deletions were shown in TSG000 genomic DNA and transcripts by gel and sequence analysis , and mutations affecting two TSG000 alleles were identified in four of these cancers .", "entities": [{"start": 7, "end": 9, "span": "breast carcinomas", "e_type": "Disease"}, {"start": 38, "end": 39, "span": "cancers", "e_type": "Disease"}]}
{"idx": 666, "sentence": "No TSG000 defects were found in matched normal breast tissue from the breast cancer patients .", "entities": [{"start": 12, "end": 14, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 667, "sentence": "These findings strongly implicate TSG000 mutations in human breast cancer", "entities": [{"start": 8, "end": 10, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 668, "sentence": "Moderate intergenerational and somatic instability of a 0 - CTG repeat in transgenic mice .", "entities": []}
{"idx": 669, "sentence": "Myotonic dystrophy ( DM ) is associated with the expansion of a ( CTG ) n trinucleotide repeat in the 0 untranslated region ( UTR ) of the DM protein kinase gene ( DMPK ) .", "entities": [{"start": 0, "end": 2, "span": "Myotonic dystrophy", "e_type": "Disease"}, {"start": 3, "end": 4, "span": "DM", "e_type": "Disease"}, {"start": 28, "end": 29, "span": "DM", "e_type": "Disease"}]}
{"idx": 670, "sentence": "The ( CTG ) n repeat is polymorphic and varies in size between 0 and 0 repeats in unaffected individuals whereas in affected patients there are between 0 and 0 , 0 CTGs .", "entities": []}
{"idx": 671, "sentence": "The size of the ( CTG ) n repeat , which increases through generations , generally correlates with clinical severity and age of onset .", "entities": []}
{"idx": 672, "sentence": "The instability of the CTG repeat appears to depend on its size as well as on the sex of the transmitting parent .", "entities": []}
{"idx": 673, "sentence": "Moreover , mitotic instability analysis of different human DM tissues shows length mosaicism between different cell lineages .", "entities": [{"start": 8, "end": 9, "span": "DM", "e_type": "Disease"}]}
{"idx": 674, "sentence": "The molecular mechanisms of triplet instability remain elusive .", "entities": []}
{"idx": 675, "sentence": "To investigate the role of genomic sequences in instability , we produced transgenic mice containing a 0 - kb genomic segment with a 0 - CTG repeat cloned from a mildly affected patient .", "entities": []}
{"idx": 676, "sentence": "In contrast to other mouse models containing CAG repeats within cDNAs , these mice showed both intergenerational and somatic repeat instability . .", "entities": []}
{"idx": 677, "sentence": "Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome : a molecular and immunological analysis .", "entities": [{"start": 8, "end": 11, "span": "autoimmune lymphoproliferative syndrome", "e_type": "Disease"}]}
{"idx": 678, "sentence": "Programmed cell death ( or apoptosis ) is a physiological process essential to the normal development and homeostatic maintenance of the immune system .", "entities": []}
{"idx": 679, "sentence": "The Fas / Apo - 0 receptor plays a crucial role in the regulation of apoptosis , as demonstrated by lymphoproliferation in MRL - lpr / lpr mice and by the recently described autoimmune lymphoproliferative syndrome ( ALPS ) in humans , both of which are due to mutations in the Fas gene .", "entities": [{"start": 33, "end": 36, "span": "autoimmune lymphoproliferative syndrome", "e_type": "Disease"}, {"start": 37, "end": 38, "span": "ALPS", "e_type": "Disease"}]}
{"idx": 680, "sentence": "We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas - induced apoptosis .", "entities": [{"start": 6, "end": 7, "span": "ALPS", "e_type": "Disease"}]}
{"idx": 681, "sentence": "The children share common clinical features including splenomegaly and lymphadenopathy , but only one developed severe autoimmune manifestations .", "entities": [{"start": 7, "end": 8, "span": "splenomegaly", "e_type": "Disease"}, {"start": 9, "end": 10, "span": "lymphadenopathy", "e_type": "Disease"}, {"start": 16, "end": 18, "span": "autoimmune manifestations", "e_type": "Disease"}]}
{"idx": 682, "sentence": "In all three siblings , we demonstrated the presence of anergic CD0 + CD0 - CD0 - ( double negative , [ DN ] ) T cells ; moreover , a chronic lymphocyte activation was found , as demonstrated by the presence of high levels of HLA - DR expression on peripheral CD0 + cells and by the presence of high levels of serum activation markers such as soluble interleukin - 0 receptor ( slL - 0R ) and soluble CD00 ( sCD00 ) . .", "entities": []}
{"idx": 683, "sentence": "The ataxia - telangiectasia gene product , a constitutively expressed nuclear protein that is not up - regulated following genome damage .", "entities": [{"start": 1, "end": 4, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 684, "sentence": "The product of the ataxia - telangiectasia gene ( ATM ) was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid sequence .", "entities": [{"start": 4, "end": 7, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 685, "sentence": "The ATM protein is a single , high - molecular weight protein predominantly confined to the nucleus of human fibroblasts , but is present in both nuclear and microsomal fractions from human lymphoblast cells and peripheral blood lymphocytes .", "entities": []}
{"idx": 686, "sentence": "ATM protein levels and localization remain constant throughout all stages of the cell cycle .", "entities": []}
{"idx": 687, "sentence": "Truncated ATM protein was not detected in lymphoblasts from ataxia - telangiectasia patients homozygous for mutations leading to premature protein termination .", "entities": [{"start": 9, "end": 12, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 688, "sentence": "Exposure of normal human cells to gamma - irradiation and the radiomimetic drug neocarzinostatin had no effect on ATM protein levels , in contrast to a noted rise in p00 levels over the same time interval .", "entities": []}
{"idx": 689, "sentence": "These findings are consistent with a role for the ATM protein in ensuring the fidelity of DNA repair and cell cycle regulation following genome damage . .", "entities": []}
{"idx": 690, "sentence": "Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development .", "entities": []}
{"idx": 691, "sentence": "Type III collagen is a fibrillar forming collagen comprising three alpha0 ( III ) chains and is expressed in early embryos and throughout embryogenesis .", "entities": []}
{"idx": 692, "sentence": "In the adult , type III collagen is a major component of the extracellular matrix in a variety of internal organs and skin .", "entities": []}
{"idx": 693, "sentence": "Mutations in the COL0A0 gene have been implicated as a cause of type IV Ehlers - Danlos syndrome , a disease leading to aortic rupture in early adult life .", "entities": [{"start": 12, "end": 18, "span": "type IV Ehlers - Danlos syndrome", "e_type": "Disease"}, {"start": 23, "end": 25, "span": "aortic rupture", "e_type": "Disease"}]}
{"idx": 694, "sentence": "To directly study the role of Col0a0 in development and disease , we have inactivated the Col0a0 gene in embryonic stem cells by homologous recombination .", "entities": []}
{"idx": 695, "sentence": "The mutated allele was transmitted through the mouse germ line and homozygous mutant animals were derived from heterozygous intercrosses .", "entities": []}
{"idx": 696, "sentence": "About 0 % of the homozygous mutant animals survived to adulthood but have a much shorter life span compared with wild - type mice .", "entities": []}
{"idx": 697, "sentence": "The major cause of death of mutant mice was rupture of the major blood vessels , similar to patients with type IV Ehlers - Danlos syndrome .", "entities": [{"start": 20, "end": 26, "span": "type IV Ehlers - Danlos syndrome", "e_type": "Disease"}]}
{"idx": 698, "sentence": "Ultrastructural analysis of tissues from mutant mice revealed that type III collagen is essential for normal collagen I fibrillogenesis in the cardiovascular system and other organs . .", "entities": []}
{"idx": 699, "sentence": "Nonsense mutation in exon 0 of the proteolipid protein gene ( PLP ) in a family with an unusual form of Pelizaeus - Merzbacher disease .", "entities": [{"start": 21, "end": 25, "span": "Pelizaeus - Merzbacher disease", "e_type": "Disease"}]}
{"idx": 700, "sentence": "We report a G - - > A transition at nucleotide 0 of the proteolipid protein gene ( PLP ) results in a nonsense codon in a family with an unusual form of Pelizaeus - Merzbacher disease ( PMD ) .", "entities": [{"start": 33, "end": 37, "span": "Pelizaeus - Merzbacher disease", "e_type": "Disease"}, {"start": 38, "end": 39, "span": "PMD", "e_type": "Disease"}]}
{"idx": 701, "sentence": "The mutation , which creates a second AluI restriction site , results in a nonsense mutation in PLP .", "entities": []}
{"idx": 702, "sentence": "The clinical picture resembles somewhat that of X - linked spastic paraplegia ( SPG ) .", "entities": [{"start": 7, "end": 12, "span": "X - linked spastic paraplegia", "e_type": "Disease"}, {"start": 13, "end": 14, "span": "SPG", "e_type": "Disease"}]}
{"idx": 703, "sentence": "It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form , onset is delayed beyond age 0 years , nystagmus is absent , tremors are prominent , mental retardation is not severe , some patients show dementia or personality disorders , the disease is progressive rather than static in some , and several females show signs of disease .", "entities": [{"start": 12, "end": 13, "span": "PMD", "e_type": "Disease"}, {"start": 30, "end": 31, "span": "nystagmus", "e_type": "Disease"}, {"start": 34, "end": 35, "span": "tremors", "e_type": "Disease"}, {"start": 38, "end": 40, "span": "mental retardation", "e_type": "Disease"}, {"start": 47, "end": 48, "span": "dementia", "e_type": "Disease"}, {"start": 49, "end": 51, "span": "personality disorders", "e_type": "Disease"}]}
{"idx": 704, "sentence": "The nonsense mutation , which is in exon 0B , should block the synthesis of normal PLP but spare DM00 , the isoform whose persistence has been associated with mild forms of PLP - associated disease in both humans and mice . .", "entities": [{"start": 32, "end": 36, "span": "PLP - associated disease", "e_type": "Disease"}]}
{"idx": 705, "sentence": "Common BRCA0 variants and susceptibility to breast and ovarian cancer in the general population .", "entities": [{"start": 6, "end": 10, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 706, "sentence": "Most multiple case families of young onset breast cancer and ovarian cancer are thought to be due to highly penetrant mutations in the predisposing genes BRCA0 and BRCA0 .", "entities": [{"start": 7, "end": 9, "span": "breast cancer", "e_type": "Disease"}, {"start": 10, "end": 12, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 707, "sentence": "However , these mutations are uncommon in the population and they probably account for only a few percent of all breast cancer incidence .", "entities": [{"start": 20, "end": 22, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 708, "sentence": "A much larger fraction of breast cancer might , in principle , be due to common variants which confer more modest individual risks .", "entities": [{"start": 5, "end": 7, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 709, "sentence": "There are several common polymorphisms in the BRCA0 gene which generate amino acid substitutions .", "entities": []}
{"idx": 710, "sentence": "We have examined the frequency of four of these polymorphisms Gln000Arg , Pro000Leu , Glu0000Gly and Ser0000Gly in large series of breast and ovarian cancer cases and matched controls .", "entities": [{"start": 21, "end": 25, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 711, "sentence": "Due to strong linkage disequilibrium , these four sites generate only three haplotypes with a frequency > 0 .", "entities": []}
{"idx": 712, "sentence": "0 % .", "entities": []}
{"idx": 713, "sentence": "The most common haplotypes , defined by the alleles Gln000Pro000Glu0000Ser0000 and Gln000Leu000Gly0000Gly0000 , have frequencies of 0 .", "entities": []}
{"idx": 714, "sentence": "0 and 0 .", "entities": []}
{"idx": 715, "sentence": "0 respectively , and these frequencies do not differ significantly between patient and control groups .", "entities": []}
{"idx": 716, "sentence": "Thus the most common polymorphisms of the BRCA0 gene do not make a significant contribution to breast or ovarian cancer risk .", "entities": [{"start": 16, "end": 20, "span": "breast or ovarian cancer", "e_type": "Disease"}]}
{"idx": 717, "sentence": "However , our data suggest that the Arg000 allele may have a different genotype distribution in breast cancer patients from that in controls ( Arg000 homozygotes are more frequent in the control groups , P = 0 . 0 ) , indicating that it may be protective against breast cancer .", "entities": [{"start": 16, "end": 18, "span": "breast cancer", "e_type": "Disease"}, {"start": 48, "end": 50, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 718, "sentence": "If this finding can be confirmed , it may provide an insight into the structural features of the BRCA0 protein that are important for its function .", "entities": []}
{"idx": 719, "sentence": "Kniest dysplasia : Dr . W .", "entities": [{"start": 0, "end": 2, "span": "Kniest dysplasia", "e_type": "Disease"}]}
{"idx": 720, "sentence": "Kniest , his patient , the molecular defect .", "entities": []}
{"idx": 721, "sentence": "Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen .", "entities": [{"start": 0, "end": 2, "span": "Kniest dysplasia", "e_type": "Disease"}, {"start": 5, "end": 6, "span": "chondrodysplasia", "e_type": "Disease"}, {"start": 9, "end": 15, "span": "defective formation of type II collagen", "e_type": "Disease"}]}
{"idx": 722, "sentence": "We report about Dr . Kniest , who first described the condition in 0 , and his patient , who , at the age of 0 years is severely handicapped with short stature , restricted joint mobility , and blindness but is mentally alert and leads an active life .", "entities": [{"start": 28, "end": 30, "span": "severely handicapped", "e_type": "Disease"}, {"start": 31, "end": 33, "span": "short stature", "e_type": "Disease"}, {"start": 34, "end": 37, "span": "restricted joint mobility", "e_type": "Disease"}, {"start": 39, "end": 40, "span": "blindness", "e_type": "Disease"}]}
{"idx": 723, "sentence": "Molecular analysis of the patients DNA showed a single base ( G ) deletion involving the GT dinucleotide at the start of intron 0 destroying a splice site of the COL0A0 gene .", "entities": []}
{"idx": 724, "sentence": "This is in accordance with molecular findings in other patients with Kniest dysplasia and confirms , in the original patient , that the disorder is caused by small inframe deletions often due to exon skipping as a result of COL0A0 splice site mutations . .", "entities": [{"start": 11, "end": 13, "span": "Kniest dysplasia", "e_type": "Disease"}]}
{"idx": 725, "sentence": "Cloning of the homogentisate 0 , 0 - dioxygenase gene , the key enzyme of alkaptonuria in mouse .", "entities": [{"start": 15, "end": 16, "span": "alkaptonuria", "e_type": "Disease"}]}
{"idx": 726, "sentence": "We determined 0 amino acid residues from five peptides from the homogeneous monomer of homogentisate 0 , 0 - dioxygenase ( HGO ; E . C . 0 . 0 . 0 . 0 ) of mouse liver .", "entities": []}
{"idx": 727, "sentence": "After digestion with trypsin , peptides were separated by reversed phase chromatography and amino acid sequenced .", "entities": []}
{"idx": 728, "sentence": "The deduced codon sequence of three peptides was used to derive degenerated oligomeres .", "entities": []}
{"idx": 729, "sentence": "By combining these oligos , we were able to amplify fragments from 0 to 0 bases ( b ) from mouse liver cDNA by polymerase chain reaction after reverse transcription ( RT - PCR ) .", "entities": []}
{"idx": 730, "sentence": "A fragment of 0 b was cloned and used as a probe to screen a mouse liver cDNA library .", "entities": []}
{"idx": 731, "sentence": "One clone from this library contained the complete cDNA - insert for HGO as determined by sequencing .", "entities": []}
{"idx": 732, "sentence": "The cDNA encodes for a protein of 0 kDa , as predicted .", "entities": []}
{"idx": 733, "sentence": "The cDNA of mouse HGO has an overall identity of 0 % to the corresponding gene hmgA from Aspergillus .", "entities": []}
{"idx": 734, "sentence": "Sequence similarities to human expressed sequence tags ( EST ) clones ranged from 0 % to 0 % .", "entities": []}
{"idx": 735, "sentence": "The positions of 0 conserved amino acids could be determined by multiple sequence alignment .", "entities": []}
{"idx": 736, "sentence": "We identified one first intron of 0 b in the mouse gene .", "entities": []}
{"idx": 737, "sentence": "The gene for HGO seems to be expressed in various tissues , as shown by RT - PCR on different cDNAs .", "entities": []}
{"idx": 738, "sentence": "FISH experiments with the whole murine cDNA as probe clearly revealed signals at the human chromosomal band 0q00 .", "entities": []}
{"idx": 739, "sentence": "0 - q00 .", "entities": []}
{"idx": 740, "sentence": "This corresponds well to the previous assignment of the locus for the human alkaptonuria gene ( AKU ) to the same chromosomal region by multipoint linkage analysis .", "entities": [{"start": 13, "end": 14, "span": "alkaptonuria", "e_type": "Disease"}]}
{"idx": 741, "sentence": "We therefore conclude that the HGO cDNA encodes the gene responsible for alkaptonuria .", "entities": [{"start": 12, "end": 13, "span": "alkaptonuria", "e_type": "Disease"}]}
{"idx": 742, "sentence": "PTEN , a putative protein tyrosine phosphatase gene mutated in human brain , breast , and prostate cancer .", "entities": [{"start": 11, "end": 18, "span": "brain , breast , and prostate cancer", "e_type": "Disease"}]}
{"idx": 743, "sentence": "Mapping of homozygous deletions on human chromosome 00q00 has led to the isolation of a candidate tumor suppressor gene , PTEN , that appears to be mutated at considerable frequency in human cancers .", "entities": [{"start": 16, "end": 17, "span": "tumor", "e_type": "Disease"}, {"start": 32, "end": 33, "span": "cancers", "e_type": "Disease"}]}
{"idx": 744, "sentence": "In preliminary screens , mutations of PTEN were detected in 0 % ( 0 / 0 ) of glioblastoma cell lines and xenografts , 0 % ( 0 / 0 ) of prostate cancer cell lines , 0 % ( 0 / 0 ) of breast cancer cell lines and xenografts , and 0 % ( 0 / 0 ) of primary glioblastomas .", "entities": [{"start": 18, "end": 19, "span": "glioblastoma", "e_type": "Disease"}, {"start": 32, "end": 34, "span": "prostate cancer", "e_type": "Disease"}, {"start": 45, "end": 47, "span": "breast cancer", "e_type": "Disease"}, {"start": 61, "end": 63, "span": "primary glioblastomas", "e_type": "Disease"}]}
{"idx": 745, "sentence": "The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin , a protein that interacts with actin filaments at focal adhesions .", "entities": []}
{"idx": 746, "sentence": "These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions . .", "entities": [{"start": 7, "end": 8, "span": "tumor", "e_type": "Disease"}, {"start": 18, "end": 19, "span": "tumor", "e_type": "Disease"}, {"start": 22, "end": 23, "span": "metastasis", "e_type": "Disease"}]}
{"idx": 747, "sentence": "Heterogeneity in Schwartz - Jampel chondrodystrophic myotonia .", "entities": [{"start": 2, "end": 7, "span": "Schwartz - Jampel chondrodystrophic myotonia", "e_type": "Disease"}]}
{"idx": 748, "sentence": "The Schwartz - Jampel syndrome ( SJS ; chondrodystrophic myotonia ; McK 0 , 0 ) is a recessively inherited condition defined by myotonia , short stature , and bone dysplasia .", "entities": [{"start": 1, "end": 5, "span": "Schwartz - Jampel syndrome", "e_type": "Disease"}, {"start": 6, "end": 7, "span": "SJS", "e_type": "Disease"}, {"start": 8, "end": 10, "span": "chondrodystrophic myotonia", "e_type": "Disease"}, {"start": 18, "end": 21, "span": "recessively inherited condition", "e_type": "Disease"}, {"start": 23, "end": 24, "span": "myotonia", "e_type": "Disease"}, {"start": 25, "end": 27, "span": "short stature", "e_type": "Disease"}, {"start": 29, "end": 31, "span": "bone dysplasia", "e_type": "Disease"}]}
{"idx": 749, "sentence": "Genetic linkage between SJS and chromosomal region 0q00 - 0 has been observed in several families , but the gene has not yet been identified .", "entities": [{"start": 3, "end": 4, "span": "SJS", "e_type": "Disease"}]}
{"idx": 750, "sentence": "We studied the clinical and radiological features in 0 patients from the literature and 0 own patients trying to identify distinct subgroups .", "entities": []}
{"idx": 751, "sentence": "In addition , we tested genetic linkage to the SJS locus on chromosome 0 in one family with two affected sibs .", "entities": [{"start": 9, "end": 10, "span": "SJS", "e_type": "Disease"}]}
{"idx": 752, "sentence": "We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia , while another group of patients appear to have primary bone dysplasia with myotonia .", "entities": [{"start": 17, "end": 18, "span": "myotonia", "e_type": "Disease"}, {"start": 28, "end": 30, "span": "bone dysplasia", "e_type": "Disease"}, {"start": 31, "end": 32, "span": "myotonia", "e_type": "Disease"}]}
{"idx": 753, "sentence": "Within this latter group , there are differences in age of manifestation , clinical course and pattern of bone changes .", "entities": []}
{"idx": 754, "sentence": "We tentatively isolate three different types of SJS type 1A , usually recognized in childhood , with moderate bone dysplasia , corresponding to the original descriptions of Schwartz , Jampel and Aberfeld ; type 0B , similar to type 0A but recognizable at birth , with more pronounced bone dysplasia resembling Kniest dysplasia ; and type 0 , manifest at birth , with increased mortality and bone dysplasia resembling Pyle disease .", "entities": [{"start": 7, "end": 10, "span": "SJS type 1A", "e_type": "Disease"}, {"start": 18, "end": 20, "span": "bone dysplasia", "e_type": "Disease"}, {"start": 48, "end": 50, "span": "bone dysplasia", "e_type": "Disease"}, {"start": 51, "end": 53, "span": "Kniest dysplasia", "e_type": "Disease"}, {"start": 66, "end": 68, "span": "bone dysplasia", "e_type": "Disease"}, {"start": 69, "end": 71, "span": "Pyle disease", "e_type": "Disease"}]}
{"idx": 755, "sentence": "Genetic analysis of the family with two sibs affected by SJS type 2 showed evidence against linkage to chromosome 0p00 - 0 .", "entities": [{"start": 10, "end": 13, "span": "SJS type 2", "e_type": "Disease"}]}
{"idx": 756, "sentence": "CONCLUSIONS SJS is clinically and radiologically heterogeneous .", "entities": [{"start": 1, "end": 2, "span": "SJS", "e_type": "Disease"}]}
{"idx": 757, "sentence": "The causes of heterogeneity are not known yet but are likely to include both different mutations at the SJS locus on chromosome 0 and the presence of a second SJS locus .", "entities": [{"start": 18, "end": 19, "span": "SJS", "e_type": "Disease"}, {"start": 29, "end": 30, "span": "SJS", "e_type": "Disease"}]}
{"idx": 758, "sentence": "A tentative clinico - radiological classification can be useful for the characterization of patients and the development of genotype - phenotype correlations . .", "entities": []}
{"idx": 759, "sentence": "A clinical overview of WT0 gene mutations .", "entities": []}
{"idx": 760, "sentence": "Mutations in the WT0 gene were anticipated to explain the genetic basis of the childhood kidney cancer , Wilms tumour ( WT ) .", "entities": [{"start": 15, "end": 17, "span": "kidney cancer", "e_type": "Disease"}, {"start": 18, "end": 20, "span": "Wilms tumour", "e_type": "Disease"}, {"start": 21, "end": 22, "span": "WT", "e_type": "Disease"}]}
{"idx": 761, "sentence": "Six years on , we review 0 reports of intragenic WT0 mutations and examine the accompanying clinical phenotypes .", "entities": []}
{"idx": 762, "sentence": "While only 0 % of sporadic Wilms tumours have intragenic WT0 mutations , > 0 % of patients with the Denys - Drash syndrome ( renal nephropathy , gonadal anomaly , predisposition to WT ) carry constitutional intragenic WT0 mutations .", "entities": [{"start": 5, "end": 8, "span": "sporadic Wilms tumours", "e_type": "Disease"}, {"start": 20, "end": 24, "span": "Denys - Drash syndrome", "e_type": "Disease"}, {"start": 25, "end": 27, "span": "renal nephropathy", "e_type": "Disease"}, {"start": 28, "end": 30, "span": "gonadal anomaly", "e_type": "Disease"}, {"start": 31, "end": 34, "span": "predisposition to WT", "e_type": "Disease"}]}
{"idx": 763, "sentence": "WT0 mutations have also been reported in juvenile granulosa cell tumour , non - asbestos related mesothelioma , desmoplastic small round cell tumour and , most recently , acute myeloid leukemia . .", "entities": [{"start": 7, "end": 11, "span": "juvenile granulosa cell tumour", "e_type": "Disease"}, {"start": 12, "end": 17, "span": "non - asbestos related mesothelioma", "e_type": "Disease"}, {"start": 18, "end": 23, "span": "desmoplastic small round cell tumour", "e_type": "Disease"}, {"start": 28, "end": 31, "span": "acute myeloid leukemia", "e_type": "Disease"}]}
{"idx": 764, "sentence": "A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel .", "entities": [{"start": 3, "end": 7, "span": "autosomal dominant myotonia congenita", "e_type": "Disease"}]}
{"idx": 765, "sentence": "Autosomal dominant myotonia congenita is an inherited disorder of skeletal muscle caused by mutations in a voltage - gated Cl - channel gene ( CLCN0 , 0q00 ) .", "entities": [{"start": 0, "end": 4, "span": "Autosomal dominant myotonia congenita", "e_type": "Disease"}, {"start": 6, "end": 11, "span": "inherited disorder of skeletal muscle", "e_type": "Disease"}]}
{"idx": 766, "sentence": "Here , we report that a mutation predicting the substitution of Gly 0 by glutamic acid ( G000E ) between segments D0 and D0 dramatically alters the pore properties of a recombinant human muscle Cl - channel ( hCIC - 0 ) expressed in a mammalian cell line ( tsA000 ) .", "entities": []}
{"idx": 767, "sentence": "The G000E mutation causes substantial changes in anion and cation selectivity as well as a fundamental change in rectification of the current - voltage relationship .", "entities": []}
{"idx": 768, "sentence": "Whereas wild - type channels are characterized by pronounced inward rectification and a Cl > thiocyanate > Br > NO ( 0 ) > I > CH ( 0 ) SO ( 0 ) selectivity , G000E exhibits outward rectification at positive potentials and a thiocyanate > NO ( 0 ) > I > Br > Cl > CH ( 0 ) SO ( 0 ) selectivity .", "entities": []}
{"idx": 769, "sentence": "Furthermore , the cation - to - anion permeability ratio of the mutant is much greater than that of the wild - type channel .", "entities": []}
{"idx": 770, "sentence": "Voltage - dependent blocks by intracellular and extracellular iodide help to distinguish two distinct ion binding sites within the hClC - 0 conduction pathway .", "entities": []}
{"idx": 771, "sentence": "Both binding sites are preserved in the mutant but have decreased affinities for iodide .", "entities": []}
{"idx": 772, "sentence": "These findings suggest that Gly 0 is critical for normal ion conductance in hClC - 0 and that this residue resides within the channel pore . .", "entities": []}
{"idx": 773, "sentence": "The incidence of PAX0 mutation in patients with simple aniridia : an evaluation of mutation detection in 0 cases .", "entities": [{"start": 9, "end": 10, "span": "aniridia", "e_type": "Disease"}]}
{"idx": 774, "sentence": "Twelve aniridia patients , five with a family history and seven presumed to be sporadic , were exhaustively screened in order to test what proportion of people with aniridia , uncomplicated by associated anomalies , carry mutations in the human PAX0 gene .", "entities": [{"start": 1, "end": 2, "span": "aniridia", "e_type": "Disease"}, {"start": 28, "end": 29, "span": "aniridia", "e_type": "Disease"}]}
{"idx": 775, "sentence": "Mutations were detected in 0 % of the cases .", "entities": []}
{"idx": 776, "sentence": "Three mutation detection techniques were used to determine if one method was superior for this gene .", "entities": []}
{"idx": 777, "sentence": "The protein truncation test ( PTT ) was used on RT - PCR products , SSCP on genomic PCR amplifications , and chemical cleavage of mismatch on both RT - PCR and genomic amplifications .", "entities": []}
{"idx": 778, "sentence": "For RT - PCR products , only the translated portion of the gene was screened .", "entities": []}
{"idx": 779, "sentence": "On genomic products exons 0 to 0 ( including 0 bp of the 0 untranslated sequence and all intron / exon boundaries ) were screened , as was a neuroretina specific enhancer in intron 0 .", "entities": []}
{"idx": 780, "sentence": "Ten of the possible 0 mutations in the five familial cases and five of the sporadic patients were found , all of which conformed to a functional outcome of haploinsufficiency .", "entities": []}
{"idx": 781, "sentence": "Five were splice site mutations ( one in the donor site of intron 0 , two in the donor site of intron 0 , one in each of the acceptor sites of introns 0 and 0 ) and five were nonsense mutations in exons 0 , 0 , 0 , 0 , and 0 .", "entities": []}
{"idx": 782, "sentence": "SSCP analysis of individually amplified exons , with which nine of the 0 mutations were seen , was the most useful detection method for PAX0 . .", "entities": []}
{"idx": 783, "sentence": "Insulin gene region contributes to genetic susceptibility to , but may not to low incidence of , insulin - dependent diabetes mellitus in Japanese .", "entities": [{"start": 17, "end": 22, "span": "insulin - dependent diabetes mellitus", "e_type": "Disease"}]}
{"idx": 784, "sentence": "In the Caucasian population , it has been demonstrated that the insulin gene ( INS ) region contains the insulin - dependent diabetes mellitus locus ( IDDM0 ) .", "entities": [{"start": 19, "end": 24, "span": "insulin - dependent diabetes mellitus", "e_type": "Disease"}]}
{"idx": 785, "sentence": "In the Japanese population , however , there has been no report demonstrating the contribution of IDDM0 to the pathogenesis of IDDM .", "entities": [{"start": 21, "end": 22, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 786, "sentence": "We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region .", "entities": [{"start": 6, "end": 7, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 787, "sentence": "We found a significant association of the INS region with IDDM .", "entities": [{"start": 10, "end": 11, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 788, "sentence": "Alleles positively associated with IDDM in INS region were the same as those positively - associated with IDDM in Caucasian population , although positively - associated alleles are very common ( allele frequencies > 0 . 0 ) in the Japanese general population .", "entities": [{"start": 4, "end": 5, "span": "IDDM", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 789, "sentence": "These data suggest that IDDM0 is involved in the genetic susceptibility to IDDM in Japanese .", "entities": [{"start": 12, "end": 13, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 790, "sentence": "The high frequencies of disease - associated alleles in the general population suggest that IDDM0 locus is not responsible for the low incidence of IDDM in Japanese .", "entities": [{"start": 24, "end": 25, "span": "IDDM", "e_type": "Disease"}]}
{"idx": 791, "sentence": "The human complement C0 gene : identification of two mutations causing deficiency and revision of the gene structure .", "entities": []}
{"idx": 792, "sentence": "The ninth component of human complement ( C0 ) is the last of the terminal complement components creating the membrane attack complex .", "entities": []}
{"idx": 793, "sentence": "C0 is a single - chain serum protein that is encoded by a gene located on chromosome 0p .", "entities": []}
{"idx": 794, "sentence": "Deficiency of terminal complement components is generally associated with recurrent neisseria infections .", "entities": [{"start": 0, "end": 5, "span": "Deficiency of terminal complement components", "e_type": "Disease"}, {"start": 10, "end": 12, "span": "neisseria infections", "e_type": "Disease"}]}
{"idx": 795, "sentence": "We studied a previously described Swiss family with inherited C9 deficiency .", "entities": [{"start": 8, "end": 11, "span": "inherited C9 deficiency", "e_type": "Disease"}]}
{"idx": 796, "sentence": "To identify the genetic basis of C9 deficiency , we developed an approach using exon - specific PCR and direct DNA sequencing .", "entities": [{"start": 6, "end": 8, "span": "C9 deficiency", "e_type": "Disease"}]}
{"idx": 797, "sentence": "As a cause of C9 deficiency , we found two different point mutations , both generating TGA stop codons in the coding sequence .", "entities": [{"start": 4, "end": 6, "span": "C9 deficiency", "e_type": "Disease"}]}
{"idx": 798, "sentence": "One mutation , a C to A exchange , was detected in exon 0 at cDNA position 0 , the other , a C to T exchange , was located in exon 0 ( cDNA position 0 ) .", "entities": []}
{"idx": 799, "sentence": "In family studies of three first - degree relatives with heterozygous C9 deficiency , we demonstrated that the two mutations are segregating independently .", "entities": [{"start": 11, "end": 13, "span": "C9 deficiency", "e_type": "Disease"}]}
{"idx": 800, "sentence": "Therefore , these mutations are sufficient to explain the complete deficiency of both the probands studied .", "entities": []}
{"idx": 801, "sentence": "DNA sequencing of the exon - intron junctions revealed a number of revisions regarding the boundaries between exons 0 , 0 , and 0 as well as between exons 0 and 0 .", "entities": []}
{"idx": 802, "sentence": "No additional introns were detected in exons 0 and 0 .", "entities": []}
{"idx": 803, "sentence": "Furthermore , DNA marker studies were conducted using known polymorphisms of the C0 , C0 , and C0 genes , confirming the linkage of the observed C0 mutations with defined haplotypes . .", "entities": []}
{"idx": 804, "sentence": "BRCA0 mutations in women attending clinics that evaluate the risk of breast cancer .", "entities": [{"start": 11, "end": 13, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 805, "sentence": "BACKGROUND To define the incidence of BRCA0 mutations among patients seen in clinics that evaluate the risk of breast cancer , we analyzed DNA samples from women seen in this setting and constructed probability tables to provide estimates of the likelihood of finding a BRCA0 mutation in individual families .", "entities": [{"start": 18, "end": 20, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 806, "sentence": "METHODS Clinical information , family histories , and blood for DNA analysis were obtained from 0 women with breast cancer .", "entities": [{"start": 18, "end": 20, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 807, "sentence": "Conformation - sensitive gel electrophoresis and DNA sequencing were used to identify BRCA0 mutations .", "entities": []}
{"idx": 808, "sentence": "RESULTS BRCA0 mutations were identified in 0 percent of women with a family history of breast cancer .", "entities": [{"start": 15, "end": 17, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 809, "sentence": "Only 0 percent of women from families with a history of breast cancer but not ovarian cancer had BRCA0 mutations .", "entities": [{"start": 11, "end": 13, "span": "breast cancer", "e_type": "Disease"}, {"start": 15, "end": 17, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 810, "sentence": "The rates were higher among women from families with a history of both breast and ovarian cancer .", "entities": [{"start": 13, "end": 17, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 811, "sentence": "Among family members , an average age of less than 0 years at the diagnosis of breast cancer , the presence of ovarian cancer , the presence of breast and ovarian cancer in the same woman , and Ashkenazi Jewish ancestry were all associated with an increased risk of detecting a BRCA0 mutation .", "entities": [{"start": 16, "end": 18, "span": "breast cancer", "e_type": "Disease"}, {"start": 22, "end": 24, "span": "ovarian cancer", "e_type": "Disease"}, {"start": 28, "end": 32, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 812, "sentence": "No association was found between the presence of bilateral breast cancer or the number of breast cancers in a family and the detection of a BRCA0 mutation , or between the position of the mutation in the BRCA0 gene and the presence of ovarian cancer in a family .", "entities": [{"start": 9, "end": 11, "span": "breast cancer", "e_type": "Disease"}, {"start": 15, "end": 17, "span": "breast cancers", "e_type": "Disease"}, {"start": 43, "end": 45, "span": "ovarian cancer", "e_type": "Disease"}]}
{"idx": 813, "sentence": "CONCLUSIONS Among women with breast cancer and a family history of the disease , the percentage with BRCA0 coding - region mutations is less than the 0 percent predicted by genetic - linkage analysis .", "entities": [{"start": 4, "end": 6, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 814, "sentence": "These results suggest that even in a referral clinic specializing in screening women from high - risk families , the majority of tests for BRCA0 mutations will be negative and therefore uninformative . .", "entities": []}
{"idx": 815, "sentence": "Mutations in the arginine - rich protein gene ( ARP ) in pancreatic cancer .", "entities": [{"start": 12, "end": 14, "span": "pancreatic cancer", "e_type": "Disease"}]}
{"idx": 816, "sentence": "The ARP gene encodes a highly conserved arginine - rich protein from chromosomal band 0p00 .", "entities": []}
{"idx": 817, "sentence": "0 0 .", "entities": []}
{"idx": 818, "sentence": "At the cytogenetic level this region is frequently deleted in a variety of different solid tumors , although not in pancreatic cancer .", "entities": [{"start": 14, "end": 16, "span": "solid tumors", "e_type": "Disease"}, {"start": 20, "end": 22, "span": "pancreatic cancer", "e_type": "Disease"}]}
{"idx": 819, "sentence": "We have reported the presence of a specific mutation ( ATG00 - - > AGG ) or deletion of codon 0 of the ARP gene in different tumor types ( Shridhar et al . , 0 , 0000a ) .", "entities": [{"start": 27, "end": 29, "span": "tumor types", "e_type": "Disease"}]}
{"idx": 820, "sentence": "In the present study , we have observed mutations involving codon 0 in 0 of 0 pancreatic tumors .", "entities": [{"start": 16, "end": 18, "span": "pancreatic tumors", "e_type": "Disease"}]}
{"idx": 821, "sentence": "The frequency of codon 0 mutation is roughly the same in pancreatic tumors as in the other types of tumors previously examined .", "entities": [{"start": 11, "end": 13, "span": "pancreatic tumors", "e_type": "Disease"}, {"start": 19, "end": 20, "span": "tumors", "e_type": "Disease"}]}
{"idx": 822, "sentence": "In addition , we have detected mutations at codon 0 in multiple PCR subclones in two other pancreatic tumors .", "entities": [{"start": 17, "end": 19, "span": "pancreatic tumors", "e_type": "Disease"}]}
{"idx": 823, "sentence": "Mutations in the ARP gene are thus commonly observed in pancreatic cancer , as well as many other cancers .", "entities": [{"start": 10, "end": 12, "span": "pancreatic cancer", "e_type": "Disease"}, {"start": 18, "end": 19, "span": "cancers", "e_type": "Disease"}]}
{"idx": 824, "sentence": "Difficulties in the ascertainment of C9 deficiency : lessons to be drawn from a compound heterozygote C9 - deficient subject .", "entities": [{"start": 5, "end": 7, "span": "C9 deficiency", "e_type": "Disease"}, {"start": 16, "end": 19, "span": "C9 - deficient", "e_type": "Disease"}]}
{"idx": 825, "sentence": "A group of patients with long - surviving mismatched kidney allografts were investigated for complement function using haemolytic assays in agarose gels .", "entities": []}
{"idx": 826, "sentence": "One patient was found to have no alternative pathway activity but a low normal classical pathway .", "entities": []}
{"idx": 827, "sentence": "Surprisingly , investigation revealed that the patients complement was normal for all components except C0 , which was functionally absent .", "entities": []}
{"idx": 828, "sentence": "The patient was shown to be heterozygous for DNA markers in the C0 , C0 and C0 region of chromosome 0 and therefore appears to be a compound heterozygote for two uncharacterized C9 deficiency genes .", "entities": [{"start": 32, "end": 34, "span": "C9 deficiency", "e_type": "Disease"}]}
{"idx": 829, "sentence": "Serological analysis by ELISA revealed that he has trace concentrations of a non - functional C0 molecule .", "entities": []}
{"idx": 830, "sentence": "Western blot analysis was not sufficiently sensitive to permit detection of this molecule .", "entities": []}
{"idx": 831, "sentence": "We hypothesize that the patient is heterozygous for a complete deficiency of C9 and for a gene directing hyposynthesis of a defective C0 .", "entities": [{"start": 9, "end": 13, "span": "complete deficiency of C9", "e_type": "Disease"}]}
{"idx": 832, "sentence": "We also suggest that C9 deficiency may be more common among Caucasians than has been reported . .", "entities": [{"start": 4, "end": 6, "span": "C9 deficiency", "e_type": "Disease"}]}
{"idx": 833, "sentence": "Screening for ESR mutations in breast and ovarian cancer patients .", "entities": [{"start": 5, "end": 9, "span": "breast and ovarian cancer", "e_type": "Disease"}]}
{"idx": 834, "sentence": "In the present study , leukocyte DNA from 0 patients with familial clustering of breast and / or ovarian cancer and tumour DNA from 0 breast carcinomas were screened for base mutations in the estrogen receptor gene ( ESR ) .", "entities": [{"start": 14, "end": 20, "span": "breast and / or ovarian cancer", "e_type": "Disease"}, {"start": 21, "end": 22, "span": "tumour", "e_type": "Disease"}, {"start": 25, "end": 27, "span": "breast carcinomas", "e_type": "Disease"}]}
{"idx": 835, "sentence": "Three patients with a family history of cancer were carrying a Gly000Cys germline substitution .", "entities": [{"start": 7, "end": 8, "span": "cancer", "e_type": "Disease"}]}
{"idx": 836, "sentence": "This alteration was also detected in eight ( four females and four males ) of 0 controls ( 0 female , 0 males ) , indicating that the substitution probably represents a polymorphism .", "entities": []}
{"idx": 837, "sentence": "However , in the 0 female controls in whom family history of cancer was known , one of two who had a sister with breast cancer was carrying the variant allele .", "entities": [{"start": 12, "end": 13, "span": "cancer", "e_type": "Disease"}, {"start": 24, "end": 26, "span": "breast cancer", "e_type": "Disease"}]}
{"idx": 838, "sentence": "Hence , a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated .", "entities": []}
{"idx": 839, "sentence": "Somatic mutations were not detected in any of the tumours studied , and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor - positive breast carcinomas . .", "entities": [{"start": 9, "end": 10, "span": "tumours", "e_type": "Disease"}, {"start": 34, "end": 40, "span": "estrogen receptor - positive breast carcinomas", "e_type": "Disease"}]}
{"idx": 840, "sentence": "Molecular bases of C7 deficiency : three different defects .", "entities": [{"start": 3, "end": 5, "span": "C7 deficiency", "e_type": "Disease"}]}
{"idx": 841, "sentence": "The molecular basis of C7 deficiency has been investigated in two Irish families and a number of Israeli families of Moroccan Sephardic Jewish origin .", "entities": [{"start": 4, "end": 6, "span": "C7 deficiency", "e_type": "Disease"}]}
{"idx": 842, "sentence": "Exon PCR and sequencing revealed a heterozygous point mutation at the 0 splice acceptor site of intron 0 in one Irish family .", "entities": []}
{"idx": 843, "sentence": "In the other Irish family , exons 0 and 0 failed to amplify and they were shown to be deleted .", "entities": []}
{"idx": 844, "sentence": "Marker haplotype studies of the C0 and C0 gene region and Southern blots show that the Irish family with the splice defect also segregate for the deletion , which is not easily detected in heterozygotes .", "entities": []}
{"idx": 845, "sentence": "The Israeli C7 - deficient cases all share a C0 haplotype and are homozygous for a mis - sense mutation in exon 0 .", "entities": [{"start": 2, "end": 5, "span": "C7 - deficient", "e_type": "Disease"}]}
{"idx": 846, "sentence": "However , one individual is heterozygous for markers at adjacent C0 loci , showing that there has been an intergenic recombination and suggesting that the deficiency mutation is of appreciable antiquity . .", "entities": []}
{"idx": 847, "sentence": "Molecular heterogeneity of classical and Duarte galactosemia : mutation analysis by denaturing gradient gel electrophoresis .", "entities": [{"start": 3, "end": 7, "span": "classical and Duarte galactosemia", "e_type": "Disease"}]}
{"idx": 848, "sentence": "Classical galactosemia is caused by one common missense mutation ( Q000R ) and by several rare mutations in the galactose - 0 - phosphate uridyltransferase ( GALT ) gene .", "entities": [{"start": 0, "end": 2, "span": "Classical galactosemia", "e_type": "Disease"}]}
{"idx": 849, "sentence": "The most common variant of GALT , the Duarte variant , occurs as two types , Duarte - 0 ( D - 0 ) and Duarte - 0 ( D - 0 ) , both of which carry the sequence change N000D .", "entities": []}
{"idx": 850, "sentence": "D - 0 increases , whereas D - 0 decreases GALT activity .", "entities": []}
{"idx": 851, "sentence": "To study the molecular genetics of classical and Duarte galactosemia , we analyzed the GALT mutations in 0 families with classical galactosemia , in 0 families with the D - 0 variant and in 0 individuals carrying the D - 0 allele by denaturing gradient gel electrophoresis ( DGGE ) .", "entities": [{"start": 6, "end": 10, "span": "classical and Duarte galactosemia", "e_type": "Disease"}, {"start": 20, "end": 22, "span": "classical galactosemia", "e_type": "Disease"}]}
{"idx": 852, "sentence": "DGGE detected 0 of the 0 classical galactosemia alleles .", "entities": [{"start": 7, "end": 8, "span": "galactosemia", "e_type": "Disease"}]}
{"idx": 853, "sentence": "Q000R accounted for 0 % , K000N accounted for 0 % of these alleles .", "entities": []}
{"idx": 854, "sentence": "Eight novel candidate galactosemia mutations were found .", "entities": [{"start": 3, "end": 4, "span": "galactosemia", "e_type": "Disease"}]}
{"idx": 855, "sentence": "On all D - 0 alleles N000D occurred in cis with two intronic sequence changes , on the D - 0 alleles in cis with a neutral mutation in exon 0 .", "entities": []}
{"idx": 856, "sentence": "We conclude that the mutations causing galactosemia are highly heterogeneous and that K000N is a second common galactosemia mutation in our population . .", "entities": [{"start": 6, "end": 7, "span": "galactosemia", "e_type": "Disease"}, {"start": 17, "end": 18, "span": "galactosemia", "e_type": "Disease"}]}
{"idx": 857, "sentence": "Isolation of full - length ATM cDNA and correction of the ataxia - telangiectasia cellular phenotype .", "entities": [{"start": 11, "end": 14, "span": "ataxia - telangiectasia", "e_type": "Disease"}]}
{"idx": 858, "sentence": "A gene mutated in the human genetic disorder ataxia - telangiectasia ( A - T ) , ATM , was recently identified by positional cloning .", "entities": [{"start": 6, "end": 8, "span": "genetic disorder", "e_type": "Disease"}, {"start": 8, "end": 11, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 12, "end": 15, "span": "A - T", "e_type": "Disease"}]}
{"idx": 859, "sentence": "ATM is a member of the phosphatidylinositol - 0 - kinase superfamily , some of which are protein kinases and appear to have important roles in cell cycle control and radiation signal transduction .", "entities": []}
{"idx": 860, "sentence": "We describe herein , to our knowledge , for the first time , the cloning of a full - length cDNA for ATM and correction of multiple aspects of the radio - sensitive phenotype of A - T cells by transfection with this cDNA .", "entities": [{"start": 35, "end": 38, "span": "A - T", "e_type": "Disease"}]}
{"idx": 861, "sentence": "Overexpression of ATM cDNA in A - T cells enhanced the survival of these cells in response to radiation exposure , decreased radiation - induced chromosome aberrations , reduced radio - resistant DNA synthesis , and partially corrected defective cell cycle checkpoints and induction of stress - activated protein kinase .", "entities": [{"start": 5, "end": 8, "span": "A - T", "e_type": "Disease"}]}
{"idx": 862, "sentence": "This correction of the defects in A - T cells provides further evidence of the multiplicity of effector functions of the ATM protein and suggests possible approaches to gene therapy . .", "entities": [{"start": 6, "end": 9, "span": "A - T", "e_type": "Disease"}]}
{"idx": 863, "sentence": "Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene - specific mechanisms in alveolar rhabdomyosarcoma .", "entities": [{"start": 15, "end": 17, "span": "alveolar rhabdomyosarcoma", "e_type": "Disease"}]}
{"idx": 864, "sentence": "Chromosomal translocations identified in hematopoietic and solid tumors result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential .", "entities": [{"start": 4, "end": 8, "span": "hematopoietic and solid tumors", "e_type": "Disease"}]}
{"idx": 865, "sentence": "In the pediatric solid tumor alveolar rhabdomyosarcoma , a consistent t ( 0 ; 0 ) ( q00 ; q00 ) or variant t ( 0 ; 0 ) ( p00 ; q00 ) translocation generates PAX0 - FKHR or PAX0 - FKHR fusion proteins , respectively .", "entities": [{"start": 3, "end": 5, "span": "solid tumor", "e_type": "Disease"}, {"start": 5, "end": 7, "span": "alveolar rhabdomyosarcoma", "e_type": "Disease"}]}
{"idx": 866, "sentence": "In this report , we demonstrate that in addition to functional alterations these translocations are associated with fusion product overexpression .", "entities": []}
{"idx": 867, "sentence": "Furthermore , PAX0 - FKHR and PAX0 - FKHR overexpression occurs by distinct mechanisms .", "entities": []}
{"idx": 868, "sentence": "Transcription of PAX0 - FKHR is increased relative to wild - type PAX0 by a copy number - independent process .", "entities": []}
{"idx": 869, "sentence": "In contrast , PAX0 - FKHR overexpression results from fusion gene amplification .", "entities": []}
{"idx": 870, "sentence": "Thus , gene - specific mechanisms were selected to overexpress PAX0 - FKHR and PAX0 - FKHR in alveolar rhabdomyosarcoma , presumably due to differences in regulation between the wild - type loci .", "entities": [{"start": 18, "end": 20, "span": "alveolar rhabdomyosarcoma", "e_type": "Disease"}]}
{"idx": 871, "sentence": "We postulate that these overexpression mechanisms ensure a critical level of gene product for the oncogenic effects of these fusions . .", "entities": []}
{"idx": 872, "sentence": "atm and p00 cooperate in apoptosis and suppression of tumorigenesis , but not in resistance to acute radiation toxicity .", "entities": [{"start": 16, "end": 19, "span": "acute radiation toxicity", "e_type": "Disease"}]}
{"idx": 873, "sentence": "Mutations in atm and p00 cause the human cancer - associated diseases ataxia - telangiectasia and Li - Fraumeni syndrome , respectively .", "entities": [{"start": 8, "end": 12, "span": "cancer - associated diseases", "e_type": "Disease"}, {"start": 12, "end": 15, "span": "ataxia - telangiectasia", "e_type": "Disease"}, {"start": 16, "end": 20, "span": "Li - Fraumeni syndrome", "e_type": "Disease"}]}
{"idx": 874, "sentence": "The two genes are believed to interact in a number of pathways , including regulation of DNA damage - induced cell - cycle checkpoints , apoptosis and radiation sensitivity , and cellular proliferation .", "entities": []}
{"idx": 875, "sentence": "Atm - null mice , as well as those null for p00 , develop mainly T - cell lymphomas , supporting the view that these genes have similar roles in thymocyte development .", "entities": [{"start": 15, "end": 19, "span": "T - cell lymphomas", "e_type": "Disease"}]}
{"idx": 876, "sentence": "To study the interactions of these two genes on an organismal level , we bred mice heterozygous for null alleles of both atm and p00 to produce all genotypic combinations .", "entities": []}
{"idx": 877, "sentence": "Mice doubly null for atm and p00 exhibited a dramatic acceleration of tumour formation relative to singly null mice , indicating that both genes collaborate in a significant manner to prevent tumorigenesis .", "entities": [{"start": 12, "end": 13, "span": "tumour", "e_type": "Disease"}]}
{"idx": 878, "sentence": "With respect to their roles in apoptosis , loss of atm rendered thymocytes only partly resistant to irradiation - induced apoptosis , whereas additional loss of p00 engendered complete resistance .", "entities": []}
{"idx": 879, "sentence": "This implies that the irradiation - induced atm and p00 apoptotic pathways are not completely congruent .", "entities": []}
{"idx": 880, "sentence": "Finally - and in contrast to prior predictions - atm and p00 do not appear to interact in acute radiation toxicity , suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours . .", "entities": [{"start": 18, "end": 21, "span": "acute radiation toxicity", "e_type": "Disease"}, {"start": 43, "end": 44, "span": "tumours", "e_type": "Disease"}]}
{"idx": 881, "sentence": "Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP .", "entities": [{"start": 5, "end": 7, "span": "myotonic dystrophy", "e_type": "Disease"}]}
{"idx": 882, "sentence": "Myotonic dystrophy , or dystrophia myotonica ( DM ) , is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 0 untranslated region of the DMPK protein kinase gene on chromosome 00q00 .", "entities": [{"start": 0, "end": 2, "span": "Myotonic dystrophy", "e_type": "Disease"}, {"start": 4, "end": 6, "span": "dystrophia myotonica", "e_type": "Disease"}, {"start": 7, "end": 8, "span": "DM", "e_type": "Disease"}, {"start": 12, "end": 16, "span": "autosomal dominant multisystem disorder", "e_type": "Disease"}]}
{"idx": 883, "sentence": "0 ( refs 0 - 0 ) .", "entities": []}
{"idx": 884, "sentence": "Although the DM mutation was identified more than five years ago , the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive .", "entities": [{"start": 2, "end": 3, "span": "DM", "e_type": "Disease"}, {"start": 23, "end": 25, "span": "neuromuscular disease", "e_type": "Disease"}]}
{"idx": 885, "sentence": "Previous work from our laboratory demonstrated that a DNase l - hypersensitive site located adjacent to the repeats on the wild - type allele is eliminated by repeat expansion , indicating that large CTG - repeat arrays may be associated with a local chromatin environment that represses gene expression .", "entities": []}
{"idx": 886, "sentence": "Here we report that the hypersensitive site contains an enhancer element that regulates transcription of the adjacent DMAHP homeobox gene .", "entities": []}
{"idx": 887, "sentence": "Analysis of DMAHP expression in the cells of DM patients with loss of the hypersensitive site revealed a two - to fourfold reduction in steady - state DMAHP transcript levels relative to wild - type controls .", "entities": [{"start": 8, "end": 9, "span": "DM", "e_type": "Disease"}]}
{"idx": 888, "sentence": "Allele - specific analysis of DMAHP expression showed that steady - state transcript levels from the expanded allele were greatly reduced in comparison to those from the wild - type allele .", "entities": []}
{"idx": 889, "sentence": "Together , these results demonstrate that CTG - repeat expansions can suppress local gene expression and implicate DMAHP in DM pathogenesis .", "entities": [{"start": 19, "end": 20, "span": "DM", "e_type": "Disease"}]}
{"idx": 890, "sentence": "Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene ( RB0 ) .", "entities": [{"start": 10, "end": 11, "span": "retinoblastoma", "e_type": "Disease"}]}
{"idx": 891, "sentence": "A wide spectrum of mutations , ranging from point mutations to large deletions , have been described in the retinoblastoma gene ( RB0 ) .", "entities": [{"start": 19, "end": 20, "span": "retinoblastoma", "e_type": "Disease"}]}
{"idx": 892, "sentence": "Mutations have been found throughout the gene ; however , these genetic alterations do not appear to be homogeneously distributed .", "entities": []}
{"idx": 893, "sentence": "In particular , a significant proportion of disease - causing mutations results in the premature termination of protein synthesis , and the majority of these mutations occur as C - - > T transitions at CpG dinucleotides ( CpGs ) .", "entities": []}
{"idx": 894, "sentence": "Such recurrent CpG mutations , including those found in RB0 , are likely the result of the deamination of 0 - methylcytosine within these CpGs .", "entities": []}
{"idx": 895, "sentence": "In the present study , we used the sodiumbisulfite conversion method to detect cytosine methylation in representative exons of RB0 .", "entities": []}
{"idx": 896, "sentence": "We analyzed DNA from a variety of tissues and specifically targeted CGA codons in RB0 , where recurrent premature termination mutations have been reported .", "entities": []}
{"idx": 897, "sentence": "We found that DNA methylation within RB0 exons 0 , 0 , 0 , and 0 appeared to be restricted to CpGs , including six CGA codons .", "entities": []}
{"idx": 898, "sentence": "Other codons containing methylated cytosines have not been reported to be mutated .", "entities": []}
{"idx": 899, "sentence": "Therefore , disease - causing mutations at CpGs in RB0 appear to be determined by several factors , including the constitutive presence of DNA methylation at cytosines within CpGs , the specific codon within which the methylated cytosine is located , and the particular region of the gene within which that codon resides . .", "entities": []}
{"idx": 900, "sentence": "The von Hippel - Lindau tumor suppressor gene product interacts with Sp0 to repress vascular endothelial growth factor promoter activity .", "entities": [{"start": 1, "end": 6, "span": "von Hippel - Lindau tumor", "e_type": "Disease"}]}
{"idx": 901, "sentence": "The von Hippel - Lindau tumor suppressor gene ( VHL ) has a critical role in the pathogenesis of clear - cell renal cell carcinoma ( RCC ) , as VHL mutations have been found in both von Hippel - Lindau disease - associated and sporadic RCCs .", "entities": [{"start": 1, "end": 6, "span": "von Hippel - Lindau tumor", "e_type": "Disease"}, {"start": 19, "end": 25, "span": "clear - cell renal cell carcinoma", "e_type": "Disease"}, {"start": 26, "end": 27, "span": "RCC", "e_type": "Disease"}, {"start": 37, "end": 47, "span": "von Hippel - Lindau disease - associated and sporadic RCCs", "e_type": "Disease"}]}
{"idx": 902, "sentence": "Recent studies suggest that vascular endothelial growth factor ( VEGF ) mRNA is upregulated in RCC - and von Hippel - Lindau disease - associated tumors .", "entities": [{"start": 15, "end": 26, "span": "RCC - and von Hippel - Lindau disease - associated tumors", "e_type": "Disease"}]}
{"idx": 903, "sentence": "We have therefore assessed the effect of the VHL gene product on VEGF expression .", "entities": []}
{"idx": 904, "sentence": "VEGF promoter - luciferase constructs were transiently cotransfected with a wild - type VHL ( wt - VHL ) vector in several cell lines , including 0 embryonic kidney and RCC cell lines .", "entities": [{"start": 30, "end": 31, "span": "RCC", "e_type": "Disease"}]}
{"idx": 905, "sentence": "wt - VHL protein inhibited VEGF promoter activity in a dose - dependent manner up to 0 - to 0 - fold .", "entities": []}
{"idx": 906, "sentence": "Deletion analysis defined a 0 - bp region of the VEGF promoter necessary for VHL repression .", "entities": []}
{"idx": 907, "sentence": "This VHL - responsive element is GC rich and specifically binds the transcription factor Sp0 in crude nuclear extracts .", "entities": []}
{"idx": 908, "sentence": "In Drosophila cells , cotransfected VHL represses Sp0 - mediated activation but not basal activity of the VEGF promoter .", "entities": []}
{"idx": 909, "sentence": "We next demonstrated in coimmunoprecipitates that VHL and Sp0 were part of the same complex and , by using a glutathione - S - transferase - VHL fusion protein and purified Sp0 , that VHL and Sp0 directly interact .", "entities": []}
{"idx": 910, "sentence": "Furthermore , endogenous VEGF mRNA levels were suppressed in permanent RCC cell lines expressing wt - VHL , and nuclear run - on studies indicated that VHL regulation of VEGF occurs at least partly at the transcriptional level .", "entities": [{"start": 10, "end": 11, "span": "RCC", "e_type": "Disease"}]}
{"idx": 911, "sentence": "These observations support a new mechanism for VHL - mediated transcriptional repression via a direct inhibitory action on Sp0 and suggest that loss of Sp0 inhibition may be important in the pathogenesis of von Hippel - Lindau disease and RCC . .", "entities": [{"start": 33, "end": 38, "span": "von Hippel - Lindau disease", "e_type": "Disease"}, {"start": 39, "end": 40, "span": "RCC", "e_type": "Disease"}]}
{"idx": 912, "sentence": "Adult onset globoid cell leukodystrophy ( Krabbe disease ) : analysis of galactosylceramidase cDNA from four Japanese patients .", "entities": [{"start": 0, "end": 5, "span": "Adult onset globoid cell leukodystrophy", "e_type": "Disease"}, {"start": 6, "end": 8, "span": "Krabbe disease", "e_type": "Disease"}]}
{"idx": 913, "sentence": "We examined galactosylceramidase ( GALC ) cDNA in four Japanese patients with adult onset globoid cell leukodystrophy ( Krabbe disease ; AO - GLD ) by polymerase chain reaction / single - strand conformation polymorphism ( PCR - SSCP ) analysis , subsequent sequence determination , and restriction enzyme digestion of PCR products , initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade , and all patients had diminished GALC activity in their leukocytes .", "entities": [{"start": 12, "end": 17, "span": "adult onset globoid cell leukodystrophy", "e_type": "Disease"}, {"start": 18, "end": 20, "span": "Krabbe disease", "e_type": "Disease"}, {"start": 21, "end": 24, "span": "AO - GLD", "e_type": "Disease"}, {"start": 62, "end": 64, "span": "spastic paraplegia", "e_type": "Disease"}, {"start": 76, "end": 79, "span": "diminished GALC activity", "e_type": "Disease"}]}
{"idx": 914, "sentence": "We identified three missense mutations ( I00M , G000D , L000S ) and one exon - 0 skipping ( 0 - 000del ) .", "entities": []}
{"idx": 915, "sentence": "Two of the patients had only the I00M mutant mRNA , and one only the G00OD mutant mRNA .", "entities": []}
{"idx": 916, "sentence": "The fourth patient carried a compound heterozygous mutation of 0 - 000del and L000S .", "entities": []}
{"idx": 917, "sentence": "To determine the enzymatic activities produced by these mutations , we constructed mutated GALC cDNAs and expressed them in COS - 0 cells .", "entities": []}
{"idx": 918, "sentence": "Three mutations , viz . , G000D , L000S , and exon - 0 skipping ( 0 - 000del ) , produced diminished GALC activity as expected .", "entities": [{"start": 22, "end": 25, "span": "diminished GALC activity", "e_type": "Disease"}]}
{"idx": 919, "sentence": "The I00M mutation in the wild - type GALC cDNA ( I000 ) had normal activity , but when this mutation and the V000 polymorphism were introduced into the same allele , it had decreased activity .", "entities": []}
{"idx": 920, "sentence": "Thus , the combination of a unique mutation and polymorphism causes conformational change in the GALC enzyme , resulting in low enzymatic activity .", "entities": []}
{"idx": 921, "sentence": "AO - GLD mutations , including those found here , are located in the N - terminus ( I00M , G000D , 0 - 000del ) or C - terminus ( L000S ) of the GALC enzyme , whereas the reported mutations in the infantile form ( IF - GLD ) are in the central domain .", "entities": [{"start": 0, "end": 3, "span": "AO - GLD", "e_type": "Disease"}, {"start": 47, "end": 50, "span": "IF - GLD", "e_type": "Disease"}]}
{"idx": 922, "sentence": "This difference in mutation sites may affect the clinical features of GLD .", "entities": [{"start": 11, "end": 12, "span": "GLD", "e_type": "Disease"}]}
